Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
GRCh38/hg38 19p13.2-q13.31(chr19:11227942-44626354)x3	ABHD8|ACP5|ACP7|ACTMAP|ACTN4|ADGRE2|ADGRE3|ADGRE5|ADGRL1|ADGRL1-AS1|AKAP8|AKAP8L|AKT2|ALKBH6|ANGPTL8|ANKLE1|ANKRD27|ANO8|AP1M1|APLP1|ARHGAP33|ARHGEF1|ARMC6|ARRDC2|ASF1B|ATP13A1|ATP1A3|ATP4A|AXL|B3GNT3|LOC129391076|LOC129391077|LOC129391078|LOC129391079|LOC129391080|LOC129391081|LOC129391082|LOC129391083|LOC129391084|LOC129391085|LOC129391086|LOC129391087|LOC129391088|LOC129391089|LOC129391090|LOC129391091|LOC129391092|LOC129391093|LOC129391094|LOC129391095|LOC129391096|LOC129391097|LOC129391098|LOC129391099|LOC129391100|LOC129391101|LOC129391102|LOC129391103|LOC129391104|LOC129391105|LOC129391106|LOC129391107|LOC129391108|LOC129391109|LOC129391110|LOC129391111|LOC129391112|LOC129391113|LOC129391114|LOC129391115|LOC129391116|LOC129391117|LOC129391118|LOC129391119|LOC129391120|LOC130063559|LOC130063560|LOC130063561|LOC130063562|LOC130063563|LOC130063564|LOC130063565|LOC130063566|LOC130063567|LOC130063568|LOC130063569|LOC130063570|LOC130063571|LOC130063572|LOC130063573|LOC130063574|LOC130063575|LOC130063576|LOC130063577|LOC130063578|LOC130063579|LOC130063580|LOC130063581|LOC130063582|LOC130063583|LOC130063584|LOC130063585|LOC130063586|LOC130063587|LOC130063588|LOC130063589|LOC130063590|LOC130063591|LOC130063592|LOC130063593|LOC130063594|LOC130063595|LOC130063596|LOC130063597|LOC130063598|LOC130063599|LOC130063600|LOC130063601|LOC130063602|LOC130063603|LOC130063604|LOC130063605|LOC130063606|LOC130063607|LOC130063608|LOC130063609|LOC130063610|LOC130063611|LOC130063612|LOC130063613|LOC130063614|LOC130063615|LOC130063616|LOC130063617|LOC130063618|LOC130063619|LOC130063620|LOC130063621|LOC130063622|LOC130063623|LOC130063624|LOC130063625|LOC130063626|LOC130063627|LOC130063628|LOC130063629|LOC130063630|LOC130063631|LOC130063632|LOC130063633|LOC130063634|LOC130063635|LOC130063636|LOC130063637|LOC130063638|LOC130063639|LOC130063640|LOC130063641|LOC130063642|LOC130063643|LOC130063644|LOC130063645|LOC130063646|LOC130063647|LOC130063648|LOC130063649|LOC130063650|LOC130063651|LOC130063652|LOC130063653|LOC130063654|LOC130063655|LOC130063656|LOC130063657|LOC130063658|LOC130063659|LOC130063660|LOC130063661|LOC130063662|LOC130063663|LOC130063664|LOC130063665|LOC130063666|LOC130063667|LOC130063668|LOC130063669|LOC130063670|LOC130063671|LOC130063672|LOC130063673|LOC130063674|LOC130063675|LOC130063676|LOC130063677|LOC130063678|LOC130063679|LOC130063680|LOC130063681|LOC130063682|LOC130063683|LOC130063684|LOC130063685|LOC130063686|LOC130063687|LOC130063688|LOC130063689|LOC130063690|LOC130063691|LOC130063692|LOC130063693|LOC130063694|LOC130063695|LOC130063696|LOC130063697|LOC130063698|LOC130063699|LOC130063700|LOC130063701|LOC130063702|LOC130063703|LOC130063704|LOC130063705|LOC130063706|LOC130063707|LOC130063708|LOC130063709|LOC130063710|LOC130063711|LOC130063712|LOC130063713|LOC130063714|LOC130063715|LOC130063716|LOC130063717|LOC130063718|LOC130063719|LOC130063720|LOC130063721|LOC130063722|LOC130063723|LOC130063724|LOC130063725|LOC130063726|LOC130063727|LOC130063728|LOC130063729|LOC130063730|LOC130063731|LOC130063732|LOC130063733|LOC130063734|LOC130063735|LOC130063736|LOC130063737|LOC130063738|LOC130063739|LOC130063740|LOC130063741|LOC130063742|LOC130063743|LOC130063744|LOC130063745|LOC130063746|LOC130063747|LOC130063748|LOC130063749|LOC130063750|LOC130063751|LOC130063752|LOC130063753|LOC130063754|LOC130063755|LOC130063756|LOC130063757|LOC130063758|LOC130063759|LOC130063760|LOC130063761|LOC130063762|LOC130063763|LOC130063764|LOC130063765|LOC130063766|LOC130063767|LOC130063768|LOC130063769|LOC130063770|LOC130063771|LOC130063772|LOC130063773|LOC130063774|LOC130063775|LOC130063776|LOC130063777|LOC130063778|LOC130063779|LOC130063780|LOC130063781|LOC130063782|LOC130063783|LOC130063784|LOC130063785|LOC130063786|LOC130063787|LOC130063788|LOC130063789|LOC130063790|LOC130063791|LOC130063792|LOC130063793|LOC130063794|LOC130063795|LOC130063796|LOC130063797|LOC130063798|LOC130063799|LOC130063800|LOC130063801|LOC130063802|LOC130063803|LOC130063804|LOC130063805|LOC130063806|LOC130063807|LOC130063808|LOC130063809|LOC130063810|LOC130063811|LOC130063812|LOC130063813|LOC130063814|LOC130063815|LOC130063816|LOC130063817|LOC130063818|LOC130063819|LOC130063820|LOC130063821|LOC130063822|LOC130063823|LOC130063824|LOC130063825|LOC130063826|LOC130063827|LOC130063828|LOC130063829|LOC130063830|LOC130063831|LOC130063832|LOC130063833|LOC130063834|LOC130063835|LOC130063836|LOC130063837|LOC130063838|LOC130063839|LOC130063840|LOC130063841|LOC130063842|LOC130063843|LOC130063844|LOC130063845|LOC130063846|LOC130063847|LOC130063848|LOC130063849|LOC130063850|LOC130063851|LOC130063852|LOC130063853|LOC130063854|LOC130063855|LOC130063856|LOC130063857|LOC130063858|LOC130063859|LOC130063860|LOC130063861|LOC130063862|LOC130063863|LOC130063864|LOC130063865|LOC130063866|LOC130063867|LOC130063868|LOC130063869|LOC130063870|LOC130063871|LOC130063872|LOC130063873|LOC130063874|LOC130063875|LOC130063876|LOC130063877|LOC130063878|LOC130063879|LOC130063880|LOC130063881|LOC130063882|LOC130063883|LOC130063884|LOC130063885|LOC130063886|LOC130063887|LOC130063888|LOC130063889|LOC130063890|LOC130063891|LOC130063892|LOC130063893|LOC130063894|LOC130063895|LOC130063896|LOC130063897|LOC130063898|LOC130063899|LOC130063900|LOC130063901|LOC130063902|LOC130063903|LOC130063904|LOC130063905|LOC130063906|LOC130063907|LOC130063908|LOC130063909|LOC130063910|LOC130063911|LOC130063912|LOC130063913|LOC130063914|LOC130063915|LOC130063916|LOC130063917|LOC130063918|LOC130063919|LOC130063920|LOC130063921|LOC130063922|LOC130063923|LOC130063924|LOC130063925|LOC130063926|LOC130063927|LOC130063928|LOC130063929|LOC130063930|LOC130063931|LOC130063932|LOC130063933|LOC130063934|LOC130063935|LOC130063936|LOC130063937|LOC130063938|LOC130063939|LOC130063940|LOC130063941|LOC130063942|LOC130063943|LOC130063944|LOC130063945|LOC130063946|LOC130063947|LOC130063948|LOC130063949|LOC130063950|LOC130063951|LOC130063952|LOC130063953|LOC130063954|LOC130063955|LOC130063956|LOC130063957|LOC130063958|LOC130063959|LOC130063960|LOC130063961|LOC130063962|LOC130063963|LOC130063964|LOC130063965|LOC130063966|LOC130063967|LOC130063968|LOC130063969|LOC130063970|LOC130063971|LOC130063972|LOC130063973|LOC130063974|LOC130063975|LOC130063976|LOC130063977|LOC130063978|LOC130063979|LOC130063980|LOC130063981|LOC130063982|LOC130063983|LOC130063984|LOC130063985|LOC130063986|LOC130063987|LOC130063988|LOC130063989|LOC130063990|LOC130063991|LOC130063992|LOC130063993|LOC130063994|LOC130063995|LOC130063996|LOC130063997|LOC130063998|LOC130063999|LOC130064000|LOC130064001|LOC130064002|LOC130064003|LOC130064004|LOC130064005|LOC130064006|LOC130064007|LOC130064008|LOC130064009|LOC130064010|LOC130064011|LOC130064012|LOC130064013|LOC130064014|LOC130064015|LOC130064016|LOC130064017|LOC130064018|LOC130064019|LOC130064020|LOC130064021|LOC130064022|LOC130064023|LOC130064024|LOC130064025|LOC130064026|LOC130064027|LOC130064028|LOC130064029|LOC130064030|LOC130064031|LOC130064544|LOC130064545|LOC130064546|LOC130064547|LOC130064548|LOC130064549|LOC130064550|LOC130064551|LOC130064552|LOC130064553|LOC130064554|LOC130064555|LOC130064556|LOC130064557|LOC130064558|LOC130064559|LOC130064560|LOC130064561|LOC130064562|LOC130064563|LOC130064564|LOC130064565|LOC130064566|LOC130064567|LOC130064568|LOC130064569|LOC130064570|LOC130064571|LOC130064572|LOC130064573|LOC130064574|LOC130064575|LOC130064576|LOC130064577|LOC130064578|LOC130064579|LOC130064580|LOC130064581|LOC130064582|LOC130064583|LOC130064584|LOC130064585|LOC130064586|LOC130064587|LOC130064588|LOC130064589|LOC130064590|LOC130064591|LOC130064592|LOC130064593|LOC130064594|LOC130064595|LOC130064596|LOC130064597|LOC130064598|LOC130064599|LOC130064600|LOC130064601|LOC130064602|LOC130064603|LOC130064604|LOC130064605|LOC130064606|LOC130064607|LOC130064608|LOC130064609|LOC130064610|LOC130064611|LOC130064612|LOC130064613|LOC130064614|LOC130064615|LOC130064616|LOC130064617|LOC130064618|LOC130064619|LOC130064620|LOC130064621|LOC130064622|LOC130064623|LOC130064624|LOC130064625|LOC130064626|LOC130064627|LOC130064628|LOC130064629|LOC130064630|LOC130064631|LOC130064632|LOC130064633|LOC130064634|LOC132090533|LOC132090534|LOC132090535|LOC132090536|LOC132090537|LOC132090538|LOC132090539|LOC132090540|LOC132090541|LOC132090542|LOC132090543|LOC132090544|LOC132090545|LOC132090546|LOC132090547|LOC132090548|LOC132090549|LOC132090550|LOC132090904|LOC132090905|LOC132090906|LOC132090907|LOC132090908|LOC132090909|LOC284344|LOC284412|LOC644554|LOC728485|LPAR2|LRFN1|LRFN3|LRP3|LRRC25|LSM14A|LSM4|LSR|LTBP4|LYL1|LYPD3|LYPD4|LYPD5|MAG|MAN2B1|MAP1S|MAP3K10|MAP4K1|MAP4K1-AS1|MAST1|MAST3|MAU2|MED26|MED29|MEF2B|MEGF8|MIA|MIA-RAB4B|MIR1199|MIR1270|MIR1470|MIR181C|MIR181D|MIR23A|MIR23AHG|MIR24-2|MIR27A|MIR3188|MIR3189|MIR4323|MIR4530|MIR5196|MIR5684|MIR5695|MIR639|MIR640|MIR641|MIR6515|MIR6719|MIR6794|MIR6795|MIR6796|MIR6797|MIR6887|MIR7974|MIR8077|MISP3|MPV17L2|MRI1|MRPL34|MRPS12|MVB12A|MYO9B|NACC1|NANOS3|NCAN|NCCRP1|NDUFA13|NDUFB7|NFIX|NFKBIB|NFKBID|NIBAN3|NOTCH3|NPHS1|NR2C2AP|NR2F6|NUDT19|NUDT19-DT|NUMBL|NWD1|NXNL1|OCEL1|ODAD3|OR10H1|OR10H2|OR10H3|OR10H4|OR10H5|OR1I1|OR7A10|OR7A17|OR7A5|OR7C1|OR7C2|OVOL3|PAF1|PAFAH1B3|PAK4|PALM3|PBX4|PCAT19|PDCD2L|PDCD5|PDE4C|PEPD|PGLS|PGLS-DT|PGLYRP2|PGPEP1|PHLDB3|PIK3R2|PINLYP|PKN1|PLAUR|PLD3|PLEKHF1|PLEKHG2|PLPPR2|PLVAP|PMIS2|PODNL1|POLR2I|POP4|POU2F2|POU2F2-AS2|PPP1R14A|PRDX2|PRG1|PRKACA|PRKCSH|PRODH2|PROSER3|PRR19|PRX|PSENEN|PSG1|PSG11|PSG11-AS1|PSG2|PSG3|PSG4|PSG5|PSG6|PSG7|PSG8|PSG8-AS1|PSG9|PSMC4|PSMD8|PTGER1|RAB3A|RAB3D|RAB4B|RAB4B-EGLN2|RAB8A|RABAC1|RAD23A|RASAL3|RASGRP4|RBM42|REX1BD|RFX1|RFXANK|RGL3|RGS9BP|RHPN2|RINL|RLN3|RNASEH2A|RPL18A|RPS16|RPS19|RPSA2|RTBDN|RYR1|SAMD1|SAMD4B|SARS2|SBSN|SCGB2B2|SCN1B|SDHAF1|SELENOV|SERTAD1|SERTAD3|SERTAD3-AS1|SHKBP1|SIN3B|SIPA1L3|SIRT2|SLC1A6|SLC25A42|SLC27A1|SLC35E1|SLC5A5|SLC7A10|SLC7A9|SMG9|SMIM46|SMIM7|SNORA104|SNORA118|SNORA68|SNORA68B|SNORD135|SNORD152|SNORD175|SNORD41|SNRPA|SPINT2|SPRED3|SPTBN4|SRRM5|SSBP4|STX10|SUGP1|SUGP2|SUNO1|SUPT5H|SWSAP1|SYCE2|SYCN|SYDE1|SYNE4|TBCB|TDRD12|TECR|TEKTL1|TEX101|TGFB1|THAP8|THSD8|TIMM50|TM6SF2|TMEM145|TMEM147|TMEM147-AS1|TMEM161A|TMEM205|TMEM221|TMEM38A|TMEM59L|TMEM91|TNPO2|TPM4|TRI-TAT1-1|TRIR|TRMT1|TRT-AGT1-3|TSHZ3|TSPAN16|TSSK6|TTC9B|TYROBP|U2AF1L4|UBA2|UBA52|UCA1|UCA1-AS1|UNC13A|UPF1|UPK1A|UPK1A-AS1|UQCRFS1|UQCRFS1-DT|URI1|USE1|USF2|USHBP1|VSTM2B|VSTM2B-DT|WDR62|WDR83|WDR83OS|WDR87|WDR87BP|WDR88|WIZ|WTIP|XRCC1|YIF1B|YJEFN3|YJU2B|ZBTB32|ZFP14|ZFP30|ZFP36|ZFP82|ZNF100|ZNF101|ZNF112|ZNF136|ZNF14|ZNF146|ZNF155|ZNF180|ZNF181|ZNF20|ZNF208|ZNF221|ZNF222|ZNF222-DT|ZNF223|ZNF224|ZNF225|ZNF225-AS1|ZNF226|ZNF227|ZNF229|ZNF230|ZNF230-DT|ZNF233|ZNF234|ZNF235|ZNF253|ZNF254|ZNF257|ZNF260|ZNF283|ZNF284|ZNF285|ZNF30|ZNF30-AS1|ZNF302|ZNF333|ZNF345|ZNF382|ZNF383|ZNF404|ZNF420|ZNF428|ZNF429|ZNF43|ZNF430|ZNF431|ZNF433|ZNF433-AS1|ZNF439|ZNF44|ZNF440|ZNF441|ZNF442|ZNF443|ZNF45|ZNF45-AS1|ZNF461|ZNF486|ZNF490|ZNF491|ZNF492|ZNF493|ZNF506|ZNF507|ZNF526|ZNF527|ZNF529|ZNF529-AS1|ZNF536|ZNF540|ZNF546|ZNF563|ZNF564|ZNF565|ZNF566|ZNF566-AS1|ZNF567|ZNF567-DT|ZNF568|ZNF569|ZNF570|ZNF571|ZNF571-AS1|ZNF573|ZNF574|ZNF575|ZNF576|ZNF585A|ZNF585B|ZNF599|ZNF607|ZNF625|ZNF625-ZNF20|ZNF626|ZNF627|ZNF653|ZNF66|ZNF675|ZNF676|ZNF681|ZNF682|ZNF69|ZNF700|ZNF708|ZNF709|ZNF714|ZNF723|ZNF724|ZNF726|ZNF728|ZNF729|ZNF730|ZNF737|ZNF738|ZNF763|ZNF780A|ZNF780B|ZNF781|ZNF790|ZNF790-AS1|ZNF791|ZNF792|ZNF793|LOC130064032|LOC130064033|LOC130064034|LOC130064035|LOC130064036|LOC130064037|LOC130064038|LOC130064039|LOC130064040|LOC130064041|LOC130064042|LOC130064043|LOC130064044|LOC130064045|LOC130064046|LOC130064047|LOC130064048|LOC130064049|LOC130064050|LOC130064051|LOC130064052|LOC130064053|LOC130064054|LOC130064055|LOC130064056|LOC130064057|LOC130064058|LOC130064059|LOC130064060|LOC130064061|LOC130064062|LOC130064063|LOC130064064|LOC130064065|LOC130064066|LOC130064067|LOC130064068|LOC130064069|LOC130064070|LOC130064071|LOC130064072|LOC130064073|LOC130064074|LOC130064075|LOC130064076|LOC130064077|LOC130064078|LOC130064079|LOC130064080|LOC130064081|LOC130064082|LOC130064083|LOC130064084|LOC130064085|LOC130064086|LOC130064087|LOC130064088|LOC130064089|LOC130064090|LOC130064091|LOC130064092|LOC130064093|LOC130064094|LOC130064095|LOC130064096|LOC130064097|LOC130064098|LOC130064099|LOC130064100|LOC130064101|LOC130064102|LOC130064103|LOC130064104|LOC130064105|LOC130064106|LOC130064107|LOC130064108|LOC130064109|LOC130064110|LOC130064111|LOC130064112|LOC130064113|LOC130064114|LOC130064115|LOC130064116|LOC130064117|LOC130064118|LOC130064119|LOC130064120|LOC130064121|LOC130064122|LOC130064123|LOC130064124|LOC130064125|LOC130064126|LOC130064127|LOC130064128|LOC130064129|LOC130064130|LOC130064131|LOC130064132|LOC130064133|LOC130064134|LOC130064135|LOC130064136|LOC130064137|LOC130064138|LOC130064139|LOC130064140|LOC130064141|LOC130064142|LOC130064143|LOC130064144|LOC130064145|LOC130064146|LOC130064147|LOC130064148|LOC130064149|LOC130064150|LOC130064151|LOC130064152|LOC130064153|LOC130064154|LOC130064155|LOC130064156|LOC130064157|LOC130064158|LOC130064159|LOC130064160|LOC130064161|LOC130064162|LOC130064163|LOC130064164|LOC130064165|LOC130064166|LOC130064167|LOC130064168|LOC130064169|LOC130064170|LOC130064171|LOC130064172|LOC130064173|LOC130064174|LOC130064175|LOC130064176|LOC130064177|LOC130064178|LOC130064179|LOC130064180|LOC130064181|LOC130064182|LOC130064183|LOC130064184|LOC130064185|LOC130064186|LOC130064187|LOC130064188|LOC130064189|LOC130064190|LOC130064191|LOC130064192|LOC130064193|LOC130064194|LOC130064195|LOC130064196|LOC130064197|LOC130064198|LOC130064199|LOC130064200|LOC130064201|LOC130064202|LOC130064203|LOC130064204|LOC130064205|LOC130064206|LOC130064207|LOC130064208|LOC130064209|LOC130064210|LOC130064211|LOC130064212|LOC130064213|LOC130064214|LOC130064215|LOC130064216|LOC130064217|LOC130064218|LOC130064219|LOC130064220|LOC130064221|LOC130064222|LOC130064223|LOC130064224|LOC130064225|LOC130064226|LOC130064227|LOC130064228|LOC130064229|LOC130064230|LOC130064231|LOC130064232|LOC130064233|LOC130064234|LOC130064235|LOC130064236|LOC130064237|LOC130064238|LOC130064239|LOC130064240|LOC130064241|LOC130064242|LOC130064243|LOC130064244|LOC130064245|LOC130064246|LOC130064247|LOC130064248|LOC130064249|LOC130064250|LOC130064251|LOC130064252|LOC130064253|LOC130064254|LOC130064255|LOC130064256|LOC130064257|LOC130064258|LOC130064259|LOC130064260|LOC130064261|LOC130064262|LOC130064263|LOC130064264|LOC130064265|LOC130064266|LOC130064267|LOC130064268|LOC130064269|LOC130064270|LOC130064271|LOC130064272|LOC130064273|LOC130064274|LOC130064275|LOC130064276|LOC130064277|LOC130064278|LOC130064279|LOC130064280|LOC130064281|LOC130064282|LOC130064283|LOC130064284|LOC130064285|LOC130064286|LOC130064287|LOC130064288|LOC130064289|LOC130064290|LOC130064291|LOC130064292|LOC130064293|LOC130064294|LOC130064295|LOC130064296|LOC130064297|LOC130064298|LOC130064299|LOC130064300|LOC130064301|LOC130064302|LOC130064303|LOC130064304|LOC130064305|LOC130064306|LOC130064307|LOC130064308|LOC130064309|LOC130064310|LOC130064311|LOC130064312|LOC130064313|LOC130064314|LOC130064315|LOC130064316|LOC130064317|LOC130064318|LOC130064319|LOC130064320|LOC130064321|LOC130064322|LOC130064323|LOC130064324|LOC130064325|LOC130064326|LOC130064327|LOC130064328|LOC130064329|LOC130064330|LOC130064331|LOC130064332|LOC130064333|LOC130064334|LOC130064335|LOC130064336|LOC130064337|LOC130064338|LOC130064339|LOC130064340|LOC130064341|LOC130064342|LOC130064343|LOC130064344|LOC130064345|LOC130064346|LOC130064347|LOC130064348|LOC130064349|LOC130064350|LOC130064351|LOC130064352|LOC130064353|LOC130064354|LOC130064355|LOC130064356|LOC130064357|LOC130064358|LOC130064359|LOC130064360|LOC130064361|LOC130064362|LOC130064363|LOC130064364|LOC130064365|LOC130064366|LOC130064367|LOC130064368|LOC130064369|LOC130064370|LOC130064371|LOC130064372|LOC130064373|LOC130064374|LOC130064375|LOC130064376|LOC130064377|LOC130064378|LOC130064379|LOC130064380|LOC130064381|LOC130064382|LOC130064383|LOC130064384|LOC130064385|LOC130064386|LOC130064387|LOC130064388|LOC130064389|LOC130064390|LOC130064391|LOC130064392|LOC130064393|LOC130064394|LOC130064395|LOC130064396|LOC130064397|LOC130064398|LOC130064399|LOC130064400|LOC130064401|LOC130064402|LOC130064403|LOC130064404|LOC130064405|LOC130064406|LOC130064407|LOC130064408|LOC130064409|LOC130064410|LOC130064411|LOC130064412|LOC130064413|LOC130064414|LOC130064415|LOC130064416|LOC130064417|LOC130064418|LOC130064419|LOC130064420|LOC130064421|LOC130064422|LOC130064423|LOC130064424|LOC130064425|LOC130064426|LOC130064427|LOC130064428|LOC130064429|LOC130064430|LOC130064431|LOC130064432|LOC130064433|LOC130064434|LOC130064435|LOC130064436|LOC130064437|LOC130064438|LOC130064439|LOC130064440|LOC130064441|LOC130064442|LOC130064443|LOC130064444|LOC130064445|LOC130064446|LOC130064447|LOC130064448|LOC130064449|LOC130064450|LOC130064451|LOC130064452|LOC130064453|LOC130064454|LOC130064455|LOC130064456|LOC130064457|LOC130064458|LOC130064459|LOC130064460|LOC130064461|LOC130064462|LOC130064463|LOC130064464|LOC130064465|LOC130064466|LOC130064467|LOC130064468|LOC130064469|LOC130064470|LOC130064471|LOC130064472|LOC130064473|LOC130064474|LOC130064475|LOC130064476|LOC130064477|LOC130064478|LOC130064479|LOC130064480|LOC130064481|LOC130064482|LOC130064483|LOC130064484|LOC130064485|LOC130064486|LOC130064487|LOC130064488|LOC130064489|LOC130064490|LOC130064491|LOC130064492|LOC130064493|LOC130064494|LOC130064495|LOC130064496|LOC130064497|LOC130064498|LOC130064499|LOC130064500|LOC130064501|LOC130064502|LOC130064503|LOC130064504|LOC130064505|LOC130064506|LOC130064507|LOC130064508|LOC130064509|LOC130064510|LOC130064511|LOC130064512|LOC130064513|LOC130064514|LOC130064515|LOC130064516|LOC130064517|LOC130064518|LOC130064519|LOC130064520|LOC130064521|LOC130064522|LOC130064523|LOC130064524|LOC130064525|LOC130064526|LOC130064527|LOC130064528|LOC130064529|LOC130064530|LOC130064531|LOC130064532|LOC130064533|LOC130064534|LOC130064535|LOC130064536|LOC130064537|LOC130064538|LOC130064539|LOC130064540|LOC130064541|LOC130064542|LOC130064543|B3GNT8|B9D2|BABAM1|BCKDHA|BEST2|BISPR|BLVRB|BORCS8|BORCS8-MEF2B|BRD4|BRME1|BST2|C19orf12|C19orf33|C19orf44|C19orf47|C19orf53|C19orf67|CACNA1A|CADM4|CALR|CALR3|CAPN12|CAPNS1|CASP14|CATSPERG|CC2D1A|CCDC124|CCDC159|CCDC194|CCDC97|CCER2|CCNE1|CCNP|CD177|CD22|CD79A|CEACAM1|CEACAM20|CEACAM21|CEACAM3|CEACAM4|CEACAM5|CEACAM6|CEACAM7|CEACAM8|CEBPA|CEBPA-DT|CEBPG|CEP89|CERS1|CHERP|CHST8|CIB3|CIC|CILP2|CIST1|CLC|CLEC17A|CLIP3|CNFN|CNN1|COLGALT1|COMP|COPE|COQ8B|COX6B1|COX7A1|CPAMD8|CRLF1|CRTC1|CXCL17|CYP2A13|CYP2A6|CYP2A7|CYP2B6|CYP2F1|CYP2S1|CYP4F11|CYP4F12|CYP4F2|CYP4F22|CYP4F3|CYP4F8|DAND5|DCAF15|DDA1|DDX39A|DDX49|DEDD2|DHPS|DLL3|DMAC2|DMKN|DMRTC2|DNAJB1|DNASE2|DOCK6|DPF1|DPY19L3|DPY19L3-DT|DYRK1B|ECH1|ECSIT|EGLN2|EID2|EID2B|EIF3K|ELAVL3|ELL|ELOF1|EPHX3|EPOR|EPS15L1|ERF|ERFL|ERICH4|ERVK-19|ERVS71-1|ETHE1|ETV2|EXOSC5|F2RL3|FAAP24|FAM187B|FAM32A|FAM98C|FARSA|FARSA-AS1|FBL|FBXO17|FBXO27|FBXW9|FCGBP|FCHO1|FFAR1|FFAR2|FFAR3|FKBP8|FXYD1|FXYD3|FXYD5|FXYD7|GADD45GIP1|GAPDHS|GARRE1|GATAD2A|GCDH|GDF1|GDF15|GET3|GGN|GIPC1|GMFG|GMIP|GNG14|GPATCH1|GPI|GPR42|GRAMD1A|GRIK5|GSK3A|GTPBP3|HAMP|HAPLN4|HAUS5|HAUS5-DT|HAUS8|HCST|HIPK4|HNRNPL|HNRNPUL1|HOMER3|HOMER3-AS1|HOOK2|HPN|HPN-AS1|HSH2D|HSPB6|HSPC102|IER2|IFI30|IFNL1|IFNL2|IFNL3|IFNL4|IGFLR1|IGSF23|IL12RB1|IL27RA|ILVBL|ILVBL-AS1|INSL3|IQCN|IRGC|IRGQ|ISYNA1|ITPKC|JAK3|JUNB|JUND|KCNK6|KCNN1|KCNN4|KCTD15|KIRREL2|KLF1|KLF2|KLF2-DT|KLHL26|KMT2B|KRTDAP|KXD1|LEUTX|LGALS13|LGALS14|LGALS16|LGALS4|LGALS7|LGALS7B|LGI4|LIN37|LINC00661|LINC00662|LINC00663|LINC00664|LINC00665|LINC00904|LINC00905|LINC00906|LINC01224|LINC01233|LINC01480|LINC01529|LINC01531|LINC01532|LINC01533|LINC01535|LINC01766|LINC01782|LINC01785|LINC01791|LINC01801|LINC01834|LINC01838|LINC01841|LINC01842|LINC01855|LINC01858|LINC01859|LINC02841|LINC02926|LINC02965|LINC02987|LINC03049|LINC03078|LINC03085|LINC03103|LIPE|LIPE-AS1|LNROP|LOC100134317|LOC100505715|LOC100505851|LOC101927522|LOC101927572|LOC101929124|LOC101930071|LOC102724908|LOC102724958|LOC102725254|LOC105372281|LOC105372321|LOC105372383|LOC105372394|LOC105376917|LOC106783503|LOC108663985|LOC110120869|LOC110120870|LOC110120871|LOC110120872|LOC110120873|LOC110120875|LOC110120890|LOC110120927|LOC110120942|LOC110121458|LOC110121465|LOC110599575|LOC110599577|LOC110673974|LOC111365151|LOC111365153|LOC111365163|LOC111413028|LOC111501767|LOC111811970|LOC112543445|LOC112543446|LOC112543448|LOC112543452|LOC112543454|LOC112543455|LOC112543458|LOC112543459|LOC112543461|LOC112543462|LOC112543463|LOC112543464|LOC112543465|LOC112543466|LOC112543467|LOC112543468|LOC112543469|LOC112543470|LOC112543471|LOC112543472|LOC112543473|LOC112543479|LOC112543483|LOC112543484|LOC112543485|LOC112543486|LOC112543487|LOC112543488|LOC112543489|LOC112552149|LOC112552150|LOC112552151|LOC112552152|LOC112552153|LOC112552154|LOC112552155|LOC112552156|LOC113939968|LOC113939969|LOC113939973|LOC116276503|LOC116276504|LOC116276505|LOC116276506|LOC116276507|LOC116276508|LOC116276509|LOC116276510|LOC116276511|LOC116276512|LOC116276513|LOC116276514|LOC116276515|LOC116286188|LOC116286189|LOC117038783|LOC117038785|LOC117038786|LOC117038787|LOC117038788|LOC117038789|LOC117038790|LOC117038791|LOC117038792|LOC117038793|LOC117038794|LOC117038795|LOC117125585|LOC117125586|LOC117125587|LOC117125588|LOC117125589|LOC117125590|LOC117125591|LOC117125592|LOC117125593|LOC117125594|LOC117125595|LOC117125596|LOC117125597|LOC117125598|LOC121627856|LOC121627857|LOC121627858|LOC121627859|LOC121627860|LOC121627861|LOC121627862|LOC121627863|LOC121627864|LOC121627865|LOC121627866|LOC121627867|LOC121627868|LOC121627869|LOC121627870|LOC121627871|LOC121627872|LOC121627873|LOC121627874|LOC121627875|LOC121627876|LOC121627877|LOC121852977|LOC121852978|LOC121852979|LOC121852980|LOC121852981|LOC121852982|LOC121852983|LOC121852984|LOC121852985|LOC121852986|LOC121852987|LOC121852988|LOC125371478|LOC125371479|LOC125371480|LOC125371481|LOC125371482|LOC125371483|LOC125371484|LOC125371486|LOC125371487|LOC125371488|LOC125371489|LOC125371491|LOC125371492|LOC125371493|LOC125371494|LOC125371495|LOC125371496|LOC125371497|LOC125371498|LOC125371499|LOC125371500|LOC125371501|LOC125371502|LOC125371503|LOC125371504|LOC125371505|LOC125371506|LOC125371507|LOC125371509|LOC125371510|LOC125371511|LOC125371513|LOC125371514|LOC125371515|LOC125371516|LOC125371517|LOC125371518|LOC125371519|LOC125371520|LOC125371521|LOC125371522|LOC125371523|LOC125371524|LOC125371525|LOC126862857|LOC126862858|LOC126862859|LOC126862860|LOC126862861|LOC126862862|LOC126862863|LOC126862864|LOC126862865|LOC126862866|LOC126862867|LOC126862868|LOC126862869|LOC126862870|LOC126862871|LOC126862872|LOC126862873|LOC126862874|LOC126862875|LOC126862876|LOC126862877|LOC126862878|LOC126862879|LOC126862880|LOC126862881|LOC126862882|LOC126862883|LOC126862884|LOC126862885|LOC126862886|LOC126862887|LOC126862888|LOC126862889|LOC126862890|LOC126862891|LOC126862892|LOC126862893|LOC126862894|LOC126862895|LOC126862896|LOC126862897|LOC126862898|LOC126862899|LOC126862900|LOC126862901|LOC126862902|LOC126862903|LOC126862904|LOC126862905|LOC126862906|LOC126862907|LOC126862908|LOC126862909|LOC126862910|LOC126862911|LOC126862912|LOC128598884|LOC128854698|LOC129391061|LOC129391062|LOC129391063|LOC129391064|LOC129391065|LOC129391066|LOC129391067|LOC129391068|LOC129391069|LOC129391070|LOC129391071|LOC129391072|LOC129391073|LOC129391074|LOC129391075|ZNF793-AS1|ZNF799|ZNF823|ZNF829|ZNF844|ZNF85|ZNF850|ZNF875|ZNF878|ZNF90|ZNF91|ZNF93|ZNF98|ZNF99|ZSWIM4		See cases	VCV000144406	19	11338618 - 45129651	19	11227942 - 44626354	144406	154157			copy number gain		Pathogenic	Mar 30, 2010	no assertion criteria provided							
GRCh38/hg38 19p13.12-q11(chr19:13974677-27839676)x3	ABHD8|ADGRE2|ADGRE3|ADGRE5|ADGRL1|ADGRL1-AS1|AKAP8|AKAP8L|ANKLE1|ANO8|AP1M1|ARMC6|ARRDC2|ASF1B|ATP13A1|B3GNT3|BABAM1|BISPR|BORCS8|BORCS8-MEF2B|BRD4|BST2|C19orf44|C19orf67|CALR3|CASP14|CCDC124|CCDC194|CERS1|CHERP|CIB3|CILP2|CIST1|CLEC17A|COLGALT1|COMP|COPE|CPAMD8|CRLF1|CRTC1|CYP4F11|CYP4F12|CYP4F2|CYP4F22|CYP4F3|CYP4F8|DDA1|DDX39A|DDX49|DNAJB1|ELL|EPHX3|EPS15L1|ERVK-19|ERVS71-1|F2RL3|FAM32A|FCHO1|FKBP8|GATAD2A|GDF1|GDF15|GIPC1|GMIP|GTPBP3|HAPLN4|HAUS8|HOMER3|HOMER3-AS1|HSH2D|IFI30|IL12RB1|IL27RA|ILVBL|ILVBL-AS1|INSL3|IQCN|ISYNA1|JAK3|JUND|KCNN1|KLF2|KLF2-DT|KLHL26|KXD1|LINC00661|LINC00662|LINC00663|LINC00664|LINC00905|LINC01224|LINC01233|LINC01785|LINC01841|LINC01842|LINC01855|LINC01858|LINC01859|LINC02987|LINC03085|LOC100505851|LOC101929124|LOC102725254|LOC105372321|LOC105376917|LOC106783503|LOC112543461|LOC112543462|LOC112543463|LOC112543464|LOC112543465|LOC112543466|LOC112543467|LOC112543468|LOC112543469|LOC112543470|LOC112543471|LOC112543472|LOC112543473|LOC113939968|LOC116276505|LOC116276506|LOC116276507|LOC116276508|LOC116276509|LOC116276510|LOC116276511|LOC116276512|LOC121627856|LOC121627857|LOC121627858|LOC121627859|LOC121627860|LOC121627861|LOC121627862|LOC121627863|LOC121627864|LOC121627865|LOC121627866|LOC121627867|LOC121852982|LOC121852983|LOC121852984|LOC121852985|LOC125371482|LOC125371483|LOC125371484|LOC125371486|LOC125371487|LOC125371488|LOC125371489|LOC125371491|LOC125371492|LOC125371493|LOC125371494|LOC125371495|LOC125371496|LOC125371497|LOC125371498|LOC125371499|LOC125371500|LOC126862867|LOC126862868|LOC126862869|LOC126862870|LOC126862871|LOC126862872|LOC126862873|LOC126862874|LOC126862875|LOC126862876|LOC126862877|LOC126862878|LOC126862879|LOC126862880|LOC126862881|LOC126862882|LOC126862883|LOC126862884|LOC126862885|LOC126862886|LOC128854698|LOC129391071|LOC129391072|LOC129391073|LOC129391074|LOC129391075|LOC129391076|LOC129391077|LOC129391078|LOC129391079|LOC129391080|LOC129391081|LOC129391082|LOC129391083|LOC129391084|LOC129391085|LOC130063749|LOC130063750|LOC130063751|LOC130063752|LOC130063753|LOC130063754|LOC130063755|LOC130063756|LOC130063757|LOC130063758|LOC130063759|LOC130063760|LOC130063761|LOC130063762|LOC130063763|LOC130063764|LOC130063765|LOC130063766|LOC130063767|LOC130063768|LOC130063769|LOC130063770|LOC130063771|LOC130063772|LOC130063773|LOC130063774|LOC130063775|LOC130063776|LOC130063777|LOC130063778|LOC130063779|LOC130063780|LOC130063781|LOC130063782|LOC130063783|LOC130063784|LOC130063785|LOC130063786|LOC130063787|LOC130063788|LOC130063789|LOC130063790|LOC130063791|LOC130063792|LOC130063793|LOC130063794|LOC130063795|LOC130063796|LOC130063797|LOC130063798|LOC130063799|LOC130063800|LOC130063801|LOC130063802|LOC130063803|LOC130063804|LOC130063805|LOC130063806|LOC130063807|LOC130063808|LOC130063809|LOC130063810|LOC130063811|LOC130063812|LOC130063813|LOC130063814|LOC130063815|LOC130063816|LOC130063817|LOC130063818|LOC130063819|LOC130063820|LOC130063821|LOC130063822|LOC130063823|LOC130063824|LOC130063825|LOC130063826|LOC130063827|LOC130063828|LOC130063829|LOC130063830|LOC130063831|LOC130063832|LOC130063833|LOC130063834|LOC130063835|LOC130063836|LOC130063837|LOC130063838|LOC130063839|LOC130063840|LOC130063841|LOC130063842|LOC130063843|LOC130063844|LOC130063845|LOC130063846|LOC130063847|LOC130063848|LOC130063849|LOC130063850|LOC130063851|LOC130063852|LOC130063853|LOC130063854|LOC130063855|LOC130063856|LOC130063857|LOC130063858|LOC130063859|LOC130063860|LOC130063861|LOC130063862|LOC130063863|LOC130063864|LOC130063865|LOC130063866|LOC130063867|LOC130063868|LOC130063869|LOC130063870|LOC130063871|LOC130063872|LOC130063873|LOC130063874|LOC130063875|LOC130063876|LOC130063877|LOC130063878|LOC130063879|LOC130063880|LOC130063881|LOC130063882|LOC130063883|LOC130063884|LOC130063885|LOC130063886|LOC130063887|LOC130063888|LOC130063889|LOC130063890|LOC130063891|LOC130063892|LOC130063893|LOC130063894|LOC130063895|LOC130063896|LOC130063897|LOC130063898|LOC130063899|LOC130063900|LOC130063901|LOC130063902|LOC130063903|LOC130063904|LOC130063905|LOC130063906|LOC130063907|LOC130063908|LOC130063909|LOC130063910|LOC130063911|LOC130063912|LOC130063913|LOC130063914|LOC130063915|LOC130063916|LOC130063917|LOC130063918|LOC130063919|LOC130063920|LOC130063921|LOC130063922|LOC130063923|LOC130063924|LOC130063925|LOC130063926|LOC130063927|LOC130063928|LOC130063929|LOC130063930|LOC130063931|LOC130063932|LOC130063933|LOC130063934|LOC130063935|LOC130063936|LOC130063937|LOC130063938|LOC130063939|LOC130063940|LOC130063941|LOC130063942|LOC130063943|LOC130063944|LOC130063945|LOC130063946|LOC130063947|LOC130063948|LOC130063949|LOC130063950|LOC130063951|LOC130063952|LOC130063953|LOC130063954|LOC130063955|LOC130063956|LOC130063957|LOC130063958|LOC130063959|LOC130063960|LOC130063961|LOC130063962|LOC130063963|LOC130063964|LOC130063965|LOC130063966|LOC130063967|LOC130063968|LOC130063969|LOC130063970|LOC130063971|LOC130063972|LOC130063973|LOC130063974|LOC130063975|LOC130063976|LOC130063977|LOC130063978|LOC130063979|LOC130063980|LOC130063981|LOC130063982|LOC130063983|LOC130063984|LOC130063985|LOC130063986|LOC130063987|LOC130063988|LOC130063989|LOC130063990|LOC130063991|LOC130063992|LOC130063993|LOC130063994|LOC130063995|LOC130063996|LOC130063997|LOC130063998|LOC130063999|LOC130064000|LOC130064001|LOC130064002|LOC130064003|LOC130064004|LOC130064005|LOC130064006|LOC130064007|LOC130064008|LOC130064009|LOC130064010|LOC130064011|LOC130064012|LOC130064013|LOC130064014|LOC130064015|LOC130064016|LOC130064017|LOC130064018|LOC130064019|LOC130064020|LOC130064021|LOC130064022|LOC130064023|LOC130064024|LOC130064025|LOC130064026|LOC130064027|LOC130064028|LOC130064029|LOC130064030|LOC130064031|LOC130064032|LOC130064033|LOC130064034|LOC130064035|LOC130064036|LOC130064037|LOC130064038|LOC130064039|LOC130064040|LOC130064041|LOC130064042|LOC130064043|LOC130064044|LOC130064045|LOC130064046|LOC130064047|LOC130064048|LOC130064049|LOC130064050|LOC130064051|LOC130064052|LOC130064053|LOC130064054|LOC130064055|LOC130064056|LOC130064057|LOC130064058|LOC130064059|LOC130064060|LOC130064061|LOC130064062|LOC130064063|LOC130064064|LOC130064065|LOC130064066|LOC130064067|LOC130064068|LOC130064069|LOC130064070|LOC130064071|LOC130064072|LOC130064073|LOC130064074|LOC130064075|LOC130064076|LOC130064077|LOC130064078|LOC130064079|LOC130064080|LOC130064081|LOC130064082|LOC130064083|LOC130064084|LOC130064085|LOC130064086|LOC130064087|LOC130064088|LOC130064089|LOC130064090|LOC130064091|LOC130064092|LOC130064093|LOC130064094|LOC130064095|LOC130064096|LOC130064097|LOC130064098|LOC130064099|LOC130064100|LOC130064101|LOC130064102|LOC130064103|LOC130064104|LOC130064105|LOC130064106|LOC130064107|LOC130064108|LOC130064109|LOC130064110|LOC130064111|LOC130064112|LOC130064113|LPAR2|LRRC25|LSM4|MAP1S|MAST3|MAU2|MED26|MEF2B|MIR1199|MIR1270|MIR1470|MIR3188|MIR3189|MIR639|MIR640|MIR6795|MISP3|MPV17L2|MRPL34|MVB12A|MYO9B|NCAN|NDUFA13|NDUFB7|NIBAN3|NOTCH3|NR2C2AP|NR2F6|NWD1|NXNL1|OCEL1|OR10H1|OR10H2|OR10H3|OR10H4|OR10H5|OR1I1|OR7A10|OR7A17|OR7A5|OR7C1|OR7C2|PALM3|PBX4|PDE4C|PGLS|PGLS-DT|PGLYRP2|PGPEP1|PIK3R2|PKN1|PLVAP|PRKACA|PTGER1|RAB3A|RAB8A|RASAL3|REX1BD|RFX1|RFXANK|RLN3|RPL18A|RPSA2|SAMD1|SIN3B|SLC1A6|SLC25A42|SLC27A1|SLC35E1|SLC5A5|SMIM46|SMIM7|SNORA104|SNORA118|SNORA68|SSBP4|SUGP1|SUGP2|SYDE1|TECR|TEKTL1|TM6SF2|TMEM161A|TMEM221|TMEM38A|TMEM59L|TPM4|TSSK6|UBA52|UCA1|UCA1-AS1|UNC13A|UPF1|USE1|USHBP1|WIZ|YJEFN3|ZNF100|ZNF101|ZNF14|ZNF208|ZNF253|ZNF254|ZNF257|ZNF333|ZNF429|ZNF43|ZNF430|ZNF431|ZNF486|ZNF492|ZNF493|ZNF506|ZNF626|ZNF66|ZNF675|ZNF676|ZNF681|ZNF682|ZNF708|ZNF714|ZNF723|ZNF724|ZNF726|ZNF728|ZNF729|ZNF730|ZNF737|ZNF738|ZNF85|ZNF90|ZNF91|ZNF93|ZNF98|ZNF99		See cases	VCV000059114	19	14085489 - 28330584	19	13974677 - 27839676	59114	73709			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
GRCh38/hg38 19p13.12-12(chr19:15133594-24193591)x3	ABHD8|AKAP8|AKAP8L|ANKLE1|ANO8|AP1M1|ARMC6|ARRDC2|ATP13A1|B3GNT3|BABAM1|BISPR|BORCS8|BORCS8-MEF2B|BRD4|BST2|C19orf44|CALR3|CCDC124|CCDC194|CERS1|CHERP|CIB3|CILP2|CIST1|COLGALT1|COMP|COPE|CPAMD8|CRLF1|CRTC1|CYP4F11|CYP4F12|CYP4F2|CYP4F22|CYP4F3|CYP4F8|DDA1|DDX49|ELL|EPHX3|EPS15L1|ERVS71-1|F2RL3|FAM32A|FCHO1|FKBP8|GATAD2A|GDF1|GDF15|GMIP|GTPBP3|HAPLN4|HAUS8|HOMER3|HOMER3-AS1|HSH2D|IFI30|IL12RB1|INSL3|IQCN|ISYNA1|JAK3|JUND|KCNN1|KLF2|KLF2-DT|KLHL26|KXD1|LINC00661|LINC00663|LINC00664|LINC00905|LINC01224|LINC01233|LINC01785|LINC01855|LINC01858|LINC01859|LINC03085|LOC100505851|LOC101929124|LOC102725254|LOC105372321|LOC105376917|LOC106783503|LOC112543462|LOC112543463|LOC112543464|LOC112543465|LOC112543466|LOC112543467|LOC112543468|LOC112543469|LOC112543470|LOC112543471|LOC112543472|LOC112543473|LOC116276507|LOC116276508|LOC116276509|LOC116276510|LOC116276511|LOC116276512|LOC121627859|LOC121627860|LOC121627861|LOC121627862|LOC121627863|LOC121627864|LOC121627865|LOC121627866|LOC121627867|LOC121852982|LOC121852983|LOC121852984|LOC121852985|LOC125371486|LOC125371487|LOC125371488|LOC125371489|LOC125371491|LOC125371492|LOC125371493|LOC125371494|LOC125371495|LOC125371496|LOC125371497|LOC125371498|LOC125371499|LOC125371500|LOC126862871|LOC126862872|LOC126862873|LOC126862874|LOC126862875|LOC126862876|LOC126862877|LOC126862878|LOC126862879|LOC126862880|LOC126862881|LOC126862882|LOC126862883|LOC126862884|LOC126862885|LOC126862886|LOC128854698|LOC129391075|LOC129391076|LOC129391077|LOC129391078|LOC129391079|LOC129391080|LOC129391081|LOC129391082|LOC129391083|LOC129391084|LOC129391085|LOC130063807|LOC130063808|LOC130063809|LOC130063810|LOC130063811|LOC130063812|LOC130063813|LOC130063814|LOC130063815|LOC130063816|LOC130063817|LOC130063818|LOC130063819|LOC130063820|LOC130063821|LOC130063822|LOC130063823|LOC130063824|LOC130063825|LOC130063826|LOC130063827|LOC130063828|LOC130063829|LOC130063830|LOC130063831|LOC130063832|LOC130063833|LOC130063834|LOC130063835|LOC130063836|LOC130063837|LOC130063838|LOC130063839|LOC130063840|LOC130063841|LOC130063842|LOC130063843|LOC130063844|LOC130063845|LOC130063846|LOC130063847|LOC130063848|LOC130063849|LOC130063850|LOC130063851|LOC130063852|LOC130063853|LOC130063854|LOC130063855|LOC130063856|LOC130063857|LOC130063858|LOC130063859|LOC130063860|LOC130063861|LOC130063862|LOC130063863|LOC130063864|LOC130063865|LOC130063866|LOC130063867|LOC130063868|LOC130063869|LOC130063870|LOC130063871|LOC130063872|LOC130063873|LOC130063874|LOC130063875|LOC130063876|LOC130063877|LOC130063878|LOC130063879|LOC130063880|LOC130063881|LOC130063882|LOC130063883|LOC130063884|LOC130063885|LOC130063886|LOC130063887|LOC130063888|LOC130063889|LOC130063890|LOC130063891|LOC130063892|LOC130063893|LOC130063894|LOC130063895|LOC130063896|LOC130063897|LOC130063898|LOC130063899|LOC130063900|LOC130063901|LOC130063902|LOC130063903|LOC130063904|LOC130063905|LOC130063906|LOC130063907|LOC130063908|LOC130063909|LOC130063910|LOC130063911|LOC130063912|LOC130063913|LOC130063914|LOC130063915|LOC130063916|LOC130063917|LOC130063918|LOC130063919|LOC130063920|LOC130063921|LOC130063922|LOC130063923|LOC130063924|LOC130063925|LOC130063926|LOC130063927|LOC130063928|LOC130063929|LOC130063930|LOC130063931|LOC130063932|LOC130063933|LOC130063934|LOC130063935|LOC130063936|LOC130063937|LOC130063938|LOC130063939|LOC130063940|LOC130063941|LOC130063942|LOC130063943|LOC130063944|LOC130063945|LOC130063946|LOC130063947|LOC130063948|LOC130063949|LOC130063950|LOC130063951|LOC130063952|LOC130063953|LOC130063954|LOC130063955|LOC130063956|LOC130063957|LOC130063958|LOC130063959|LOC130063960|LOC130063961|LOC130063962|LOC130063963|LOC130063964|LOC130063965|LOC130063966|LOC130063967|LOC130063968|LOC130063969|LOC130063970|LOC130063971|LOC130063972|LOC130063973|LOC130063974|LOC130063975|LOC130063976|LOC130063977|LOC130063978|LOC130063979|LOC130063980|LOC130063981|LOC130063982|LOC130063983|LOC130063984|LOC130063985|LOC130063986|LOC130063987|LOC130063988|LOC130063989|LOC130063990|LOC130063991|LOC130063992|LOC130063993|LOC130063994|LOC130063995|LOC130063996|LOC130063997|LOC130063998|LOC130063999|LOC130064000|LOC130064001|LOC130064002|LOC130064003|LOC130064004|LOC130064005|LOC130064006|LOC130064007|LOC130064008|LOC130064009|LOC130064010|LOC130064011|LOC130064012|LOC130064013|LOC130064014|LOC130064015|LOC130064016|LOC130064017|LOC130064018|LOC130064019|LOC130064020|LOC130064021|LOC130064022|LOC130064023|LOC130064024|LOC130064025|LOC130064026|LOC130064027|LOC130064028|LOC130064029|LOC130064030|LOC130064031|LOC130064032|LOC130064033|LOC130064034|LOC130064035|LOC130064036|LOC130064037|LOC130064038|LOC130064039|LOC130064040|LOC130064041|LOC130064042|LOC130064043|LOC130064044|LOC130064045|LOC130064046|LOC130064047|LOC130064048|LOC130064049|LOC130064050|LOC130064051|LOC130064052|LOC130064053|LOC130064054|LOC130064055|LOC130064056|LOC130064057|LOC130064058|LOC130064059|LOC130064060|LOC130064061|LOC130064062|LOC130064063|LOC130064064|LOC130064065|LOC130064066|LOC130064067|LOC130064068|LOC130064069|LOC130064070|LOC130064071|LOC130064072|LOC130064073|LOC130064074|LOC130064075|LOC130064076|LOC130064077|LOC130064078|LOC130064079|LOC130064080|LOC130064081|LOC130064082|LOC130064083|LOC130064084|LOC130064085|LOC130064086|LOC130064087|LOC130064088|LOC130064089|LOC130064090|LOC130064091|LOC130064092|LOC130064093|LOC130064094|LOC130064095|LOC130064096|LOC130064097|LOC130064098|LOC130064099|LOC130064100|LOC130064101|LOC130064102|LOC130064103|LOC130064104|LOC130064105|LOC130064106|LOC130064107|LOC130064108|LOC130064109|LOC130064110|LOC130064111|LOC130064112|LPAR2|LRRC25|LSM4|MAP1S|MAST3|MAU2|MED26|MEF2B|MIR1270|MIR1470|MIR3188|MIR3189|MIR640|MIR6795|MPV17L2|MRPL34|MVB12A|MYO9B|NCAN|NDUFA13|NIBAN3|NOTCH3|NR2C2AP|NR2F6|NWD1|NXNL1|OCEL1|OR10H1|OR10H2|OR10H3|OR10H4|OR10H5|PBX4|PDE4C|PGLS|PGLS-DT|PGLYRP2|PGPEP1|PIK3R2|PLVAP|RAB3A|RAB8A|RASAL3|REX1BD|RFXANK|RPL18A|RPSA2|SIN3B|SLC25A42|SLC27A1|SLC35E1|SLC5A5|SMIM7|SNORA118|SNORA68|SSBP4|SUGP1|SUGP2|TM6SF2|TMEM161A|TMEM221|TMEM38A|TMEM59L|TPM4|TSSK6|UBA52|UCA1|UCA1-AS1|UNC13A|UPF1|USE1|USHBP1|WIZ|YJEFN3|ZNF100|ZNF101|ZNF14|ZNF208|ZNF253|ZNF254|ZNF257|ZNF429|ZNF43|ZNF430|ZNF431|ZNF486|ZNF492|ZNF493|ZNF506|ZNF626|ZNF66|ZNF675|ZNF676|ZNF681|ZNF682|ZNF708|ZNF714|ZNF723|ZNF724|ZNF726|ZNF728|ZNF729|ZNF730|ZNF737|ZNF738|ZNF85|ZNF90|ZNF91|ZNF93|ZNF98|ZNF99		See cases	VCV000147522	19	15244405 - 24376393	19	15133594 - 24193591	147522	157273			copy number gain		Pathogenic	Dec 22, 2010	no assertion criteria provided							
GRCh38/hg38 19p13.11-q13.11(chr19:17176767-34924150)x3	LOC130064154|LOC130064155|LOC130064156|LOC130064157|LOC130064158|LOC130064159|LOC130064160|LOC130064161|LOC130064162|LOC130064163|LOC130064164|LOC130064165|LOC130064166|LOC130064167|LOC130064168|LOC130064169|LOC130064170|LOC130064171|LOC130064172|LOC130064173|LOC130064174|LOC130064175|LOC130064176|LOC130064177|LOC130064178|LOC130064179|LOC130064180|LOC130064181|LOC130064182|LOC130064183|LOC130064184|LOC130064185|LOC130064186|LOC130064187|LOC130064188|LOC130064189|LOC130064190|LOC130064191|LOC130064192|LOC130064193|LOC130064194|LOC130064195|LOC130064196|LOC130064197|LOC130064198|LOC132090533|LOC132090534|LOC132090535|LOC132090536|LOC132090537|LOC132090538|LOC132090539|LOC132090540|LOC132090541|LOC132090542|LOC132090543|LOC132090544|LOC132090545|LOC132090546|LOC132090547|LOC132090548|LOC132090549|LOC132090904|LOC132090905|LOC132090906|LOC132090907|LOC132090908|LOC132090909|LPAR2|LRP3|LRRC25|LSM14A|LSM4|MAP1S|MAST3|MAU2|MEF2B|MIR1270|MIR3188|MIR3189|MIR640|MPV17L2|MRPL34|MVB12A|MYO9B|NCAN|NDUFA13|NIBAN3|NR2C2AP|NR2F6|NUDT19|NUDT19-DT|NXNL1|OCEL1|PBX4|PDCD2L|PDCD5|PDE4C|PEPD|PGLS|PGLS-DT|PGPEP1|PIK3R2|PLEKHF1|PLVAP|POP4|RAB3A|REX1BD|RFXANK|RGS9BP|RHPN2|RPL18A|RPSA2|SCGB2B2|SLC25A42|SLC27A1|SLC5A5|SLC7A10|SLC7A9|SNORA68|SNORA68B|SSBP4|SUGP1|SUGP2|SUNO1|TDRD12|TM6SF2|TMEM161A|TMEM221|TMEM59L|TRT-AGT1-3|TSHZ3|TSSK6|UBA2|UBA52|UNC13A|UPF1|UQCRFS1|UQCRFS1-DT|URI1|USE1|USHBP1|VSTM2B|VSTM2B-DT|WDR88|WTIP|YJEFN3|ZNF100|ZNF101|ZNF14|ZNF181|ZNF208|ZNF253|ZNF254|ZNF257|ZNF30|ZNF30-AS1|ZNF302|ZNF429|ZNF43|ZNF430|ZNF431|ZNF486|ZNF492|ZNF493|ZNF506|ZNF507|ZNF536|ZNF599|ZNF626|ZNF66|ZNF675|ZNF676|ZNF681|ZNF682|ZNF708|ZNF714|ZNF723|ZNF724|ZNF726|ZNF728|ZNF729|ZNF730|ZNF737|ZNF738|ZNF85|ZNF90|ZNF91|ZNF93|ZNF98|ZNF99|ABHD8|ANKLE1|ANKRD27|ANO8|ARMC6|ARRDC2|ATP13A1|B3GNT3|BABAM1|BISPR|BORCS8|BORCS8-MEF2B|BST2|C19orf12|CCDC124|CCDC194|CCNE1|CEBPA|CEBPA-DT|CEBPG|CEP89|CERS1|CHST8|CILP2|CIST1|COLGALT1|COMP|COPE|CRLF1|CRTC1|DDA1|DDX49|DPY19L3|DPY19L3-DT|ELL|ERVK-19|ERVS71-1|FAAP24|FCHO1|FKBP8|GARRE1|GATAD2A|GDF1|GDF15|GMIP|GPATCH1|GPI|GTPBP3|HAPLN4|HOMER3|HOMER3-AS1|IFI30|IL12RB1|INSL3|IQCN|ISYNA1|JAK3|JUND|KCNN1|KCTD15|KLHL26|KXD1|LINC00662|LINC00663|LINC00664|LINC00904|LINC00906|LINC01224|LINC01233|LINC01532|LINC01533|LINC01782|LINC01785|LINC01791|LINC01801|LINC01834|LINC01838|LINC01858|LINC01859|LINC02841|LINC02965|LINC02987|LINC03049|LINC03085|LINC03103|LOC100505851|LOC101929124|LOC102724908|LOC102724958|LOC102725254|LOC105372321|LOC105376917|LOC106783503|LOC110120869|LOC110120870|LOC110120871|LOC110120872|LOC110120873|LOC110120875|LOC110120890|LOC110120927|LOC110120942|LOC111365153|LOC111413028|LOC112543463|LOC112543464|LOC112543465|LOC112543466|LOC112543467|LOC112543468|LOC112543469|LOC112543470|LOC112543471|LOC112543472|LOC112543473|LOC112543479|LOC112543483|LOC112543484|LOC113939969|LOC116276507|LOC116276508|LOC116276509|LOC116276510|LOC116276511|LOC116276512|LOC121627862|LOC121627863|LOC121627864|LOC121627865|LOC121627866|LOC121627867|LOC121627868|LOC121627869|LOC121627870|LOC121852983|LOC121852984|LOC121852985|LOC121852986|LOC125371491|LOC125371492|LOC125371493|LOC125371494|LOC125371495|LOC125371496|LOC125371497|LOC125371498|LOC125371499|LOC125371500|LOC125371501|LOC125371502|LOC125371503|LOC125371504|LOC125371505|LOC125371506|LOC125371507|LOC126862875|LOC126862876|LOC126862877|LOC126862878|LOC126862879|LOC126862880|LOC126862881|LOC126862882|LOC126862883|LOC126862884|LOC126862885|LOC126862886|LOC126862887|LOC126862888|LOC126862889|LOC126862890|LOC126862891|LOC126862892|LOC126862893|LOC126862894|LOC126862895|LOC129391077|LOC129391078|LOC129391079|LOC129391080|LOC129391081|LOC129391082|LOC129391083|LOC129391084|LOC129391085|LOC129391086|LOC129391087|LOC129391088|LOC129391089|LOC129391090|LOC129391091|LOC129391092|LOC129391093|LOC129391094|LOC130063912|LOC130063913|LOC130063914|LOC130063915|LOC130063916|LOC130063917|LOC130063918|LOC130063919|LOC130063920|LOC130063921|LOC130063922|LOC130063923|LOC130063924|LOC130063925|LOC130063926|LOC130063927|LOC130063928|LOC130063929|LOC130063930|LOC130063931|LOC130063932|LOC130063933|LOC130063934|LOC130063935|LOC130063936|LOC130063937|LOC130063938|LOC130063939|LOC130063940|LOC130063941|LOC130063942|LOC130063943|LOC130063944|LOC130063945|LOC130063946|LOC130063947|LOC130063948|LOC130063949|LOC130063950|LOC130063951|LOC130063952|LOC130063953|LOC130063954|LOC130063955|LOC130063956|LOC130063957|LOC130063958|LOC130063959|LOC130063960|LOC130063961|LOC130063962|LOC130063963|LOC130063964|LOC130063965|LOC130063966|LOC130063967|LOC130063968|LOC130063969|LOC130063970|LOC130063971|LOC130063972|LOC130063973|LOC130063974|LOC130063975|LOC130063976|LOC130063977|LOC130063978|LOC130063979|LOC130063980|LOC130063981|LOC130063982|LOC130063983|LOC130063984|LOC130063985|LOC130063986|LOC130063987|LOC130063988|LOC130063989|LOC130063990|LOC130063991|LOC130063992|LOC130063993|LOC130063994|LOC130063995|LOC130063996|LOC130063997|LOC130063998|LOC130063999|LOC130064000|LOC130064001|LOC130064002|LOC130064003|LOC130064004|LOC130064005|LOC130064006|LOC130064007|LOC130064008|LOC130064009|LOC130064010|LOC130064011|LOC130064012|LOC130064013|LOC130064014|LOC130064015|LOC130064016|LOC130064017|LOC130064018|LOC130064019|LOC130064020|LOC130064021|LOC130064022|LOC130064023|LOC130064024|LOC130064025|LOC130064026|LOC130064027|LOC130064028|LOC130064029|LOC130064030|LOC130064031|LOC130064032|LOC130064033|LOC130064034|LOC130064035|LOC130064036|LOC130064037|LOC130064038|LOC130064039|LOC130064040|LOC130064041|LOC130064042|LOC130064043|LOC130064044|LOC130064045|LOC130064046|LOC130064047|LOC130064048|LOC130064049|LOC130064050|LOC130064051|LOC130064052|LOC130064053|LOC130064054|LOC130064055|LOC130064056|LOC130064057|LOC130064058|LOC130064059|LOC130064060|LOC130064061|LOC130064062|LOC130064063|LOC130064064|LOC130064065|LOC130064066|LOC130064067|LOC130064068|LOC130064069|LOC130064070|LOC130064071|LOC130064072|LOC130064073|LOC130064074|LOC130064075|LOC130064076|LOC130064077|LOC130064078|LOC130064079|LOC130064080|LOC130064081|LOC130064082|LOC130064083|LOC130064084|LOC130064085|LOC130064086|LOC130064087|LOC130064088|LOC130064089|LOC130064090|LOC130064091|LOC130064092|LOC130064093|LOC130064094|LOC130064095|LOC130064096|LOC130064097|LOC130064098|LOC130064099|LOC130064100|LOC130064101|LOC130064102|LOC130064103|LOC130064104|LOC130064105|LOC130064106|LOC130064107|LOC130064108|LOC130064109|LOC130064110|LOC130064111|LOC130064112|LOC130064113|LOC130064114|LOC130064115|LOC130064116|LOC130064117|LOC130064118|LOC130064119|LOC130064120|LOC130064121|LOC130064122|LOC130064123|LOC130064124|LOC130064125|LOC130064126|LOC130064127|LOC130064128|LOC130064129|LOC130064130|LOC130064131|LOC130064132|LOC130064133|LOC130064134|LOC130064135|LOC130064136|LOC130064137|LOC130064138|LOC130064139|LOC130064140|LOC130064141|LOC130064142|LOC130064143|LOC130064144|LOC130064145|LOC130064146|LOC130064147|LOC130064148|LOC130064149|LOC130064150|LOC130064151|LOC130064152|LOC130064153		See cases	VCV000057042	19	17287576 - 35415054	19	17176767 - 34924150	57042	71637			copy number gain		Pathogenic	Aug 12, 2011	criteria provided, single submitter							
NC_000019.10:g.17824778_17824779del	JAK3		Severe combined immunodeficiency disease	VCV000369259	19	17935585 - 17935586	19	17824776 - 17824777	369259	353488	rs10580414	NC_000019.10:17824775:AAAA:AA	Deletion		Benign	Jun 14, 2016	criteria provided, single submitter							
NC_000019.10:g.17824778_17824779insCA	JAK3		Severe combined immunodeficiency disease	VCV000369260	19	17935586 - 17935587	19	17824777 - 17824778	369260	353489	rs10672762	NC_000019.10:17824777:A:ACA	Insertion		Benign	Jun 14, 2016	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1931del	JAK3		Severe combined immunodeficiency disease|not provided	VCV000328461	19	17935621	19	17824812	328461	348310	rs147498283	NC_000019.10:17824811:AAA:AA	Deletion	3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 1, 2023	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.*1926A>G	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328462	19	17935626	19	17824817	328462	332795	rs11888	NC_000019.10:17824816:T:C	single nucleotide variant	3 prime UTR variant	Benign	Jan 12, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.*1835G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000888877	19	17935717	19	17824908	888877	880087	rs990232897	NC_000019.10:17824907:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1833G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000888878	19	17935719	19	17824910	888878	880088	rs546293977	NC_000019.10:17824909:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1787C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328463	19	17935765	19	17824956	328463	342963	rs569854764	NC_000019.10:17824955:G:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1778A>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328464	19	17935774	19	17824965	328464	349510	rs886054266	NC_000019.10:17824964:T:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1761T>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000890572	19	17935791	19	17824982	890572	880089	rs188773566	NC_000019.10:17824981:A:T	single nucleotide variant	3 prime UTR variant	Likely benign	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1752A>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328465	19	17935800	19	17824991	328465	348311	rs886054267	NC_000019.10:17824990:T:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1661T>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000890573	19	17935891	19	17825082	890573	880090	rs1406329008	NC_000019.10:17825081:A:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1548C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328466	19	17936004	19	17825195	328466	348314	rs191522931	NC_000019.10:17825194:G:A	single nucleotide variant	3 prime UTR variant	Likely benign	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1531T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328467	19	17936021	19	17825212	328467	348315	rs886054268	NC_000019.10:17825211:A:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1523C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328468	19	17936029	19	17825220	328468	349511	rs145985086	NC_000019.10:17825219:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1522C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000890574	19	17936030	19	17825221	890574	880091	rs1449106505	NC_000019.10:17825220:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1509G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000890575	19	17936043	19	17825234	890575	880092	rs750558618	NC_000019.10:17825233:C:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 15, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1422G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328469	19	17936130	19	17825321	328469	342964	rs79972191	NC_000019.10:17825320:C:T	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1398G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000891135	19	17936154	19	17825345	891135	880093	rs2094202113	NC_000019.10:17825344:C:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1353dup	JAK3		Severe combined immunodeficiency disease	VCV000328470	19	17936198 - 17936199	19	17825389 - 17825390	328470	332796	rs886054269	NC_000019.10:17825389:AAA:AAAA	Duplication	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1319G>A	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000891136	19	17936233	19	17825424	891136	880094	rs118101939	NC_000019.10:17825423:C:T	single nucleotide variant	3 prime UTR variant	Benign	Jan 12, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.*1293C>T	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328471	19	17936259	19	17825450	328471	349513	rs73014967	NC_000019.10:17825449:G:A	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.*1287A>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328472	19	17936265	19	17825456	328472	342967	rs771793558	NC_000019.10:17825455:T:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1264G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000891137	19	17936288	19	17825479	891137	880095	rs552602675	NC_000019.10:17825478:C:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1218C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328473	19	17936334	19	17825525	328473	342968	rs886054270	NC_000019.10:17825524:G:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1197G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328474	19	17936355	19	17825546	328474	349515	rs3213415	NC_000019.10:17825545:C:T	single nucleotide variant	3 prime UTR variant	Likely benign	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1094G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328475	19	17936458	19	17825649	328475	349516	rs886054271	NC_000019.10:17825648:C:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1038A>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328476	19	17936514	19	17825705	328476	332803	rs373917722	NC_000019.10:17825704:T:C	single nucleotide variant	3 prime UTR variant	Benign	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*1014C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328477	19	17936538	19	17825729	328477	349517	rs560529368	NC_000019.10:17825728:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*985C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328478	19	17936567	19	17825758	328478	342975	rs886054272	NC_000019.10:17825757:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*974G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328479	19	17936578	19	17825769	328479	342976	rs543679158	NC_000019.10:17825768:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*943G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000892335	19	17936609	19	17825800	892335	880096	rs370189146	NC_000019.10:17825799:C:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Apr 27, 2017	criteria provided, single submitter							
NM_000215.4(JAK3):c.*937G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328480	19	17936615	19	17825806	328480	332805	rs3212803	NC_000019.10:17825805:C:T	single nucleotide variant	3 prime UTR variant	Likely benign	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*899A>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000892336	19	17936653	19	17825844	892336	880097	rs2094202959	NC_000019.10:17825843:T:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Mar 16, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*847C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328481	19	17936705	19	17825896	328481	332806	rs886054273	NC_000019.10:17825895:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*841_*842dup	JAK3		not provided|Severe combined immunodeficiency disease	VCV000328482	19	17936709 - 17936710	19	17825900 - 17825901	328482	349518	rs34803277	NC_000019.10:17825900:AAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAA	Duplication	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.*771C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000888940	19	17936781	19	17825972	888940	880098	rs923086181	NC_000019.10:17825971:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*654A>T	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328483	19	17936898	19	17826089	328483	348316	rs71332114	NC_000019.10:17826088:T:A	single nucleotide variant	3 prime UTR variant	Benign	Jan 12, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.*653T>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328484	19	17936899	19	17826090	328484	342979	rs886054274	NC_000019.10:17826089:A:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*607G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000888941	19	17936945	19	17826136	888941	880099	rs1364267735	NC_000019.10:17826135:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*593C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328485	19	17936959	19	17826150	328485	342984	rs886054275	NC_000019.10:17826149:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*507A>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000888942	19	17937045	19	17826236	888942	880100	rs572139474	NC_000019.10:17826235:T:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*503G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328486	19	17937049	19	17826240	328486	342988	rs201036874	NC_000019.10:17826239:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*501C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328487	19	17937051	19	17826242	328487	349520	rs192417008	NC_000019.10:17826241:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*448C>A	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328488	19	17937104	19	17826295	328488	348320	rs3212802	NC_000019.10:17826294:G:T	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.*422C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000890635	19	17937130	19	17826321	890635	880101	rs902489404	NC_000019.10:17826320:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*404G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000890636	19	17937148	19	17826339	890636	880102	rs200207634	NC_000019.10:17826338:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*403C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000890637	19	17937149	19	17826340	890637	880103	rs1011458072	NC_000019.10:17826339:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*371C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000890638	19	17937181	19	17826372	890638	880104	rs185462850	NC_000019.10:17826371:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*340dup	JAK3		Severe combined immunodeficiency disease	VCV000328489	19	17937211 - 17937212	19	17826402 - 17826403	328489	342993	rs886054276	NC_000019.10:17826402:AAAAAAAA:AAAAAAAAA	Duplication	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_000215.4(JAK3):c.*306G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000890639	19	17937246	19	17826437	890639	880105	rs200658727	NC_000019.10:17826436:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Apr 27, 2017	criteria provided, single submitter							
NM_000215.4(JAK3):c.*299C>T	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328490	19	17937253	19	17826444	328490	349521	rs201718854	NC_000019.10:17826443:G:A	single nucleotide variant	3 prime UTR variant	Likely benign	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.*298C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000891188	19	17937254	19	17826445	891188	880106	rs190366074	NC_000019.10:17826444:G:T	single nucleotide variant	3 prime UTR variant	Likely benign	Apr 27, 2017	criteria provided, single submitter							
NM_000215.4(JAK3):c.*271G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328491	19	17937281	19	17826472	328491	332810	rs886054277	NC_000019.10:17826471:C:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*252A>T	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328492	19	17937300	19	17826491	328492	348322	rs79044512	NC_000019.10:17826490:T:A	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.*222CT[1]	JAK3		Severe combined immunodeficiency disease|not provided	VCV000328493	19	17937325 - 17937328	19	17826516 - 17826519	328493	342997	rs3212801	NC_000019.10:17826515:AGAGAG:AG	Microsatellite	3 prime UTR variant	Benign	Jul 9, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.*204G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000891189	19	17937348	19	17826539	891189	880107	rs2094204211	NC_000019.10:17826538:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*138G>C	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328494	19	17937414	19	17826605	328494	349524	rs3212800	NC_000019.10:17826604:C:G	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.*137G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000891190	19	17937415	19	17826606	891190	880108	rs199679264	NC_000019.10:17826605:C:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.*123T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not specified|not provided	VCV000328495	19	17937429	19	17826620	328495	348324	rs3008	NC_000019.10:17826619:A:G	single nucleotide variant	3 prime UTR variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.*73T>C	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000892390	19	17937479	19	17826670	892390	880109	rs149873298	NC_000019.10:17826669:A:G	single nucleotide variant	3 prime UTR variant	Conflicting classifications of pathogenicity	Jun 1, 2023	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.*36G>A	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328496	19	17937516	19	17826707	328496	343000	rs3212799	NC_000019.10:17826706:C:T	single nucleotide variant	3 prime UTR variant	Benign	Jul 7, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.*10G>A	JAK3		JAK3-related disorder	VCV003050786	19	17937542	19	17826733	3050786	3212771		NC_000019.10:17826732:C:T	single nucleotide variant	3 prime UTR variant	Likely benign	Feb 19, 2019	no assertion criteria provided							
NM_000215.4(JAK3):c.3371_3372insTTTTTTTTTTTTTTTTTTTTNNNNNNNNNNTGCCCTGGGCCGCAGCGCAGCCGCGCAAACCACCACCCGCGGCCACCATGGCCGGACAGTATAATTTCCCCTGTCCTTTTC (p.Ser1124_Ter1125insPhePhePhePhePhePheXaaXaaXaaXaaAlaLeuGlyArgSerAlaAlaAlaGlnThrThrThrArgGlyHisHisGlyArgThrValTer)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002696185	19	17937555 - 17937556	19	17826746 - 17826747	2696185	2861040			Insertion	nonsense|inframe_insertion	Pathogenic	Nov 15, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3371C>T (p.Ser1124Leu)	JAK3	S1124L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000646334	19	17937556	19	17826747	646334	647796	rs1599862815	NC_000019.10:17826746:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2020	criteria provided, single submitter							
NM_000215.4(JAK3):c.3366C>T (p.Ser1122=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000732476	19	17937561	19	17826752	732476	741704	rs141069196	NC_000019.10:17826751:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3360C>G (p.Ser1120=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001079751	19	17937567	19	17826758	1079751	1084517	rs1217168188	NC_000019.10:17826757:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 12, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.3356A>G (p.His1119Arg)	JAK3	H1119R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000640630	19	17937571	19	17826762	640630	647797	rs1275983760	NC_000019.10:17826761:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.3345G>A (p.Glu1115=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001579677	19	17937582	19	17826773	1579677	1533635	rs536693961	NC_000019.10:17826772:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 15, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3340C>T (p.Pro1114Ser)	JAK3	P1114S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002096020	19	17937587	19	17826778	2096020	2149937		NC_000019.10:17826777:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3337C>T (p.His1113Tyr)	JAK3	H1113Y	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001352749	19	17937590	19	17826781	1352749	1505957	rs1269489339	NC_000019.10:17826780:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3317A>G (p.Glu1106Gly)	JAK3	E1106G	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001995590	19	17937610	19	17826801	1995590	2059962		NC_000019.10:17826800:T:C	single nucleotide variant	missense variant	Uncertain significance	May 1, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3312G>T (p.Gly1104=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002998330	19	17937615	19	17826806	2998330	3159922		NC_000019.10:17826805:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 25, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3312G>A (p.Gly1104=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002711929	19	17937615	19	17826806	2711929	2871657		NC_000019.10:17826805:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 7, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3308G>A (p.Arg1103Gln)	JAK3	R1103Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001359421	19	17937619	19	17826810	1359421	1370601	rs757920411	NC_000019.10:17826809:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3300C>T (p.Ser1100=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided	VCV000532757	19	17937627	19	17826818	532757	532778	rs201073968	NC_000019.10:17826817:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.3289A>G (p.Met1097Val)	JAK3	M1097V	Inborn genetic diseases	VCV003531265	19	17937638	19	17826829	3531265	3684181		NC_000019.10:17826828:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3289A>C (p.Met1097Leu)	JAK3	M1097L	not provided	VCV002649556	19	17937638	19	17826829	2649556	2811823		NC_000019.10:17826828:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3289A>T (p.Met1097Leu)	JAK3	M1097L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000892391	19	17937638	19	17826829	892391	880110	rs201301192	NC_000019.10:17826828:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 20, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.3282G>A (p.Gln1094=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001548912	19	17937645	19	17826836	1548912	1573027	rs577496865	NC_000019.10:17826835:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 2, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3281del (p.Gln1094fs)	JAK3	Q1094fs	not specified	VCV001321438	19	17937646	19	17826837	1321438	1311721	rs2147669921	NC_000019.10:17826836:T:	Deletion	frameshift variant	Uncertain significance	Oct 29, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.3279C>T (p.Pro1093=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002787294	19	17937648	19	17826839	2787294	2945843		NC_000019.10:17826838:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 5, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3276C>T (p.Gly1092=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001671453	19	17937651	19	17826842	1671453	1583691	rs199611932	NC_000019.10:17826841:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 16, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3276C>A (p.Gly1092=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001136088	19	17937651	19	17826842	1136088	1127680	rs199611932	NC_000019.10:17826841:G:T	single nucleotide variant	synonymous variant	Likely benign	Sep 24, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3275G>A (p.Gly1092Asp)	JAK3	G1092D	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002917028	19	17937652	19	17826843	2917028	3077090		NC_000019.10:17826842:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3274G>A (p.Gly1092Ser)	JAK3	G1092S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002891836	19	17937653	19	17826844	2891836	3051978		NC_000019.10:17826843:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3270C>T (p.Ala1090=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002973138	19	17937657	19	17826848	2973138	3133085		NC_000019.10:17826847:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 26, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3270C>A (p.Ala1090=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002826233	19	17937657	19	17826848	2826233	2989454		NC_000019.10:17826847:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3269C>A (p.Ala1090Asp)	JAK3	A1090D	Inborn genetic diseases	VCV002466271	19	17937658	19	17826849	2466271	2447678		NC_000019.10:17826848:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3268G>A (p.Ala1090Thr)	JAK3	A1090T	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000134579	19	17937659	19	17826850	134579	138318	rs144968714	NC_000019.10:17826849:C:T	single nucleotide variant	missense variant	Benign	Apr 3, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.3267C>T (p.Ser1089=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000706218	19	17937660	19	17826851	706218	694358	rs138593705	NC_000019.10:17826850:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 23, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.3257C>T (p.Pro1086Leu)	JAK3	P1086L	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive	VCV000523048	19	17937670	19	17826861	523048	513657	rs777493612	NC_000019.10:17826860:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2017	criteria provided, single submitter							
NM_000215.4(JAK3):c.3254G>A (p.Arg1085Gln)	JAK3	R1085Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency|not specified	VCV001497167	19	17937673	19	17826864	1497167	1475788	rs2094204878	NC_000019.10:17826863:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.3253C>T (p.Arg1085Trp)	JAK3	R1085W	not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000495735	19	17937674	19	17826865	495735	488045	rs1265005806	NC_000019.10:17826864:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2021	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.3252C>T (p.Asp1084=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002897982	19	17937675	19	17826866	2897982	3067363		NC_000019.10:17826865:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3225G>A (p.Lys1075=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002801557	19	17937702	19	17826893	2801557	2956200		NC_000019.10:17826892:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 15, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3217C>T (p.Leu1073Phe)	JAK3	L1073F	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000861674	19	17937710	19	17826901	861674	847413	rs200580168	NC_000019.10:17826900:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.3214G>C (p.Glu1072Gln)	JAK3	E1072Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001475913	19	17937713	19	17826904	1475913	1423633	rs752088869	NC_000019.10:17826903:C:G	single nucleotide variant	missense variant	Uncertain significance	May 18, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.3214G>A (p.Glu1072Lys)	JAK3	E1072K	not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000861116	19	17937713	19	17826904	861116	847414	rs752088869	NC_000019.10:17826903:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 27, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.3213C>T (p.His1071=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000532754	19	17937714	19	17826905	532754	532779	rs757910571	NC_000019.10:17826904:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 9, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.3208-1G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001174743	19	17937720	19	17826911	1174743	1164544	rs1160856608	NC_000019.10:17826910:C:T	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	Apr 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.3208-7C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003691066	19	17937726	19	17826917	3691066	3827854		NC_000019.10:17826916:G:T	single nucleotide variant	intron variant	Likely benign	Apr 26, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3208-9G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002805708	19	17937728	19	17826919	2805708	2974070		NC_000019.10:17826918:C:A	single nucleotide variant	intron variant	Likely benign	May 30, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3208-9G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001113147	19	17937728	19	17826919	1113147	1106267	rs201379612	NC_000019.10:17826918:C:T	single nucleotide variant	intron variant	Likely benign	Dec 17, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3208-10C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001564860	19	17937729	19	17826920	1564860	1567814	rs200159093	NC_000019.10:17826919:G:A	single nucleotide variant	intron variant	Likely benign	Nov 7, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3208-11C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002798720	19	17937730	19	17826921	2798720	2952075		NC_000019.10:17826920:G:A	single nucleotide variant	intron variant	Likely benign	Nov 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3208-12C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002175744	19	17937731	19	17826922	2175744	1908401		NC_000019.10:17826921:G:A	single nucleotide variant	intron variant	Likely benign	Feb 8, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3208-16G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001667044	19	17937735	19	17826926	1667044	1622469	rs200008494	NC_000019.10:17826925:C:A	single nucleotide variant	intron variant	Likely benign	Jun 12, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3208-18C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002823533	19	17937737	19	17826928	2823533	2985898		NC_000019.10:17826927:G:A	single nucleotide variant	intron variant	Likely benign	Dec 23, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3208-39G>A	JAK3		not provided|not specified	VCV001290849	19	17937758	19	17826949	1290849	1280677	rs3212798	NC_000019.10:17826948:C:T	single nucleotide variant	intron variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.3208-67G>A	JAK3		not provided	VCV001236370	19	17937786	19	17826977	1236370	1228079	rs3212797	NC_000019.10:17826976:C:T	single nucleotide variant	intron variant	Benign	Jul 7, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.3208-74C>T	JAK3		not provided	VCV001175538	19	17937793	19	17826984	1175538	1165120	rs115332460	NC_000019.10:17826983:G:A	single nucleotide variant	intron variant	Likely benign	Oct 4, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.3207+326dup	JAK3		not provided	VCV001259402	19	17940580 - 17940581	19	17829771 - 17829772	1259402	1250165	rs59186613	NC_000019.10:17829771:AAAAAAAAAAA:AAAAAAAAAAAA	Duplication	intron variant	Benign	Aug 6, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.3207+336del	JAK3		not provided	VCV001245728	19	17940581	19	17829772	1245728	1234397	rs59186613	NC_000019.10:17829771:AAAAAAAAAAA:AAAAAAAAAA	Deletion	intron variant	Benign	Aug 10, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.3207+212G>A	JAK3		not provided	VCV001244267	19	17940705	19	17829896	1244267	1236796	rs60485073	NC_000019.10:17829895:C:T	single nucleotide variant	intron variant	Benign	Jul 9, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.3207+101C>G	JAK3		not provided|not specified	VCV001277864	19	17940816	19	17830007	1277864	1269197	rs3212781	NC_000019.10:17830006:G:C	single nucleotide variant	intron variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.3207+75C>T	JAK3		not provided|not specified	VCV001283176	19	17940842	19	17830033	1283176	1270885	rs3212780	NC_000019.10:17830032:G:A	single nucleotide variant	intron variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.3207+73G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000135549	19	17940844	19	17830035	135549	139288	rs536358097	NC_000019.10:17830034:C:T	single nucleotide variant	intron variant	Likely benign	Sep 20, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3207+17dup	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002843756	19	17940899 - 17940900	19	17830090 - 17830091	2843756	3011229		NC_000019.10:17830090:A:AA	Duplication	intron variant	Likely benign	Mar 8, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3207+10G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001558740	19	17940907	19	17830098	1558740	1563405	rs866815271	NC_000019.10:17830097:C:T	single nucleotide variant	intron variant	Likely benign	Jul 19, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3207+9C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002986018	19	17940908	19	17830099	2986018	3150154		NC_000019.10:17830098:G:A	single nucleotide variant	intron variant	Likely benign	Nov 24, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3207+9C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002153672	19	17940908	19	17830099	2153672	1892447		NC_000019.10:17830098:G:T	single nucleotide variant	intron variant	Likely benign	Jul 14, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3207G>A (p.Glu1069=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001913971	19	17940917	19	17830108	1913971	1970302		NC_000019.10:17830107:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Oct 16, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3204T>A (p.Ala1068=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001479499	19	17940920	19	17830111	1479499	1439222	rs778126810	NC_000019.10:17830110:A:T	single nucleotide variant	synonymous variant	Likely benign	Nov 5, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3201T>G (p.Pro1067=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002918833	19	17940923	19	17830114	2918833	3077583		NC_000019.10:17830113:A:C	single nucleotide variant	synonymous variant	Likely benign	Jul 1, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3200C>T (p.Pro1067Leu)	JAK3	P1067L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000840904	19	17940924	19	17830115	840904	847415	rs1223885282	NC_000019.10:17830114:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.3189T>A (p.Pro1063=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001617061	19	17940935	19	17830126	1617061	1580063	rs1007591322	NC_000019.10:17830125:A:T	single nucleotide variant	synonymous variant	Likely benign	Jul 11, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3183G>A (p.Pro1061=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002769161	19	17940941	19	17830132	2769161	2923436		NC_000019.10:17830131:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3183G>T (p.Pro1061=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328497	19	17940941	19	17830132	328497	343008	rs369402343	NC_000019.10:17830131:C:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 4, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.3174G>A (p.Gln1058=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001673063	19	17940950	19	17830141	1673063	1531509	rs773788067	NC_000019.10:17830140:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 25, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3165G>A (p.Glu1055=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000766561	19	17940959	19	17830150	766561	772517	rs1599865897	NC_000019.10:17830149:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 5, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3164A>G (p.Glu1055Gly)	JAK3	E1055G	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002174061	19	17940960	19	17830151	2174061	1908009		NC_000019.10:17830150:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3161T>C (p.Leu1054Pro)	JAK3	L1054P	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001718385	19	17940963	19	17830154	1718385	1778745		NC_000019.10:17830153:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3160C>A (p.Leu1054Met)	JAK3	L1054M	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002009566	19	17940964	19	17830155	2009566	2073930		NC_000019.10:17830154:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3159G>T (p.Leu1053=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002967657	19	17940965	19	17830156	2967657	3121520		NC_000019.10:17830155:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3151T>C (p.Leu1051=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003010376	19	17940973	19	17830164	3010376	3173266		NC_000019.10:17830163:A:G	single nucleotide variant	synonymous variant	Likely benign	Jun 19, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3146G>T (p.Arg1049Leu)	JAK3	R1049L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001392573	19	17940978	19	17830169	1392573	1502476	rs750073941	NC_000019.10:17830168:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.3144C>T (p.Cys1048=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001662777	19	17940980	19	17830171	1662777	1555583	rs201735857	NC_000019.10:17830170:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 18, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3141C>G (p.Leu1047=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002784104	19	17940983	19	17830174	2784104	2941363		NC_000019.10:17830173:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 8, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3135C>T (p.Pro1045=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002883466	19	17940989	19	17830180	2883466	3046222		NC_000019.10:17830179:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3123G>A (p.Glu1041=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002849841	19	17941001	19	17830192	2849841	3005796		NC_000019.10:17830191:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3113T>C (p.Met1038Thr)	JAK3	M1038T	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002907483	19	17941011	19	17830202	2907483	3062630		NC_000019.10:17830201:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3110T>A (p.Met1037Lys)	JAK3	M1037K	Inborn genetic diseases	VCV002496460	19	17941014	19	17830205	2496460	2467600		NC_000019.10:17830204:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3108G>A (p.Arg1036=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002838707	19	17941016	19	17830207	2838707	2999809		NC_000019.10:17830206:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3104T>A (p.Leu1035Gln)	JAK3	L1035Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001396409	19	17941020	19	17830211	1396409	1418160	rs2094211254	NC_000019.10:17830210:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3103del (p.Leu1035fs)	JAK3	L1035fs	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000523047	19	17941021	19	17830212	523047	513658	rs1424732031	NC_000019.10:17830211:GG:G	Deletion	frameshift variant	Conflicting classifications of pathogenicity	Apr 19, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.3097-12C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002800220	19	17941039	19	17830230	2800220	2952278		NC_000019.10:17830229:G:A	single nucleotide variant	intron variant	Likely benign	Aug 5, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3097-15C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002819778	19	17941042	19	17830233	2819778	2988133		NC_000019.10:17830232:G:C	single nucleotide variant	intron variant	Likely benign	Dec 16, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3097-17C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002961123	19	17941044	19	17830235	2961123	3119741		NC_000019.10:17830234:G:A	single nucleotide variant	intron variant	Likely benign	May 13, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3097-18G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002707305	19	17941045	19	17830236	2707305	2866996		NC_000019.10:17830235:C:A	single nucleotide variant	intron variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3097-116T>G	JAK3		not provided|not specified	VCV001225967	19	17941143	19	17830334	1225967	1214649	rs2302600	NC_000019.10:17830333:A:C	single nucleotide variant	intron variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.3096+139G>C	JAK3		not provided	VCV001286411	19	17941173	19	17830364	1286411	1276248	rs2302601	NC_000019.10:17830363:C:G	single nucleotide variant	intron variant	Benign	Jul 9, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.3096+58A>G	JAK3		not provided	VCV001258763	19	17941254	19	17830445	1258763	1248255	rs2302602	NC_000019.10:17830444:T:C	single nucleotide variant	intron variant	Benign	Jul 7, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.3096+20C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003711574	19	17941292	19	17830483	3711574	3837256		NC_000019.10:17830482:G:C	single nucleotide variant	intron variant	Likely benign	Jan 14, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.3096+20C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002886952	19	17941292	19	17830483	2886952	3047111		NC_000019.10:17830482:G:A	single nucleotide variant	intron variant	Likely benign	Sep 12, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3096+20C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001591517	19	17941292	19	17830483	1591517	1577633	rs765910786	NC_000019.10:17830482:G:T	single nucleotide variant	intron variant	Likely benign	Nov 13, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.3096+19G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003627060	19	17941293	19	17830484	3627060	3755700		NC_000019.10:17830483:C:A	single nucleotide variant	intron variant	Likely benign	Dec 25, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3096+19G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002820167	19	17941293	19	17830484	2820167	2985098		NC_000019.10:17830483:C:T	single nucleotide variant	intron variant	Likely benign	Dec 18, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3096+18A>G	JAK3		not specified|Severe combined immunodeficiency disease|T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided	VCV000036421	19	17941294	19	17830485	36421	45084	rs2302603	NC_000019.10:17830484:T:C	single nucleotide variant	intron variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.3096+15C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003640857	19	17941297	19	17830488	3640857	3768575		NC_000019.10:17830487:G:A	single nucleotide variant	intron variant	Likely benign	Feb 14, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3096+15C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002768686	19	17941297	19	17830488	2768686	2926836		NC_000019.10:17830487:G:C	single nucleotide variant	intron variant	Likely benign	Oct 15, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3096+10C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002726270	19	17941302	19	17830493	2726270	2888906		NC_000019.10:17830492:G:A	single nucleotide variant	intron variant	Likely benign	Jan 4, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3096+9G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002762505	19	17941303	19	17830494	2762505	2931000		NC_000019.10:17830493:C:G	single nucleotide variant	intron variant	Likely benign	Nov 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3096+8G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000761029	19	17941304	19	17830495	761029	776570	rs374300158	NC_000019.10:17830494:C:G	single nucleotide variant	intron variant	Likely benign	Jan 6, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3096+8G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000728554	19	17941304	19	17830495	728554	745384	rs374300158	NC_000019.10:17830494:C:T	single nucleotide variant	intron variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3096+1G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002503798	19	17941311	19	17830502	2503798	2668994		NC_000019.10:17830501:C:A	single nucleotide variant	splice donor variant	Likely pathogenic		criteria provided, single submitter							
NM_000215.4(JAK3):c.3094G>A (p.Ala1032Thr)	JAK3	A1032T	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000940767	19	17941314	19	17830505	940767	938613	rs2094211935	NC_000019.10:17830504:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.3087C>T (p.Ser1029=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002857792	19	17941321	19	17830512	2857792	3021687		NC_000019.10:17830511:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3087C>G (p.Ser1029Arg)	JAK3	S1029R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001439984	19	17941321	19	17830512	1439984	1368434	rs202044618	NC_000019.10:17830511:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3085dup (p.Ser1029fs)	JAK3	S1029fs	not specified|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001705246	19	17941322 - 17941323	19	17830513 - 17830514	1705246	1699774		NC_000019.10:17830513:T:TT	Duplication	frameshift variant	Conflicting classifications of pathogenicity	Jun 4, 2023	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.3084C>T (p.Cys1028=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000796950	19	17941324	19	17830515	796950	786108	rs200096249	NC_000019.10:17830514:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 14, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.3071_3072delinsAA (p.Cys1024Ter)	JAK3	C1024*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002764602	19	17941336 - 17941337	19	17830527 - 17830528	2764602	2931805		NC_000019.10:17830526:GC:TT	Indel	nonsense	Pathogenic	Sep 30, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3067T>C (p.Tyr1023His)	JAK3	Y1023H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000855164	19	17941341	19	17830532	855164	847416	rs145260622	NC_000019.10:17830531:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3066C>G (p.Thr1022=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002909794	19	17941342	19	17830533	2909794	3078461		NC_000019.10:17830532:G:C	single nucleotide variant	synonymous variant	Likely benign	Apr 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3066C>T (p.Thr1022=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001616434	19	17941342	19	17830533	1616434	1526624	rs200112920	NC_000019.10:17830532:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3055_3065del (p.Glu1019fs)	JAK3	E1019fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003642656	19	17941343 - 17941353	19	17830534 - 17830544	3642656	3765427		NC_000019.10:17830533:GTGAAGAGCTCGT:GT	Deletion	frameshift variant	Pathogenic	Mar 12, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3055G>A (p.Glu1019Lys)	JAK3	E1019K	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003068186	19	17941353	19	17830544	3068186	3227521		NC_000019.10:17830543:C:T	single nucleotide variant	missense variant	Likely pathogenic	Apr 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.3048C>T (p.Val1016=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003007997	19	17941360	19	17830551	3007997	3169572		NC_000019.10:17830550:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 1, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3045C>T (p.Val1015=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002961928	19	17941363	19	17830554	2961928	3126640		NC_000019.10:17830553:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3039C>T (p.Phe1013=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002972060	19	17941369	19	17830560	2972060	3139775		NC_000019.10:17830559:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 8, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3032G>A (p.Trp1011Ter)	JAK3	W1011*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001453819	19	17941376	19	17830567	1453819	1451345	rs2147674587	NC_000019.10:17830566:C:T	single nucleotide variant	nonsense	Pathogenic	Jul 19, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3027C>T (p.Asp1009=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002883719	19	17941381	19	17830572	2883719	3046474		NC_000019.10:17830571:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 3, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3021G>A (p.Gln1007=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001119804	19	17941387	19	17830578	1119804	1106268	rs553571090	NC_000019.10:17830577:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 24, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.3008TCT[1] (p.Phe1004del)	JAK3	F1004del	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002736842	19	17941395 - 17941397	19	17830586 - 17830588	2736842	2905412		NC_000019.10:17830585:AGAAGA:AGA	Microsatellite	inframe_deletion	Pathogenic	Jun 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3012C>T (p.Phe1004=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003014398	19	17941396	19	17830587	3014398	3170834		NC_000019.10:17830586:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.3002ACA[1] (p.Asn1002del)	JAK3	N1002del	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002048132	19	17941401 - 17941403	19	17830592 - 17830594	2048132	2107318		NC_000019.10:17830591:TGTTGT:TGT	Microsatellite	inframe_deletion	Uncertain significance	Nov 2, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.3007A>G (p.Ile1003Val)	JAK3	I1003V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001164943	19	17941401	19	17830592	1164943	1158458	rs137901277	NC_000019.10:17830591:T:C	single nucleotide variant	missense variant	Benign	Oct 28, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2996T>C (p.Leu999Pro)	JAK3	L999P	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001716968	19	17941412	19	17830603	1716968	1775793		NC_000019.10:17830602:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2989G>T (p.Glu997Ter)	JAK3	E997*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000572507	19	17941419	19	17830610	572507	572974	rs1568400897	NC_000019.10:17830609:C:A	single nucleotide variant	nonsense	Pathogenic	May 22, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.2988C>G (p.Pro996=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002785633	19	17941420	19	17830611	2785633	2945480		NC_000019.10:17830610:G:C	single nucleotide variant	synonymous variant	Likely benign	Sep 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2987C>T (p.Pro996Leu)	JAK3	P996L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002768188	19	17941421	19	17830612	2768188	2929356		NC_000019.10:17830611:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2985C>G (p.Ala995=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001675032	19	17941423	19	17830614	1675032	1597210	rs1382312413	NC_000019.10:17830613:G:C	single nucleotide variant	synonymous variant	Likely benign	Dec 16, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2982T>C (p.Tyr994=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002746573	19	17941426	19	17830617	2746573	2897448		NC_000019.10:17830616:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2979G>A (p.Trp993Ter)	JAK3	W993*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003005350	19	17941429	19	17830620	3005350	3161764		NC_000019.10:17830619:C:T	single nucleotide variant	nonsense	Pathogenic	Mar 7, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2979-8_2979-6dup	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002757843	19	17941434 - 17941435	19	17830625 - 17830626	2757843	2914686		NC_000019.10:17830625:GAGG:GAGGAGG	Duplication	intron variant	Likely benign	Sep 5, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2979-6C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002918760	19	17941435	19	17830626	2918760	3077511		NC_000019.10:17830625:G:A	single nucleotide variant	intron variant	Likely benign	Mar 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2979-8C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002743387	19	17941437	19	17830628	2743387	2896843		NC_000019.10:17830627:G:A	single nucleotide variant	intron variant	Likely benign	Oct 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2979-16C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002972025	19	17941445	19	17830636	2972025	3139740		NC_000019.10:17830635:G:A	single nucleotide variant	intron variant	Likely benign	Nov 6, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2979-234del	JAK3		not provided	VCV001287350	19	17941663	19	17830854	1287350	1277183	rs35483219	NC_000019.10:17830853:GGGGG:GGGG	Deletion	intron variant	Benign	Aug 19, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.2978+210C>T	JAK3		not provided	VCV001226741	19	17941827	19	17831018	1226741	1216713	rs3212779	NC_000019.10:17831017:G:A	single nucleotide variant	intron variant	Benign	Jul 11, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.2978+110C>T	JAK3		not provided	VCV001203258	19	17941927	19	17831118	1203258	1195377	rs3212778	NC_000019.10:17831117:G:A	single nucleotide variant	intron variant	Likely benign	Jul 7, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2978+100T>C	JAK3		not provided	VCV001265923	19	17941937	19	17831128	1265923	1257546	rs3212777	NC_000019.10:17831127:A:G	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2978+88G>T	JAK3		not provided	VCV001687670	19	17941949	19	17831140	1687670	1679965	rs527281163	NC_000019.10:17831139:C:A	single nucleotide variant	intron variant	Likely benign	May 26, 2021	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2978+78C>T	JAK3		not provided	VCV001183574	19	17941959	19	17831150	1183574	1173203	rs3212776	NC_000019.10:17831149:G:A	single nucleotide variant	intron variant	Benign	Jul 9, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2978+53C>T	JAK3		not provided	VCV001279243	19	17941984	19	17831175	1279243	1266527	rs3212775	NC_000019.10:17831174:G:A	single nucleotide variant	intron variant	Benign	Jul 9, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2978+32T>C	JAK3		not specified|not provided	VCV001241957	19	17942005	19	17831196	1241957	1232732	rs3212774	NC_000019.10:17831195:A:G	single nucleotide variant	intron variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2978+15C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not specified	VCV000137598	19	17942022	19	17831213	137598	141301	rs587780955	NC_000019.10:17831212:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2978+12G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001588566	19	17942025	19	17831216	1588566	1640893	rs1164733759	NC_000019.10:17831215:C:T	single nucleotide variant	intron variant	Likely benign	Oct 21, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2978+10_2978+11del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002881777	19	17942026 - 17942027	19	17831217 - 17831218	2881777	3037133		NC_000019.10:17831216:GGG:G	Deletion	intron variant	Likely benign	Jun 10, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2978+11del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002712357	19	17942026	19	17831217	2712357	2868197		NC_000019.10:17831216:GGG:GG	Deletion	intron variant	Likely benign	Jun 12, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2978+9C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001634460	19	17942028	19	17831219	1634460	1632545	rs750682558	NC_000019.10:17831218:G:T	single nucleotide variant	intron variant	Likely benign	Oct 15, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2978+1G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002750516	19	17942036	19	17831227	2750516	2915579		NC_000019.10:17831226:C:G	single nucleotide variant	splice donor variant	Likely pathogenic	Aug 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2978G>A (p.Trp993Ter)	JAK3	W993*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003393068	19	17942037	19	17831228	3393068	3552146		NC_000019.10:17831227:C:T	single nucleotide variant	nonsense	Likely pathogenic	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2973T>C (p.Ile991=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002417198	19	17942042	19	17831233	2417198	1941025		NC_000019.10:17831232:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 1, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2970C>T (p.Pro990=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001984064	19	17942045	19	17831236	1984064	2039317		NC_000019.10:17831235:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2964G>A (p.Gln988=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001967481	19	17942051	19	17831242	1967481	2024909		NC_000019.10:17831241:C:T	single nucleotide variant	synonymous variant	Uncertain significance	May 18, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2943C>T (p.Tyr981=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002856600	19	17942072	19	17831263	2856600	3017499		NC_000019.10:17831262:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 15, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2937C>G (p.Asp979Glu)	JAK3	D979E	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001392754	19	17942078	19	17831269	1392754	1502656	rs2147675743	NC_000019.10:17831268:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2933_2934del (p.Lys978fs)	JAK3	K978fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000803541	19	17942081 - 17942082	19	17831272 - 17831273	803541	791912	rs1380154594	NC_000019.10:17831271:TTT:T	Deletion	frameshift variant	Pathogenic	May 28, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.2919G>A (p.Leu973=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided	VCV001582376	19	17942096	19	17831287	1582376	1662439	rs769510241	NC_000019.10:17831286:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2908C>T (p.Leu970=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002762744	19	17942107	19	17831298	2762744	2931238		NC_000019.10:17831297:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2872G>T (p.Glu958Ter)	JAK3	E958*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003583517	19	17942143	19	17831334	3583517	3709362		NC_000019.10:17831333:C:A	single nucleotide variant	nonsense	Likely pathogenic	Feb 5, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2868C>T (p.Leu956=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002850378	19	17942147	19	17831338	2850378	3015986		NC_000019.10:17831337:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 25, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2867T>C (p.Leu956Pro)	JAK3	L956P	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002072084	19	17942148	19	17831339	2072084	2120024		NC_000019.10:17831338:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2865C>T (p.Ile955=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002884263	19	17942150	19	17831341	2884263	3043564		NC_000019.10:17831340:G:A	single nucleotide variant	synonymous variant	Likely benign	May 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2862C>T (p.Asn954=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001167417	19	17942153	19	17831344	1167417	1158459	rs199553891	NC_000019.10:17831343:G:A	single nucleotide variant	synonymous variant	Benign	Dec 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2854G>T (p.Ala952Ser)	JAK3	A952S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001908377	19	17942161	19	17831352	1908377	1962561		NC_000019.10:17831351:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2850G>T (p.Leu950=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001153317	19	17942165	19	17831356	1153317	1148617	rs2094214171	NC_000019.10:17831355:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 23, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2842C>G (p.Arg948Gly)	JAK3	R948G	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002842295	19	17942173	19	17831364	2842295	3000832		NC_000019.10:17831363:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2841C>T (p.His947=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002896791	19	17942174	19	17831365	2896791	3063380		NC_000019.10:17831364:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2835C>T (p.Cys945=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002703221	19	17942180	19	17831371	2703221	2862917		NC_000019.10:17831370:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2829C>T (p.Arg943=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002747783	19	17942186	19	17831377	2747783	2904676		NC_000019.10:17831376:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2825C>T (p.Ser942Phe)	JAK3	S942F	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001383426	19	17942190	19	17831381	1383426	1354567	rs372733285	NC_000019.10:17831380:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2818C>T (p.Leu940=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002804833	19	17942197	19	17831388	2804833	2971061		NC_000019.10:17831387:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2817C>A (p.Tyr939Ter)	JAK3	Y939*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003583518	19	17942198	19	17831389	3583518	3709363		NC_000019.10:17831388:G:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2809A>G (p.Met937Val)	JAK3	M937V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001906681	19	17942206	19	17831397	1906681	1962165		NC_000019.10:17831396:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2806-2A>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002693187	19	17942211	19	17831402	2693187	2857171		NC_000019.10:17831401:T:G	single nucleotide variant	splice acceptor variant	Likely pathogenic	Nov 4, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2806-14CCGC[4]	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000792966	19	17942211 - 17942212	19	17831402 - 17831403	792966	788042	rs1599867265	NC_000019.10:17831402:GCGGGCGGGCGG:GCGGGCGGGCGGGCGG	Microsatellite	intron variant	Likely benign	Oct 15, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.2806-4G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002096078	19	17942213	19	17831404	2096078	2149995		NC_000019.10:17831403:C:T	single nucleotide variant	intron variant	Likely benign	Feb 10, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2806-5C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002755001	19	17942214	19	17831405	2755001	2909700		NC_000019.10:17831404:G:A	single nucleotide variant	intron variant	Likely benign	Aug 24, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2806-8G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002824530	19	17942217	19	17831408	2824530	2989033		NC_000019.10:17831407:C:A	single nucleotide variant	intron variant	Likely benign	Jun 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2806-12G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002991830	19	17942221	19	17831412	2991830	3144440		NC_000019.10:17831411:C:G	single nucleotide variant	intron variant	Likely benign	Jan 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2806-12G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002986087	19	17942221	19	17831412	2986087	3150223		NC_000019.10:17831411:C:A	single nucleotide variant	intron variant	Likely benign	Nov 7, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2806-13C>T	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000377982	19	17942222	19	17831413	377982	377343	rs193156379	NC_000019.10:17831412:G:A	single nucleotide variant	intron variant	Benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2806-14C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000888994	19	17942223	19	17831414	888994	880710	rs976222264	NC_000019.10:17831413:G:C	single nucleotide variant	intron variant	Uncertain significance	Aug 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2806-16C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003604495	19	17942225	19	17831416	3604495	3743246		NC_000019.10:17831415:G:A	single nucleotide variant	intron variant	Likely benign	Feb 1, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2806-18C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002820144	19	17942227	19	17831418	2820144	2985075		NC_000019.10:17831417:G:C	single nucleotide variant	intron variant	Likely benign	Mar 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2806-20C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001598619	19	17942229	19	17831420	1598619	1630618	rs199653549	NC_000019.10:17831419:G:C	single nucleotide variant	intron variant	Benign	Jan 30, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.2805+113A>G	JAK3		not provided|not specified	VCV001258955	19	17942370	19	17831561	1258955	1247166	rs1122385	NC_000019.10:17831560:T:C	single nucleotide variant	intron variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2805+71C>T	JAK3		not provided	VCV001213519	19	17942412	19	17831603	1213519	1203513	rs73020668	NC_000019.10:17831602:G:A	single nucleotide variant	intron variant	Likely benign	Aug 12, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2805+17dup	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001638608	19	17942465 - 17942466	19	17831656 - 17831657	1638608	1624294	rs2147676559	NC_000019.10:17831656:GGGG:GGGGG	Duplication	intron variant	Benign	Nov 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2805+17C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003728118	19	17942466	19	17831657	3728118	3855318		NC_000019.10:17831656:G:A	single nucleotide variant	intron variant	Likely benign	Jul 10, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2805+12C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003687842	19	17942471	19	17831662	3687842	3827214		NC_000019.10:17831661:G:A	single nucleotide variant	intron variant	Likely benign	Feb 22, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2805+11dup	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003016400	19	17942471 - 17942472	19	17831662 - 17831663	3016400	3181882		NC_000019.10:17831662:CCCCC:CCCCCC	Duplication	intron variant	Benign	Jan 15, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2805+9G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003608765	19	17942474	19	17831665	3608765	3737591		NC_000019.10:17831664:C:T	single nucleotide variant	intron variant	Likely benign	Apr 25, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2805+7G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002856932	19	17942476	19	17831667	2856932	3017831		NC_000019.10:17831666:C:T	single nucleotide variant	intron variant	Likely benign	Apr 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2805+7G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002720186	19	17942476	19	17831667	2720186	2880699		NC_000019.10:17831666:C:G	single nucleotide variant	intron variant	Likely benign	Jan 27, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2805+5G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000749256	19	17942478	19	17831669	749256	760833	rs200731018	NC_000019.10:17831668:C:T	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.2805+4C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001905975	19	17942479	19	17831670	1905975	1964912		NC_000019.10:17831669:G:T	single nucleotide variant	intron variant	Uncertain significance	Jun 13, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2787T>G (p.Tyr929Ter)	JAK3	Y929*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002736843	19	17942501	19	17831692	2736843	2905413		NC_000019.10:17831691:A:C	single nucleotide variant	nonsense	Pathogenic	Feb 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2784C>G (p.Leu928=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002817691	19	17942504	19	17831695	2817691	2987332		NC_000019.10:17831694:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 30, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2773C>T (p.Arg925Cys)	JAK3	R925C	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000888995	19	17942515	19	17831706	888995	880111	rs149452625	NC_000019.10:17831705:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2773C>A (p.Arg925Ser)	JAK3	R925S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000418267	19	17942515	19	17831706	418267	410548	rs149452625	NC_000019.10:17831705:G:T	single nucleotide variant	missense variant	Likely benign	Nov 14, 2023	reviewed by expert panel							
NM_000215.4(JAK3):c.2772C>T (p.Ser924=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328498	19	17942516	19	17831707	328498	332811	rs199939250	NC_000019.10:17831706:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 27, 2023	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.2769C>T (p.Ala923=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001992587	19	17942519	19	17831710	1992587	2059108		NC_000019.10:17831709:G:A	single nucleotide variant	synonymous variant	Likely benign	May 30, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2766T>C (p.Asp922=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003679542	19	17942522	19	17831713	3679542	3814566		NC_000019.10:17831712:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 6, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2764G>C (p.Asp922His)	JAK3	D922H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001498781	19	17942524	19	17831715	1498781	1395682	rs763951351	NC_000019.10:17831714:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2764G>A (p.Asp922Asn)	JAK3	D922N	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000664756	19	17942524	19	17831715	664756	647798	rs763951351	NC_000019.10:17831714:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2763C>T (p.Leu921=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002964865	19	17942525	19	17831716	2964865	3120884		NC_000019.10:17831715:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2761C>T (p.Leu921Phe)	JAK3	L921F	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328499	19	17942527	19	17831718	328499	343009	rs886054278	NC_000019.10:17831717:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.2759_2760del (p.Arg920fs)	JAK3	R920fs	Severe combined immunodeficiency disease|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001878321	19	17942528 - 17942529	19	17831719 - 17831720	1878321	1935087		NC_000019.10:17831718:GCGCGCGCG:GCGCGCG	Microsatellite	frameshift variant	Pathogenic/Likely pathogenic	May 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2757G>A (p.Ala919=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002709580	19	17942531	19	17831722	2709580	2878325		NC_000019.10:17831721:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 16, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2756C>T (p.Ala919Val)	JAK3	A919V	T-B+ severe combined immunodeficiency due to JAK3 deficiency|Inborn genetic diseases	VCV000565744	19	17942532	19	17831723	565744	570590	rs767424476	NC_000019.10:17831722:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 29, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.2755G>C (p.Ala919Pro)	JAK3	A919P	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002019189	19	17942533	19	17831724	2019189	2065561		NC_000019.10:17831723:C:G	single nucleotide variant	missense variant	Likely benign	Jul 23, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2754_2755delinsGC (p.Ala919Pro)	JAK3	A919P	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001492650	19	17942533 - 17942534	19	17831724 - 17831725	1492650	1516788	rs2147676832	NC_000019.10:17831723:CG:GC	Indel	missense variant	Uncertain significance	Oct 28, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2754C>G (p.Arg918=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003642564	19	17942534	19	17831725	3642564	3765335		NC_000019.10:17831724:G:C	single nucleotide variant	synonymous variant	Likely benign	Feb 29, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2753G>C (p.Arg918Pro)	JAK3	R918P	Inborn genetic diseases|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001417318	19	17942535	19	17831726	1417318	1377685	rs753577833	NC_000019.10:17831725:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2751C>T (p.His917=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002896790	19	17942537	19	17831728	2896790	3063379		NC_000019.10:17831727:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 3, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2749C>A (p.His917Asn)	JAK3	H917N	Inborn genetic diseases	VCV003531263	19	17942539	19	17831730	3531263	3684179		NC_000019.10:17831729:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2748G>A (p.Arg916=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002906352	19	17942540	19	17831731	2906352	3069250		NC_000019.10:17831730:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 21, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2746C>T (p.Arg916Trp)	JAK3	R916W	Inborn genetic diseases	VCV003531259	19	17942542	19	17831733	3531259	3684175		NC_000019.10:17831732:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2743C>T (p.Gln915Ter)	JAK3	Q915*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002440936	19	17942545	19	17831736	2440936	2412223		NC_000019.10:17831735:G:A	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jan 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2740C>T (p.Leu914=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001583372	19	17942548	19	17831739	1583372	1601069	rs747463452	NC_000019.10:17831738:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2734G>T (p.Asp912Tyr)	JAK3	D912Y	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001473118	19	17942554	19	17831745	1473118	1501363	rs2147676935	NC_000019.10:17831744:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2733C>A (p.Arg911=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002780799	19	17942555	19	17831746	2780799	2940652		NC_000019.10:17831745:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 7, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2731C>G (p.Arg911Gly)	JAK3	R911G	not specified	VCV000134578	19	17942557	19	17831748	134578	138317	rs587778417	NC_000019.10:17831747:G:C	single nucleotide variant	missense variant	not provided	Sep 19, 2013	no classification provided							
NM_000215.4(JAK3):c.2721C>T (p.Ser907=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002989394	19	17942567	19	17831758	2989394	3150941		NC_000019.10:17831757:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2719A>G (p.Ser907Gly)	JAK3	S907G	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001356768	19	17942569	19	17831760	1356768	1348199	rs1259843283	NC_000019.10:17831759:T:C	single nucleotide variant	missense variant	Uncertain significance	May 27, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2718C>A (p.Pro906=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001611600	19	17942570	19	17831761	1611600	1552116	rs370066330	NC_000019.10:17831760:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 6, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2716C>T (p.Pro906Ser)	JAK3	P906S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002851081	19	17942572	19	17831763	2851081	3009583		NC_000019.10:17831762:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2712C>G (p.Tyr904Ter)	JAK3	Y904*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003583519	19	17942576	19	17831767	3583519	3709364		NC_000019.10:17831766:G:C	single nucleotide variant	nonsense	Likely pathogenic	Apr 29, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2712C>A (p.Tyr904Ter)	JAK3	Y904*	Severe combined immunodeficiency disease|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002782819	19	17942576	19	17831767	2782819	2937920		NC_000019.10:17831766:G:T	single nucleotide variant	nonsense	Pathogenic	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2709G>A (p.Glu903=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001978551	19	17942579	19	17831770	1978551	2041627		NC_000019.10:17831769:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2704A>G (p.Met902Val)	JAK3	M902V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000944488	19	17942584	19	17831775	944488	928892	rs200855932	NC_000019.10:17831774:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2683_2704del (p.Arg895fs)	JAK3	R895fs	Severe combined immunodeficiency disease	VCV000495737	19	17942584 - 17942605	19	17831775 - 17831796	495737	487945	rs1555743321	NC_000019.10:17831774:TGACCAGCCGCAGGCTCTGGCG:	Deletion	frameshift variant	Likely pathogenic	Aug 24, 2016	criteria provided, single submitter							
NM_000215.4(JAK3):c.2696_2697insCA (p.Leu900fs)	JAK3	L900fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003583520	19	17942591 - 17942592	19	17831782 - 17831783	3583520	3709365		NC_000019.10:17831782::TG	Insertion	frameshift variant	Likely pathogenic	Apr 22, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2697G>T (p.Arg899=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002713954	19	17942591	19	17831782	2713954	2872377		NC_000019.10:17831781:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2694G>A (p.Leu898=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003021127	19	17942594	19	17831785	3021127	3172332		NC_000019.10:17831784:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 3, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2693T>G (p.Leu898Arg)	JAK3	L898R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000846577	19	17942595	19	17831786	846577	847417	rs2094215030	NC_000019.10:17831785:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2692C>T (p.Leu898=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000888996	19	17942596	19	17831787	888996	880112	rs202043320	NC_000019.10:17831786:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 21, 2023	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.2682C>T (p.Gly894=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003015200	19	17942606	19	17831797	3015200	3178027		NC_000019.10:17831796:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 10, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2681-4C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002955348	19	17942611	19	17831802	2955348	3125251		NC_000019.10:17831801:G:A	single nucleotide variant	intron variant	Likely benign	Apr 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2681-6C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002704170	19	17942613	19	17831804	2704170	2866440		NC_000019.10:17831803:G:A	single nucleotide variant	intron variant	Likely benign	May 24, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2681-9C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002413403	19	17942616	19	17831807	2413403	1946795		NC_000019.10:17831806:G:T	single nucleotide variant	intron variant	Likely benign	Dec 23, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2681-11G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328500	19	17942618	19	17831809	328500	343016	rs201970522	NC_000019.10:17831808:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 8, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.2681-12T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003020085	19	17942619	19	17831810	3020085	3182952		NC_000019.10:17831809:A:G	single nucleotide variant	intron variant	Likely benign	Oct 4, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2681-20A>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003606344	19	17942627	19	17831818	3606344	3739918		NC_000019.10:17831817:T:C	single nucleotide variant	intron variant	Likely benign	Mar 1, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2681-201C>T	JAK3		not provided	VCV001243746	19	17942808	19	17831999	1243746	1233234	rs3212772	NC_000019.10:17831998:G:A	single nucleotide variant	intron variant	Benign	Sep 2, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.2681-320G>A	JAK3		not provided	VCV001283112	19	17942927	19	17832118	1283112	1270821	rs2071183	NC_000019.10:17832117:C:T	single nucleotide variant	intron variant	Benign	Jul 9, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.2680+89G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002054022	19	17943239	19	17832430	2054022	2115772		NC_000019.10:17832429:C:T	single nucleotide variant	intron variant	Likely pathogenic	Nov 14, 2023	reviewed by expert panel							
NM_000215.4(JAK3):c.2680+19G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002114594	19	17943309	19	17832500	2114594	2168599		NC_000019.10:17832499:C:T	single nucleotide variant	intron variant	Likely benign	Mar 19, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2680+15G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328501	19	17943313	19	17832504	328501	349525	rs201288968	NC_000019.10:17832503:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 22, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.2680+14C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002883547	19	17943314	19	17832505	2883547	3046302		NC_000019.10:17832504:G:A	single nucleotide variant	intron variant	Likely benign	Oct 25, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2680+9G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002963041	19	17943319	19	17832510	2963041	3120361		NC_000019.10:17832509:C:G	single nucleotide variant	intron variant	Likely benign	Dec 31, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2680+9G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000794065	19	17943319	19	17832510	794065	788312	rs935414486	NC_000019.10:17832509:C:T	single nucleotide variant	intron variant	Likely benign	Feb 14, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2680+8A>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002844515	19	17943320	19	17832511	2844515	3008156		NC_000019.10:17832510:T:G	single nucleotide variant	intron variant	Likely benign	Mar 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2680+3G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328503	19	17943325	19	17832516	328503	348327	rs749481781	NC_000019.10:17832515:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 21, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.2679G>A (p.Pro893=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000848362	19	17943329	19	17832520	848362	847418	rs200480252	NC_000019.10:17832519:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Oct 8, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2678C>T (p.Pro893Leu)	JAK3	P893L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328502	19	17943330	19	17832521	328502	332813	rs772027199	NC_000019.10:17832520:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2673T>C (p.Tyr891=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001105284	19	17943335	19	17832526	1105284	1106269	rs201537885	NC_000019.10:17832525:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 21, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.2670C>G (p.Ser890Arg)	JAK3	S890R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002808244	19	17943338	19	17832529	2808244	2971885		NC_000019.10:17832528:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 29, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2667C>G (p.Val889=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002807984	19	17943341	19	17832532	2807984	2971625		NC_000019.10:17832531:G:C	single nucleotide variant	synonymous variant	Likely benign	Jan 2, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2664T>G (p.Gly888=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001102614	19	17943344	19	17832535	1102614	1106270	rs2147678142	NC_000019.10:17832534:A:C	single nucleotide variant	synonymous variant	Likely benign	Sep 11, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2660G>A (p.Arg887His)	JAK3	R887H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000639139	19	17943348	19	17832539	639139	647799	rs148688786	NC_000019.10:17832538:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2659C>T (p.Arg887Cys)	JAK3	R887C	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000841595	19	17943349	19	17832540	841595	847419	rs759015510	NC_000019.10:17832539:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2655G>A (p.Lys885=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001595227	19	17943353	19	17832544	1595227	1590867	rs1479562469	NC_000019.10:17832543:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2652C>T (p.Val884=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001028621	19	17943356	19	17832547	1028621	1018526	rs2094216237	NC_000019.10:17832546:G:A	single nucleotide variant	synonymous variant	Likely pathogenic	Oct 31, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.2643T>C (p.Asp881=)	JAK3		not provided	VCV000730354	19	17943365	19	17832556	730354	741705	rs1599868171	NC_000019.10:17832555:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 29, 2017	criteria provided, single submitter							
NM_000215.4(JAK3):c.2637C>T (p.His879=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002843119	19	17943371	19	17832562	2843119	2993991		NC_000019.10:17832561:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 4, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2636A>G (p.His879Arg)	JAK3	H879R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000372390	19	17943372	19	17832563	372390	360407	rs3179893	NC_000019.10:17832562:T:C	single nucleotide variant	missense variant	Likely benign	Nov 14, 2023	reviewed by expert panel							
NM_000215.4(JAK3):c.2634G>A (p.Leu878=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002887989	19	17943374	19	17832565	2887989	3054402		NC_000019.10:17832564:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 25, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2630C>T (p.Ala877Val)	JAK3	A877V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000889681	19	17943378	19	17832569	889681	880113	rs201869359	NC_000019.10:17832568:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2625C>T (p.Leu875=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000036419	19	17943383	19	17832574	36419	45082	rs2230589	NC_000019.10:17832573:G:A	single nucleotide variant	synonymous variant	Benign	Nov 14, 2023	reviewed by expert panel							
NM_000215.4(JAK3):c.2624T>A (p.Leu875His)	JAK3	L875H	not provided	VCV002498766	19	17943384	19	17832575	2498766	2476743		NC_000019.10:17832574:A:T	single nucleotide variant	missense variant	Likely pathogenic	Jan 1, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2619G>T (p.Gln873His)	JAK3	Q873H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000660868	19	17943389	19	17832580	660868	647800	rs200645418	NC_000019.10:17832579:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2615T>C (p.Ile872Thr)	JAK3	I872T	not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000962093	19	17943393	19	17832584	962093	950712	rs2094216320	NC_000019.10:17832583:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2613G>A (p.Glu871=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002754401	19	17943395	19	17832586	2754401	2913843		NC_000019.10:17832585:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2609G>T (p.Arg870Leu)	JAK3	R870L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003064100	19	17943399	19	17832590	3064100	3224306		NC_000019.10:17832589:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2609G>C (p.Arg870Pro)	JAK3	R870P	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001714627	19	17943399	19	17832590	1714627	1777628		NC_000019.10:17832589:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2609G>A (p.Arg870Gln)	JAK3	R870Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000654610	19	17943399	19	17832590	654610	647801	rs376945173	NC_000019.10:17832589:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2596A>C (p.Arg866=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003005487	19	17943412	19	17832603	3005487	3161901		NC_000019.10:17832602:T:G	single nucleotide variant	synonymous variant	Likely benign	Jan 12, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2593C>G (p.Gln865Glu)	JAK3	Q865E	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000532744	19	17943415	19	17832606	532744	532843	rs749480147	NC_000019.10:17832605:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2581G>A (p.Gly861Arg)	JAK3	G861R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000652514	19	17943427	19	17832618	652514	647802	rs200784656	NC_000019.10:17832617:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.2580C>T (p.Ser860=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002896484	19	17943428	19	17832619	2896484	3052725		NC_000019.10:17832618:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 21, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2572C>T (p.Gln858Ter)	JAK3	Q858*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003637590	19	17943436	19	17832627	3637590	3767874		NC_000019.10:17832626:G:A	single nucleotide variant	nonsense	Pathogenic	Jan 31, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2571G>A (p.Leu857=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002707335	19	17943437	19	17832628	2707335	2867026		NC_000019.10:17832627:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2571G>T (p.Leu857=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001631399	19	17943437	19	17832628	1631399	1543810	rs2050410603	NC_000019.10:17832627:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 29, 2020	criteria provided, single submitter							
NM_000215.4(JAK3):c.2565A>G (p.Lys855=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002135034	19	17943443	19	17832634	2135034	2190442		NC_000019.10:17832633:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2562G>C (p.Val854=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001154119	19	17943446	19	17832637	1154119	1148618	rs2147678363	NC_000019.10:17832636:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 25, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.2559C>A (p.Ala853=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002852283	19	17943449	19	17832640	2852283	3009927		NC_000019.10:17832639:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 6, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2559C>T (p.Ala853=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002195483	19	17943449	19	17832640	2195483	1929849		NC_000019.10:17832639:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 9, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2554G>C (p.Val852Leu)	JAK3	V852L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001715337	19	17943454	19	17832645	1715337	1775482		NC_000019.10:17832644:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2553G>C (p.Leu851=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002872640	19	17943455	19	17832646	2872640	3037719		NC_000019.10:17832645:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 6, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2552del (p.Leu851fs)	JAK3	L851fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002848353	19	17943456	19	17832647	2848353	3005595		NC_000019.10:17832646:A:	Deletion	frameshift variant	Pathogenic	Jun 15, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2550C>A (p.Ala850=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002765624	19	17943458	19	17832649	2765624	2922498		NC_000019.10:17832648:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 4, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2547T>G (p.Gly849=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002892682	19	17943461	19	17832652	2892682	3045485		NC_000019.10:17832651:A:C	single nucleotide variant	synonymous variant	Likely benign	Sep 6, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2536G>A (p.Asp846Asn)	JAK3	D846N	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001928988	19	17943472	19	17832663	1928988	1987876		NC_000019.10:17832662:C:T	single nucleotide variant	missense variant	Uncertain significance	May 31, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2535C>T (p.Gly845=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000889682	19	17943473	19	17832664	889682	880114	rs200746503	NC_000019.10:17832663:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Oct 30, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.2523_2532del (p.Arg840_Tyr841insTer)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002802831	19	17943476 - 17943485	19	17832667 - 17832676	2802831	2970353		NC_000019.10:17832666:TAGCGGGTCATAGCGG:TAGCGG	Deletion	nonsense	Pathogenic	Feb 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2530C>T (p.Leu844=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003678677	19	17943478	19	17832669	3678677	3807413		NC_000019.10:17832668:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 16, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2530C>G (p.Leu844Val)	JAK3	L844V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001492841	19	17943478	19	17832669	1492841	1515677	rs2147678424	NC_000019.10:17832668:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2529G>T (p.Pro843=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003673728	19	17943479	19	17832670	3673728	3816523		NC_000019.10:17832669:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 8, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2529G>A (p.Pro843=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided	VCV001103953	19	17943479	19	17832670	1103953	1106271	rs775003661	NC_000019.10:17832669:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2519G>T (p.Arg840Leu)	JAK3	R840L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001402296	19	17943489	19	17832680	1402296	1454106	rs140837014	NC_000019.10:17832679:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2519G>A (p.Arg840His)	JAK3	R840H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001054471	19	17943489	19	17832680	1054471	1051153	rs140837014	NC_000019.10:17832679:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2518C>T (p.Arg840Cys)	JAK3	R840C	not specified|not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000664577	19	17943490	19	17832681	664577	647803	rs200077579	NC_000019.10:17832680:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2514G>C (p.Leu838=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002965343	19	17943494	19	17832685	2965343	3117910		NC_000019.10:17832684:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2512C>T (p.Leu838=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002697824	19	17943496	19	17832687	2697824	2861386		NC_000019.10:17832686:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 7, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2505C>T (p.Ser835=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000791757	19	17943503	19	17832694	791757	716285	rs201199096	NC_000019.10:17832693:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 1, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.2503A>T (p.Ser835Cys)	JAK3	S835C	not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000636504	19	17943505	19	17832696	636504	624654	rs201966394	NC_000019.10:17832695:T:A	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2494_2497del (p.Asn832fs)	JAK3	N832fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003583521	19	17943511 - 17943514	19	17832702 - 17832705	3583521	3709366		NC_000019.10:17832701:AGTT:	Deletion	frameshift variant	Likely pathogenic	May 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2495A>G (p.Asn832Ser)	JAK3	N832S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001384262	19	17943513	19	17832704	1384262	1348542	rs2147678543	NC_000019.10:17832703:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2491-3C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000567444	19	17943520	19	17832711	567444	574906	rs1568401934	NC_000019.10:17832710:G:C	single nucleotide variant	intron variant	Uncertain significance	Mar 6, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.2491-4C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003727816	19	17943521	19	17832712	3727816	3858439		NC_000019.10:17832711:G:C	single nucleotide variant	intron variant	Likely benign	Dec 23, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2491-8T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003022766	19	17943525	19	17832716	3022766	3176520		NC_000019.10:17832715:A:G	single nucleotide variant	intron variant	Likely benign	Jul 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2491-12G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002198528	19	17943529	19	17832720	2198528	1933753		NC_000019.10:17832719:C:T	single nucleotide variant	intron variant	Likely benign	Aug 7, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2491-13C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002974077	19	17943530	19	17832721	2974077	3136561		NC_000019.10:17832720:G:A	single nucleotide variant	intron variant	Likely benign	Mar 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2491-14C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001643177	19	17943531	19	17832722	1643177	1587135	rs202094680	NC_000019.10:17832721:G:A	single nucleotide variant	intron variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2491-15C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002958270	19	17943532	19	17832723	2958270	3116028		NC_000019.10:17832722:G:A	single nucleotide variant	intron variant	Likely benign	Dec 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2491-16T>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001657932	19	17943533	19	17832724	1657932	1541670	rs2147678611	NC_000019.10:17832723:A:C	single nucleotide variant	intron variant	Likely benign	Dec 3, 2020	criteria provided, single submitter							
NM_000215.4(JAK3):c.2490+17C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002981675	19	17943582	19	17832773	2981675	3135145		NC_000019.10:17832772:G:A	single nucleotide variant	intron variant	Likely benign	Aug 31, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2490+17C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001627840	19	17943582	19	17832773	1627840	1531058	rs1012424691	NC_000019.10:17832772:G:T	single nucleotide variant	intron variant	Likely benign	Oct 25, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2490+15G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002906451	19	17943584	19	17832775	2906451	3069348		NC_000019.10:17832774:C:G	single nucleotide variant	intron variant	Likely benign	Jun 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2490+14G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002123943	19	17943585	19	17832776	2123943	2174071		NC_000019.10:17832775:C:T	single nucleotide variant	intron variant	Likely benign	Mar 8, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2490+4A>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000889683	19	17943595	19	17832786	889683	880711	rs745806475	NC_000019.10:17832785:T:G	single nucleotide variant	intron variant	Uncertain significance	Jun 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2490+1G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001066836	19	17943598	19	17832789	1066836	1056548	rs2147678827	NC_000019.10:17832788:C:A	single nucleotide variant	splice donor variant	Likely pathogenic	Jul 6, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2481G>A (p.Gln827=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002819133	19	17943608	19	17832799	2819133	2977659		NC_000019.10:17832798:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2479C>G (p.Gln827Glu)	JAK3	Q827E	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001058261	19	17943610	19	17832801	1058261	1051154	rs144683649	NC_000019.10:17832800:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2478A>C (p.Ser826=)	JAK3		not provided	VCV000739182	19	17943611	19	17832802	739182	756819	rs1599868483	NC_000019.10:17832801:T:G	single nucleotide variant	synonymous variant	Likely benign	Mar 29, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.2477C>G (p.Ser826Ter)	JAK3	S826*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002880666	19	17943612	19	17832803	2880666	3034159		NC_000019.10:17832802:G:C	single nucleotide variant	nonsense	Pathogenic	Apr 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2475C>G (p.Ile825Met)	JAK3	I825M	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001494673	19	17943614	19	17832805	1494673	1344815	rs1459489474	NC_000019.10:17832804:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2466C>G (p.Leu822=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002057419	19	17943623	19	17832814	2057419	2116576		NC_000019.10:17832813:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 5, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2463C>T (p.His821=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001134076	19	17943626	19	17832817	1134076	1127681	rs200691724	NC_000019.10:17832816:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 2, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2454G>A (p.Glu818=)	JAK3		JAK3-related disorder	VCV003051504	19	17943635	19	17832826	3051504	3218769		NC_000019.10:17832825:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 13, 2020	no assertion criteria provided							
NM_000215.4(JAK3):c.2452G>A (p.Glu818Lys)	JAK3	E818K	T-B+ severe combined immunodeficiency due to JAK3 deficiency|Immunodeficiency|Trichiasis|Neonatal hypotonia|Lymphopenia|Abnormality of T cell physiology|Non-immune hydrops fetalis	VCV000464099	19	17943637	19	17832828	464099	470525	rs374191135	NC_000019.10:17832827:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2451C>T (p.Phe817=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328504	19	17943638	19	17832829	328504	332817	rs201576913	NC_000019.10:17832828:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2445G>A (p.Thr815=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003014354	19	17943644	19	17832835	3014354	3170791		NC_000019.10:17832834:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 19, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2444C>T (p.Thr815Met)	JAK3	T815M	Inborn genetic diseases	VCV002236175	19	17943645	19	17832836	2236175	2231659		NC_000019.10:17832835:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2442C>A (p.Pro814=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001532549	19	17943647	19	17832838	1532549	1636160	rs201364561	NC_000019.10:17832837:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 13, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2430C>G (p.Ala810=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002743745	19	17943659	19	17832850	2743745	2907098		NC_000019.10:17832849:G:C	single nucleotide variant	synonymous variant	Likely benign	Jul 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2430C>T (p.Ala810=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002730084	19	17943659	19	17832850	2730084	2886685		NC_000019.10:17832849:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2422C>T (p.Leu808Phe)	JAK3	L808F	Inborn genetic diseases	VCV003029100	19	17943667	19	17832858	3029100	3194176		NC_000019.10:17832857:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2419C>T (p.Gln807Ter)	JAK3	Q807*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002759221	19	17943670	19	17832861	2759221	2917803		NC_000019.10:17832860:G:A	single nucleotide variant	nonsense	Pathogenic	Sep 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2412T>C (p.Asn804=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001139973	19	17943677	19	17832868	1139973	1127682	rs368403369	NC_000019.10:17832867:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 3, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.2408G>A (p.Trp803Ter)	JAK3	W803*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002837879	19	17943681	19	17832872	2837879	2992597		NC_000019.10:17832871:C:T	single nucleotide variant	nonsense	Pathogenic	Feb 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2406G>A (p.Leu802=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002867311	19	17943683	19	17832874	2867311	3027099		NC_000019.10:17832873:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 5, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2397T>C (p.Arg799=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002102670	19	17943692	19	17832883	2102670	2151389		NC_000019.10:17832882:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 23, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2396G>A (p.Arg799His)	JAK3	R799H	Inborn genetic diseases	VCV003287141	19	17943693	19	17832884	3287141	3448065		NC_000019.10:17832883:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2395C>T (p.Arg799Cys)	JAK3	R799C	not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000891242	19	17943694	19	17832885	891242	880115	rs201241352	NC_000019.10:17832884:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2394T>G (p.Pro798=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002792551	19	17943695	19	17832886	2792551	2957563		NC_000019.10:17832885:A:C	single nucleotide variant	synonymous variant	Likely benign	Oct 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2391A>G (p.Ala797=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328505	19	17943698	19	17832889	328505	349527	rs199910484	NC_000019.10:17832888:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.2390C>T (p.Ala797Val)	JAK3	A797V	T-B+ severe combined immunodeficiency due to JAK3 deficiency|Inborn genetic diseases	VCV001431301	19	17943699	19	17832890	1431301	1480311	rs765366102	NC_000019.10:17832889:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2382T>G (p.Gly794=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002896832	19	17943707	19	17832898	2896832	3063421		NC_000019.10:17832897:A:C	single nucleotide variant	synonymous variant	Likely benign	Jan 22, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2381G>A (p.Gly794Asp)	JAK3	G794D	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001019054	19	17943708	19	17832899	1019054	1013594	rs935305331	NC_000019.10:17832898:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2372C>G (p.Pro791Arg)	JAK3	P791R	JAK3-related disorder	VCV002637361	19	17943717	19	17832908	2637361	2800039		NC_000019.10:17832907:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2372C>A (p.Pro791His)	JAK3	P791H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001609051	19	17943717	19	17832908	1609051	1573921	rs1413703588	NC_000019.10:17832907:G:T	single nucleotide variant	missense variant	Likely benign	Jan 31, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.2364C>T (p.Leu788=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002416014	19	17943725	19	17832916	2416014	1937418		NC_000019.10:17832915:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2358G>A (p.Glu786=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not specified	VCV000373673	19	17943731	19	17832922	373673	360379	rs1057518544	NC_000019.10:17832921:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 21, 2023	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.2351-5C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001006965	19	17943743	19	17832934	1006965	998446	rs2094217117	NC_000019.10:17832933:G:T	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2351-6C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001990561	19	17943744	19	17832935	1990561	2044500		NC_000019.10:17832934:G:A	single nucleotide variant	intron variant	Likely benign	May 20, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2351-7A>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002753115	19	17943745	19	17832936	2753115	2909113		NC_000019.10:17832935:T:A	single nucleotide variant	intron variant	Likely benign	May 31, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2351-8C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003623518	19	17943746	19	17832937	3623518	3754773		NC_000019.10:17832936:G:A	single nucleotide variant	intron variant	Likely benign	Mar 25, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2351-11C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001617838	19	17943749	19	17832940	1617838	1614691	rs200386518	NC_000019.10:17832939:G:A	single nucleotide variant	intron variant	Likely benign	Oct 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2351-15A>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002101094	19	17943753	19	17832944	2101094	2151114		NC_000019.10:17832943:T:C	single nucleotide variant	intron variant	Likely benign	Jun 1, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2351-18C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002826203	19	17943756	19	17832947	2826203	2979596		NC_000019.10:17832946:G:A	single nucleotide variant	intron variant	Likely benign	Jan 5, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2351-58C>G	JAK3		not provided	VCV001325915	19	17943796	19	17832987	1325915	1316175	rs73922623	NC_000019.10:17832986:G:C	single nucleotide variant	intron variant	Likely benign	May 21, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2350+18T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002773078	19	17945362	19	17834553	2773078	2930356		NC_000019.10:17834552:A:G	single nucleotide variant	intron variant	Likely benign	Oct 31, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2350+16G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002724202	19	17945364	19	17834555	2724202	2892004		NC_000019.10:17834554:C:T	single nucleotide variant	intron variant	Likely benign	Jun 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2350+15G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002961327	19	17945365	19	17834556	2961327	3119945		NC_000019.10:17834555:C:T	single nucleotide variant	intron variant	Likely benign	Nov 30, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2350+14C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002694573	19	17945366	19	17834557	2694573	2860712		NC_000019.10:17834556:G:C	single nucleotide variant	intron variant	Likely benign	Jan 19, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2350+14C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001596485	19	17945366	19	17834557	1596485	1633568	rs771815977	NC_000019.10:17834556:G:A	single nucleotide variant	intron variant	Likely benign	Jan 9, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2350+12G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002984745	19	17945368	19	17834559	2984745	3146357		NC_000019.10:17834558:C:G	single nucleotide variant	intron variant	Likely benign	Aug 24, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2350+12G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001597366	19	17945368	19	17834559	1597366	1664901	rs199675950	NC_000019.10:17834558:C:T	single nucleotide variant	intron variant	Likely benign	Feb 6, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2350+7G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000785722	19	17945373	19	17834564	785722	779992	rs200658439	NC_000019.10:17834563:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 3, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.2350+6C>T	JAK3		not specified|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001063395	19	17945374	19	17834565	1063395	1051155	rs200193137	NC_000019.10:17834564:G:A	single nucleotide variant	intron variant	Uncertain significance	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2350+5C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001379761	19	17945375	19	17834566	1379761	1483140	rs2147681249	NC_000019.10:17834565:G:A	single nucleotide variant	intron variant	Uncertain significance	Mar 19, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2350+2T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003723483	19	17945378	19	17834569	3723483	3850694		NC_000019.10:17834568:A:G	single nucleotide variant	splice donor variant	Pathogenic	Jul 25, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2350+1G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002865417	19	17945379	19	17834570	2865417	3030198		NC_000019.10:17834569:C:G	single nucleotide variant	splice donor variant	Likely pathogenic	Nov 13, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2350+1G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002747421	19	17945379	19	17834570	2747421	2904314		NC_000019.10:17834569:C:A	single nucleotide variant	splice donor variant	Likely pathogenic	Jul 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2350G>A (p.Asp784Asn)	JAK3	D784N	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002152312	19	17945380	19	17834571	2152312	1892383		NC_000019.10:17834570:C:T	single nucleotide variant	missense variant	Pathogenic	Sep 19, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2349A>T (p.Ser783=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002140128	19	17945381	19	17834572	2140128	1868959		NC_000019.10:17834571:T:A	single nucleotide variant	synonymous variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2348C>T (p.Ser783Leu)	JAK3	S783L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001954391	19	17945382	19	17834573	1954391	2018406		NC_000019.10:17834572:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2345C>T (p.Ser782Phe)	JAK3	S782F	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002156169	19	17945385	19	17834576	2156169	1889768		NC_000019.10:17834575:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2333A>G (p.Asn778Ser)	JAK3	N778S	T-B+ severe combined immunodeficiency due to JAK3 deficiency|Inborn genetic diseases	VCV000840789	19	17945397	19	17834588	840789	847420	rs199861157	NC_000019.10:17834587:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2319_2325dup (p.Asp776delinsHisSerTer)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002692977	19	17945404 - 17945405	19	17834595 - 17834596	2692977	2863804		NC_000019.10:17834595:ACGAATGACG:ACGAATGACGAATGACG	Duplication	nonsense	Pathogenic	Nov 3, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2324G>A (p.Arg775His)	JAK3	R775H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001339536	19	17945406	19	17834597	1339536	1330682	rs1251299279	NC_000019.10:17834596:C:T	single nucleotide variant	missense variant	Pathogenic	Dec 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2323C>T (p.Arg775Cys)	JAK3	R775C	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000134574	19	17945407	19	17834598	134574	138313	rs200624610	NC_000019.10:17834597:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.2317G>A (p.Val773Ile)	JAK3	V773I	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000933853	19	17945413	19	17834604	933853	938614	rs201531563	NC_000019.10:17834603:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.2316C>T (p.Ala772=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003020097	19	17945414	19	17834605	3020097	3182964		NC_000019.10:17834604:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2316C>A (p.Ala772=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000657554	19	17945414	19	17834605	657554	647804	rs139268535	NC_000019.10:17834604:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.2311C>A (p.Arg771=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002783873	19	17945419	19	17834610	2783873	2945017		NC_000019.10:17834609:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 4, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2311C>T (p.Arg771Ter)	JAK3	R771*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001459771	19	17945419	19	17834610	1459771	1484959	rs1198251679	NC_000019.10:17834609:G:A	single nucleotide variant	nonsense	Pathogenic	Feb 21, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.2304C>T (p.Pro768=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002764104	19	17945426	19	17834617	2764104	2922273		NC_000019.10:17834616:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2295C>G (p.Val765=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003697460	19	17945435	19	17834626	3697460	3832945		NC_000019.10:17834625:G:C	single nucleotide variant	synonymous variant	Likely benign	Mar 2, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2292G>A (p.Pro764=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000728428	19	17945438	19	17834629	728428	741706	rs200685231	NC_000019.10:17834628:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2291C>T (p.Pro764Leu)	JAK3	P764L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000863482	19	17945439	19	17834630	863482	847421	rs149982493	NC_000019.10:17834629:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.2285A>G (p.Tyr762Cys)	JAK3	Y762C	not specified	VCV003366594	19	17945445	19	17834636	3366594	3525798		NC_000019.10:17834635:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2280G>T (p.Met760Ile)	JAK3	M760I	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001998302	19	17945450	19	17834641	1998302	2054083		NC_000019.10:17834640:C:A	single nucleotide variant	missense variant	Uncertain significance	May 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2279T>C (p.Met760Thr)	JAK3	M760T	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003017627	19	17945451	19	17834642	3017627	3175294		NC_000019.10:17834641:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2272C>T (p.Gln758Ter)	JAK3	Q758*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002704615	19	17945458	19	17834649	2704615	2863027		NC_000019.10:17834648:G:A	single nucleotide variant	nonsense	Pathogenic	Dec 21, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2263del (p.Leu754_Leu755insTer)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002853266	19	17945467	19	17834658	2853266	3016738		NC_000019.10:17834657:G:	Deletion	nonsense	Pathogenic	Apr 7, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2262G>A (p.Leu754=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000464098	19	17945468	19	17834659	464098	468562	rs375857709	NC_000019.10:17834658:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 7, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2261T>C (p.Leu754Pro)	JAK3	L754P	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002756878	19	17945469	19	17834660	2756878	2920649		NC_000019.10:17834659:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2259C>G (p.Ala753=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002187216	19	17945471	19	17834662	2187216	1914624		NC_000019.10:17834661:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2259C>T (p.Ala753=)	JAK3		Severe combined immunodeficiency disease|T-B+ severe combined immunodeficiency due to JAK3 deficiency|not specified|not provided	VCV000036418	19	17945471	19	17834662	36418	45081	rs35458530	NC_000019.10:17834661:G:A	single nucleotide variant	synonymous variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2258C>A (p.Ala753Asp)	JAK3	A753D	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000891243	19	17945472	19	17834663	891243	880116	rs2094220604	NC_000019.10:17834662:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.2254C>T (p.Leu752=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000891244	19	17945476	19	17834667	891244	880117	rs200123352	NC_000019.10:17834666:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 20, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.2243del (p.Lys748fs)	JAK3	K748fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003583522	19	17945487	19	17834678	3583522	3709367		NC_000019.10:17834677:TT:T	Deletion	frameshift variant	Pathogenic	Apr 15, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2243A>G (p.Lys748Arg)	JAK3	K748R	Inborn genetic diseases	VCV003112154	19	17945487	19	17834678	3112154	3275308		NC_000019.10:17834677:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2242A>T (p.Lys748Ter)	JAK3	K748*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003610270	19	17945488	19	17834679	3610270	3737798		NC_000019.10:17834678:T:A	single nucleotide variant	nonsense	Pathogenic	Feb 18, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2237C>T (p.Ala746Val)	JAK3	A746V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001483289	19	17945493	19	17834684	1483289	1380408	rs2094220656	NC_000019.10:17834683:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2235G>A (p.Pro745=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000703296	19	17945495	19	17834686	703296	694359	rs149207170	NC_000019.10:17834685:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2222G>A (p.Arg741Gln)	JAK3	R741Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000835046	19	17945508	19	17834699	835046	847422	rs202027945	NC_000019.10:17834698:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2021	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2219A>G (p.Asp740Gly)	JAK3	D740G	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002804090	19	17945511	19	17834702	2804090	2973752		NC_000019.10:17834701:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2208A>G (p.Gln736=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002905366	19	17945522	19	17834713	2905366	3065471		NC_000019.10:17834712:T:C	single nucleotide variant	synonymous variant	Likely benign	Jan 18, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2200-5dup	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002853785	19	17945534 - 17945535	19	17834725 - 17834726	2853785	3013584		NC_000019.10:17834725:GGG:GGGG	Duplication	intron variant	Likely benign	Apr 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2200-8A>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003017214	19	17945538	19	17834729	3017214	3174882		NC_000019.10:17834728:T:C	single nucleotide variant	intron variant	Likely benign	Apr 10, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2200-12T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002707600	19	17945542	19	17834733	2707600	2877632		NC_000019.10:17834732:A:G	single nucleotide variant	intron variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2200-13C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002809770	19	17945543	19	17834734	2809770	2972139		NC_000019.10:17834733:G:A	single nucleotide variant	intron variant	Likely benign	Jul 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2200-14C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002823589	19	17945544	19	17834735	2823589	2985954		NC_000019.10:17834734:G:A	single nucleotide variant	intron variant	Likely benign	Sep 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2200-17G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002736293	19	17945547	19	17834738	2736293	2894985		NC_000019.10:17834737:C:A	single nucleotide variant	intron variant	Likely benign	Sep 15, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2199+20C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002840089	19	17945641	19	17834832	2840089	3003311		NC_000019.10:17834831:G:A	single nucleotide variant	intron variant	Likely benign	Feb 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2199+18G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002202191	19	17945643	19	17834834	2202191	1931314		NC_000019.10:17834833:C:T	single nucleotide variant	intron variant	Likely benign	Jan 10, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2199+17C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002910773	19	17945644	19	17834835	2910773	3070198		NC_000019.10:17834834:G:A	single nucleotide variant	intron variant	Likely benign	Oct 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2199+15C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003000260	19	17945646	19	17834837	3000260	3160555		NC_000019.10:17834836:G:A	single nucleotide variant	intron variant	Likely benign	Aug 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2199+14A>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002837402	19	17945647	19	17834838	2837402	2995959		NC_000019.10:17834837:T:G	single nucleotide variant	intron variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2199+11C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001648921	19	17945650	19	17834841	1648921	1662573	rs1380361871	NC_000019.10:17834840:G:A	single nucleotide variant	intron variant	Likely benign	Sep 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2199+10C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001570578	19	17945651	19	17834842	1570578	1537073	rs185973755	NC_000019.10:17834841:G:C	single nucleotide variant	intron variant	Likely benign	Dec 22, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2199+9C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003643925	19	17945652	19	17834843	3643925	3779779		NC_000019.10:17834842:G:A	single nucleotide variant	intron variant	Likely benign	Mar 9, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2199+8C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002967245	19	17945653	19	17834844	2967245	3124561		NC_000019.10:17834843:G:A	single nucleotide variant	intron variant	Likely benign	May 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2199+8C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002798933	19	17945653	19	17834844	2798933	2962210		NC_000019.10:17834843:G:C	single nucleotide variant	intron variant	Likely benign	Jun 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2199+4A>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001423210	19	17945657	19	17834848	1423210	1425489	rs2094221083	NC_000019.10:17834847:T:C	single nucleotide variant	intron variant	Uncertain significance	Nov 6, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2196T>C (p.Ala732=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002846149	19	17945664	19	17834855	2846149	3008509		NC_000019.10:17834854:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2185C>T (p.Leu729=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002962487	19	17945675	19	17834866	2962487	3123691		NC_000019.10:17834865:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 26, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2181T>C (p.Ser727=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002746249	19	17945679	19	17834870	2746249	2911759		NC_000019.10:17834869:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2177T>G (p.Ile726Ser)	JAK3	I726S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002003873	19	17945683	19	17834874	2003873	2051930		NC_000019.10:17834873:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2165T>C (p.Val722Ala)	JAK3	V722A	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000965790	19	17945695	19	17834886	965790	958568	rs1322146058	NC_000019.10:17834885:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2164G>A (p.Val722Ile)	JAK3	V722I	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000134573	19	17945696	19	17834887	134573	138312	rs3213409	NC_000019.10:17834886:C:T	single nucleotide variant	missense variant	Benign	Apr 3, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.2163C>T (p.Gly721=)	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001634727	19	17945697	19	17834888	1634727	1546680	rs200715301	NC_000019.10:17834887:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2158A>T (p.Ser720Cys)	JAK3	S720C	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002735499	19	17945702	19	17834893	2735499	2901522		NC_000019.10:17834892:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2157T>C (p.Phe719=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002996870	19	17945703	19	17834894	2996870	3159754		NC_000019.10:17834893:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2152G>C (p.Val718Leu)	JAK3	V718L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000134572	19	17945708	19	17834899	134572	138311	rs146837396	NC_000019.10:17834898:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.2147G>A (p.Trp716Ter)	JAK3	W716*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003638704	19	17945713	19	17834904	3638704	3771571		NC_000019.10:17834903:C:T	single nucleotide variant	nonsense	Pathogenic	Dec 9, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2142G>A (p.Thr714=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000853115	19	17945718	19	17834909	853115	847423	rs1473714442	NC_000019.10:17834908:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 7, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2141C>T (p.Thr714Met)	JAK3	T714M	Severe combined immunodeficiency disease|T-B+ severe combined immunodeficiency due to JAK3 deficiency|Neoplasm	VCV002577241	19	17945719	19	17834910	2577241	2742140		NC_000019.10:17834909:G:A	single nucleotide variant	missense variant	Pathogenic	Apr 11, 2024	criteria provided, multiple submitters, no conflicts				Uncertain significance	Jul 31, 2024	criteria provided, single submitter	
NM_000215.4(JAK3):c.2136C>T (p.Gly712=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000795356	19	17945724	19	17834915	795356	786109	rs769105045	NC_000019.10:17834914:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 7, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2134G>A (p.Gly712Ser)	JAK3	G712S	JAK3-related disorder|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001515055	19	17945726	19	17834917	1515055	1482244	rs1178958564	NC_000019.10:17834916:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.2133C>T (p.Phe711=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001091735	19	17945727	19	17834918	1091735	1084518	rs200726812	NC_000019.10:17834917:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.2125T>A (p.Trp709Arg)	JAK3	W709R		VCV000624607	19	17945735	19	17834926	624607	613418	rs748216175	NC_000019.10:17834925:A:T	single nucleotide variant	missense variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	
NM_000215.3(JAK3):c.[1796T>G;2125T>A]	JAK3	W709R, V599G	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000624581	19|19	17945735	19|19	17834926	624581	613418|613419	rs748216175|rs1568403355	NC_000019.10:17834925:A:T|NC_000019.10:17836041:A:C	Haplotype	missense variant	Pathogenic	Feb 28, 2019	no assertion criteria provided							
NM_000215.4(JAK3):c.2105T>C (p.Leu702Pro)	JAK3	L702P	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000639761	19	17945755	19	17834946	639761	647805	rs772117537	NC_000019.10:17834945:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2097G>A (p.Ala699=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328506	19	17945763	19	17834954	328506	349528	rs571402316	NC_000019.10:17834953:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 20, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.2096C>T (p.Ala699Val)	JAK3	A699V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001910226	19	17945764	19	17834955	1910226	1969151		NC_000019.10:17834954:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2095G>T (p.Ala699Ser)	JAK3	A699S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000570559	19	17945765	19	17834956	570559	574907	rs199938989	NC_000019.10:17834955:C:A	single nucleotide variant	missense variant	Uncertain significance	May 25, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2090G>A (p.Arg697Gln)	JAK3	R697Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000861796	19	17945770	19	17834961	861796	847424	rs200849846	NC_000019.10:17834960:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2089C>T (p.Arg697Trp)	JAK3	R697W	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000579162	19	17945771	19	17834962	579162	572977	rs201838318	NC_000019.10:17834961:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2079C>T (p.Pro693=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328507	19	17945781	19	17834972	328507	348329	rs145377049	NC_000019.10:17834971:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 1, 2025	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.2076C>T (p.Ala692=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002961830	19	17945784	19	17834975	2961830	3116992		NC_000019.10:17834974:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2073G>T (p.Val691=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003694242	19	17945787	19	17834978	3694242	3832343		NC_000019.10:17834977:C:A	single nucleotide variant	synonymous variant	Likely benign	Feb 16, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2073G>A (p.Val691=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002175046	19	17945787	19	17834978	2175046	1901185		NC_000019.10:17834977:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 7, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2067C>T (p.Pro689=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002840128	19	17945793	19	17834984	2840128	3003349		NC_000019.10:17834983:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2062A>T (p.Ile688Phe)	JAK3	I688F	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000134571	19	17945798	19	17834989	134571	138310	rs35785705	NC_000019.10:17834988:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 15, 2021	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.2055C>G (p.Thr685=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003020981	19	17945805	19	17834996	3020981	3176040		NC_000019.10:17834995:G:C	single nucleotide variant	synonymous variant	Likely benign	Aug 5, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2055C>A (p.Thr685=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002024126	19	17945805	19	17834996	2024126	2080752		NC_000019.10:17834995:G:T	single nucleotide variant	synonymous variant	Uncertain significance	Aug 13, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2055C>T (p.Thr685=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001633435	19	17945805	19	17834996	1633435	1598360	rs745486642	NC_000019.10:17834995:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 2, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2048-4T>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000765299	19	17945816	19	17835007	765299	776567	rs1599870679	NC_000019.10:17835006:A:C	single nucleotide variant	intron variant	Likely benign	Aug 8, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.2048-9T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002991499	19	17945821	19	17835012	2991499	3147932		NC_000019.10:17835011:A:G	single nucleotide variant	intron variant	Likely benign	Aug 30, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2048-18C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002729255	19	17945830	19	17835021	2729255	2893168		NC_000019.10:17835020:G:A	single nucleotide variant	intron variant	Likely benign	Jun 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2048-19C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002819150	19	17945831	19	17835022	2819150	2977676		NC_000019.10:17835021:G:C	single nucleotide variant	intron variant	Likely benign	May 30, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2048-19C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001531572	19	17945831	19	17835022	1531572	1666068	rs2147682566	NC_000019.10:17835021:G:T	single nucleotide variant	intron variant	Likely benign	Apr 30, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2047+20G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002028657	19	17945872	19	17835063	2028657	2085292		NC_000019.10:17835062:C:G	single nucleotide variant	intron variant	Likely benign	Sep 17, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2047+19A>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001532089	19	17945873	19	17835064	1532089	1583009	rs2147682659	NC_000019.10:17835063:T:A	single nucleotide variant	intron variant	Likely benign	Jun 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2047+15G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001639001	19	17945877	19	17835068	1639001	1525730	rs200237945	NC_000019.10:17835067:C:T	single nucleotide variant	intron variant	Likely benign	Apr 29, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2047+5G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002803857	19	17945887	19	17835078	2803857	2963681		NC_000019.10:17835077:C:G	single nucleotide variant	intron variant	Uncertain significance	Aug 19, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2031T>C (p.Ala677=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002713211	19	17945908	19	17835099	2713211	2875509		NC_000019.10:17835098:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 21, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2030C>G (p.Ala677Gly)	JAK3	A677G	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002115631	19	17945909	19	17835100	2115631	2182570		NC_000019.10:17835099:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2029G>A (p.Ala677Thr)	JAK3	A677T	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002054476	19	17945910	19	17835101	2054476	2112358		NC_000019.10:17835100:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 13, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.2028del (p.Ala677fs)	JAK3	A677fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002781950	19	17945911	19	17835102	2781950	2944393		NC_000019.10:17835101:GGGG:GGG	Deletion	frameshift variant	Pathogenic	Jan 8, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2028C>G (p.Pro676=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002034826	19	17945911	19	17835102	2034826	2090174		NC_000019.10:17835101:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 8, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.2028C>T (p.Pro676=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001528408	19	17945911	19	17835102	1528408	1603555	rs137936180	NC_000019.10:17835101:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 9, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.2016T>C (p.Pro672=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001110726	19	17945923	19	17835114	1110726	1106272	rs200250579	NC_000019.10:17835113:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2005C>T (p.Leu669=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002803230	19	17945934	19	17835125	2803230	2966911		NC_000019.10:17835124:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 25, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.2004G>A (p.Lys668=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002832085	19	17945935	19	17835126	2832085	2998299		NC_000019.10:17835125:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 2, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1997TCA[1] (p.Ile667del)	JAK3	I667del	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001390206	19	17945937 - 17945939	19	17835128 - 17835130	1390206	1373805	rs2147682930	NC_000019.10:17835127:TGATGA:TGA	Microsatellite	inframe_deletion	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1995C>T (p.Pro665=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000532751	19	17945944	19	17835135	532751	532848	rs3212768	NC_000019.10:17835134:G:A	single nucleotide variant	synonymous variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.1992G>A (p.Pro664=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001109539	19	17945947	19	17835138	1109539	1106273	rs200499852	NC_000019.10:17835137:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 12, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1991C>T (p.Pro664Leu)	JAK3	P664L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000655724	19	17945948	19	17835139	655724	647806	rs373027121	NC_000019.10:17835138:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.1990C>A (p.Pro664Thr)	JAK3	P664T	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001009937	19	17945949	19	17835140	1009937	998447	rs575352564	NC_000019.10:17835139:G:T	single nucleotide variant	missense variant	Likely benign	May 13, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1980T>C (p.Ala660=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002888365	19	17945959	19	17835150	2888365	3051109		NC_000019.10:17835149:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 19, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1977G>T (p.Gly659=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002833097	19	17945962	19	17835153	2833097	3001424		NC_000019.10:17835152:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 31, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1971G>A (p.Arg657=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001595428	19	17945968	19	17835159	1595428	1656418	rs753209740	NC_000019.10:17835158:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 25, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1970G>A (p.Arg657Gln)	JAK3	R657Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000376113	19	17945969	19	17835160	376113	362992	rs758959409	NC_000019.10:17835159:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1969C>T (p.Arg657Trp)	JAK3	R657W	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000568283	19	17945970	19	17835161	568283	574908	rs1568403015	NC_000019.10:17835160:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1965G>A (p.Leu655=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001136967	19	17945974	19	17835165	1136967	1127683	rs199607834	NC_000019.10:17835164:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1953G>C (p.Arg651=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002065171	19	17945986	19	17835177	2065171	2121731		NC_000019.10:17835176:C:G	single nucleotide variant	synonymous variant	Likely benign	Mar 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1951C>T (p.Arg651Trp)	JAK3	R651W	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002736844	19	17945988	19	17835179	2736844	2905414		NC_000019.10:17835178:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1942G>C (p.Val648Leu)	JAK3	V648L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003720673	19	17945997	19	17835188	3720673	3856478		NC_000019.10:17835187:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1933C>T (p.His645Tyr)	JAK3	H645Y	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000532746	19	17946006	19	17835197	532746	532852	rs201479407	NC_000019.10:17835196:G:A	single nucleotide variant	missense variant	Uncertain significance	May 23, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1929G>A (p.Leu643=)	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328508	19	17946010	19	17835201	328508	332826	rs138645044	NC_000019.10:17835200:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.1926C>T (p.Gly642=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003644600	19	17946013	19	17835204	3644600	3776399		NC_000019.10:17835203:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 5, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1926C>A (p.Gly642=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002799970	19	17946013	19	17835204	2799970	2955908		NC_000019.10:17835203:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 26, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1925G>C (p.Gly642Ala)	JAK3	G642A	Inborn genetic diseases	VCV002251489	19	17946014	19	17835205	2251489	2242635		NC_000019.10:17835204:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.1924G>C (p.Gly642Arg)	JAK3	G642R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001006192	19	17946015	19	17835206	1006192	998448	rs1435749725	NC_000019.10:17835205:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1917G>A (p.Glu639=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002970757	19	17946022	19	17835213	2970757	3135833		NC_000019.10:17835212:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 24, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1915-1G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002048620	19	17946025	19	17835216	2048620	2103921		NC_000019.10:17835215:C:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Nov 14, 2023	reviewed by expert panel							
NM_000215.4(JAK3):c.1915-6C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003020273	19	17946030	19	17835221	3020273	3179181		NC_000019.10:17835220:G:A	single nucleotide variant	intron variant	Likely benign	Apr 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1915-7C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002702863	19	17946031	19	17835222	2702863	2866414		NC_000019.10:17835221:G:T	single nucleotide variant	intron variant	Likely benign	Dec 13, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1915-10G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002179194	19	17946034	19	17835225	2179194	1919591		NC_000019.10:17835224:C:T	single nucleotide variant	intron variant	Likely benign	Feb 22, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1915-11G>A	JAK3		Severe combined immunodeficiency disease	VCV002581273	19	17946035	19	17835226	2581273	2748856		NC_000019.10:17835225:C:T	single nucleotide variant	intron variant	Likely pathogenic	Aug 21, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1915-17G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002778031	19	17946041	19	17835232	2778031	2937026		NC_000019.10:17835231:C:G	single nucleotide variant	intron variant	Likely benign	Feb 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1915-20C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001598810	19	17946044	19	17835235	1598810	1630806	rs564212195	NC_000019.10:17835234:G:A	single nucleotide variant	intron variant	Benign	Jan 23, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.1915-30C>T	JAK3		not specified|not provided	VCV000632862	19	17946054	19	17835245	632862	621870	rs2072496	NC_000019.10:17835244:G:A	single nucleotide variant	intron variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1914+77G>C	JAK3		not provided	VCV001706845	19	17946656	19	17835847	1706845	1705156		NC_000019.10:17835846:C:G	single nucleotide variant	intron variant	Likely benign	Jul 7, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1914+17C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001672894	19	17946716	19	17835907	1672894	1531340	rs2147684071	NC_000019.10:17835906:G:A	single nucleotide variant	intron variant	Likely benign	Jul 1, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1914+13C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002752797	19	17946720	19	17835911	2752797	2913538		NC_000019.10:17835910:G:C	single nucleotide variant	intron variant	Likely benign	Aug 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1914+11C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003679525	19	17946722	19	17835913	3679525	3814549		NC_000019.10:17835912:G:A	single nucleotide variant	intron variant	Likely benign	Feb 9, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1914+10C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided	VCV000777053	19	17946723	19	17835914	777053	778504	rs200964315	NC_000019.10:17835913:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1914+1G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000855030	19	17946732	19	17835923	855030	852319	rs936493226	NC_000019.10:17835922:C:T	single nucleotide variant	splice donor variant	Likely pathogenic	Jan 8, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.1912C>G (p.Leu638Val)	JAK3	L638V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000851590	19	17946735	19	17835926	851590	847425	rs757311496	NC_000019.10:17835925:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.1907A>G (p.Asn636Ser)	JAK3	N636S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001979548	19	17946740	19	17835931	1979548	2034927		NC_000019.10:17835930:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1899C>A (p.Tyr633Ter)	JAK3	Y633*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003583523	19	17946748	19	17835939	3583523	3709368		NC_000019.10:17835938:G:T	single nucleotide variant	nonsense	Pathogenic	May 13, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1899C>T (p.Tyr633=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not specified	VCV000389294	19	17946748	19	17835939	389294	377556	rs538081227	NC_000019.10:17835938:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1896C>G (p.Ala632=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002114705	19	17946751	19	17835942	2114705	2164708		NC_000019.10:17835941:G:C	single nucleotide variant	synonymous variant	Likely benign	May 19, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1890G>A (p.Gln630=)	JAK3		Severe combined immunodeficiency disease|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000036417	19	17946757	19	17835948	36417	45080	rs193922363	NC_000019.10:17835947:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1888C>T (p.Gln630Ter)	JAK3	Q630*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002865802	19	17946759	19	17835950	2865802	3026875		NC_000019.10:17835949:G:A	single nucleotide variant	nonsense	Pathogenic	May 19, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1881G>A (p.Val627=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002998274	19	17946766	19	17835957	2998274	3159866		NC_000019.10:17835956:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1878G>C (p.Gln626His)	JAK3	Q626H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001370965	19	17946769	19	17835960	1370965	1427171	rs2147684176	NC_000019.10:17835959:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 10, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.1869G>A (p.Trp623Ter)	JAK3	W623*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002797819	19	17946778	19	17835969	2797819	2958938		NC_000019.10:17835968:C:T	single nucleotide variant	nonsense	Pathogenic	Dec 7, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1863C>T (p.Ala621=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003661210	19	17946784	19	17835975	3661210	3790869		NC_000019.10:17835974:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1860A>C (p.Pro620=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001609980	19	17946787	19	17835978	1609980	1550936	rs2147684222	NC_000019.10:17835977:T:G	single nucleotide variant	synonymous variant	Likely benign	Dec 12, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1848C>T (p.Gly616=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003641189	19	17946799	19	17835990	3641189	3768907		NC_000019.10:17835989:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 16, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1843C>T (p.Arg615Cys)	JAK3	R615C	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000134569	19	17946804	19	17835995	134569	138308	rs200075643	NC_000019.10:17835994:G:A	single nucleotide variant	missense variant	Benign	Apr 3, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.1837C>A (p.Arg613=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002720908	19	17946810	19	17836001	2720908	2891309		NC_000019.10:17836000:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 16, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1837C>T (p.Arg613Ter)	JAK3	R613*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000644288	19	17946810	19	17836001	644288	647807	rs149316157	NC_000019.10:17836000:G:A	single nucleotide variant	nonsense	Pathogenic	Nov 14, 2023	reviewed by expert panel							
NM_000215.4(JAK3):c.1830G>A (p.Met610Ile)	JAK3	M610I	not specified	VCV000134570	19	17946817	19	17836008	134570	138309	rs587778415	NC_000019.10:17836007:C:T	single nucleotide variant	missense variant	not provided	Sep 19, 2013	no classification provided							
NM_000215.4(JAK3):c.1829T>C (p.Met610Thr)	JAK3	M610T	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001389761	19	17946818	19	17836009	1389761	1377241	rs896905338	NC_000019.10:17836008:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.1822A>G (p.Ile608Val)	JAK3	I608V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002077340	19	17946825	19	17836016	2077340	2131398		NC_000019.10:17836015:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1818G>A (p.Gly606=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003008363	19	17946829	19	17836020	3008363	3166014		NC_000019.10:17836019:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 26, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1815G>A (p.Leu605=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002803864	19	17946832	19	17836023	2803864	2963688		NC_000019.10:17836022:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1805T>C (p.Phe602Ser)	JAK3	F602S	Inborn genetic diseases|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001011563	19	17946842	19	17836033	1011563	998449	rs147408277	NC_000019.10:17836032:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1797G>C (p.Val599=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002756618	19	17946850	19	17836041	2756618	2910019		NC_000019.10:17836040:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 15, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1796T>G (p.Val599Gly)	JAK3	V599G	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000624608	19	17946851	19	17836042	624608	613419	rs1568403355	NC_000019.10:17836041:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2023	reviewed by expert panel							
NM_000215.4(JAK3):c.1794G>C (p.Met598Ile)	JAK3	M598I	Inborn genetic diseases|T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided	VCV000328509	19	17946853	19	17836044	328509	348333	rs138143146	NC_000019.10:17836043:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1791C>T (p.Thr597=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002694810	19	17946856	19	17836047	2694810	2857517		NC_000019.10:17836046:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1787-4C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001136529	19	17946864	19	17836055	1136529	1127684	rs2147684406	NC_000019.10:17836054:G:A	single nucleotide variant	intron variant	Likely benign	Dec 11, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1787-11dup	JAK3		Severe combined immunodeficiency disease|T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided	VCV000328510	19	17946870 - 17946871	19	17836061 - 17836062	328510	348336	rs397839895	NC_000019.10:17836061:G:GG	Duplication	intron variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1787-11C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002916267	19	17946871	19	17836062	2916267	3071776		NC_000019.10:17836061:G:A	single nucleotide variant	intron variant	Likely benign	Nov 13, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1787-15C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002021947	19	17946875	19	17836066	2021947	2083708		NC_000019.10:17836065:G:T	single nucleotide variant	intron variant	Likely benign	Aug 5, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1787-16C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002787335	19	17946876	19	17836067	2787335	2945884		NC_000019.10:17836066:G:A	single nucleotide variant	intron variant	Likely benign	Apr 15, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1787-18C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002885246	19	17946878	19	17836069	2885246	3046706		NC_000019.10:17836068:G:A	single nucleotide variant	intron variant	Likely benign	Jan 12, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1787-19T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002121553	19	17946879	19	17836070	2121553	2180735		NC_000019.10:17836069:A:G	single nucleotide variant	intron variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1787-20C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002816019	19	17946880	19	17836071	2816019	2976689		NC_000019.10:17836070:G:A	single nucleotide variant	intron variant	Likely benign	Nov 23, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1787-84C>T	JAK3		not provided	VCV001183170	19	17946944	19	17836135	1183170	1173204	rs28493430	NC_000019.10:17836134:G:A	single nucleotide variant	intron variant	Likely benign	Aug 26, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1787-334A>G	JAK3		not provided	VCV001223367	19	17947194	19	17836385	1223367	1211188	rs3212764	NC_000019.10:17836384:T:C	single nucleotide variant	intron variant	Benign	Jul 9, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+144_1786+147del	JAK3		not provided	VCV001277378	19	17947791 - 17947794	19	17836982 - 17836985	1277378	1265958	rs3212757	NC_000019.10:17836981:ATAAATAAA:ATAAA	Microsatellite	intron variant	Benign	Jul 9, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+91C>A	JAK3		not provided	VCV001281410	19	17947847	19	17837038	1281410	1270405	rs3212756	NC_000019.10:17837037:G:T	single nucleotide variant	intron variant	Benign	Jul 9, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1786+20C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002837096	19	17947918	19	17837109	2837096	2999475		NC_000019.10:17837108:G:A	single nucleotide variant	intron variant	Likely benign	Feb 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+19C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003642582	19	17947919	19	17837110	3642582	3765353		NC_000019.10:17837109:G:A	single nucleotide variant	intron variant	Likely benign	Feb 22, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+17C>T	JAK3		not provided	VCV001175377	19	17947921	19	17837112	1175377	1165121	rs2094226037	NC_000019.10:17837111:G:A	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+16C>T	JAK3		not provided	VCV001281897	19	17947922	19	17837113	1281897	1273124	rs1458827267	NC_000019.10:17837112:G:A	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+15C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002739868	19	17947923	19	17837114	2739868	2895918		NC_000019.10:17837113:G:A	single nucleotide variant	intron variant	Likely benign	Jan 31, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+13dup	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001534184	19	17947924 - 17947925	19	17837115 - 17837116	1534184	1647752	rs761961495	NC_000019.10:17837115:GGGGGG:GGGGGGG	Duplication	intron variant	Benign	Aug 8, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+14A>C	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001207364	19	17947924	19	17837115	1207364	1199091	rs756976635	NC_000019.10:17837114:T:G	single nucleotide variant	intron variant	Likely benign	Dec 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1786+13C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000889059	19	17947925	19	17837116	889059	880712	rs781208496	NC_000019.10:17837115:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.1786+9C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002859349	19	17947929	19	17837120	2859349	3021963		NC_000019.10:17837119:G:T	single nucleotide variant	intron variant	Likely benign	Aug 5, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+8C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002795415	19	17947930	19	17837121	2795415	2961288		NC_000019.10:17837120:G:A	single nucleotide variant	intron variant	Likely benign	Jun 10, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+8C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002202909	19	17947930	19	17837121	2202909	1928559		NC_000019.10:17837120:G:C	single nucleotide variant	intron variant	Likely benign	Oct 22, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+7G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002803802	19	17947931	19	17837122	2803802	2963626		NC_000019.10:17837121:C:G	single nucleotide variant	intron variant	Likely benign	Nov 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+7G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002801235	19	17947931	19	17837122	2801235	2959763		NC_000019.10:17837121:C:A	single nucleotide variant	intron variant	Likely benign	Jul 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+7G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001123720	19	17947931	19	17837122	1123720	1127685	rs1011716310	NC_000019.10:17837121:C:T	single nucleotide variant	intron variant	Likely benign	Nov 14, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+6A>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000704858	19	17947932	19	17837123	704858	695815	rs372156975	NC_000019.10:17837122:T:A	single nucleotide variant	intron variant	Likely benign	Feb 2, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+2_1786+5del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002775535	19	17947933 - 17947936	19	17837124 - 17837127	2775535	2942727		NC_000019.10:17837123:CTCACT:CT	Deletion	splice donor variant	Likely pathogenic	Sep 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+3G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002736845	19	17947935	19	17837126	2736845	2905415		NC_000019.10:17837125:C:A	single nucleotide variant	intron variant	Pathogenic	May 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786+1G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002745147	19	17947937	19	17837128	2745147	2897310		NC_000019.10:17837127:C:T	single nucleotide variant	splice donor variant	Likely pathogenic	Jul 19, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1786A>C (p.Ser596Arg)	JAK3	S596R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002761066	19	17947938	19	17837129	2761066	2918360		NC_000019.10:17837128:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1772G>A (p.Cys591Tyr)	JAK3	C591Y	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003638257	19	17947952	19	17837143	3638257	3774552		NC_000019.10:17837142:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1768G>A (p.Val590Met)	JAK3	V590M	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000965844	19	17947956	19	17837147	965844	958569	rs1040476469	NC_000019.10:17837146:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1767C>T (p.Gly589=)	JAK3		Severe combined immunodeficiency disease|T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided	VCV000036416	19	17947957	19	17837148	36416	45079	rs193922362	NC_000019.10:17837147:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jul 14, 2021	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.1765G>A (p.Gly589Ser)	JAK3	G589S	Severe combined immunodeficiency disease|T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided|Adenoid cystic carcinoma	VCV000265205	19	17947959	19	17837150	265205	260213	rs886039394	NC_000019.10:17837149:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 20, 2024	criteria provided, multiple submitters, no conflicts				Uncertain significance	Nov 13, 2024	no assertion criteria provided	
NM_000215.4(JAK3):c.1764C>T (p.His588=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001140909	19	17947960	19	17837151	1140909	1127686	rs201482851	NC_000019.10:17837150:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1763A>C (p.His588Pro)	JAK3	H588P	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001009178	19	17947961	19	17837152	1009178	998450	rs1207883288	NC_000019.10:17837151:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.1755G>T (p.Val585=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001903686	19	17947969	19	17837160	1903686	1954425		NC_000019.10:17837159:C:A	single nucleotide variant	synonymous variant	Likely benign	Apr 25, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1753G>A (p.Val585Met)	JAK3	V585M	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001037955	19	17947971	19	17837162	1037955	1034153	rs199600889	NC_000019.10:17837161:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1752C>T (p.Leu584=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000728568	19	17947972	19	17837163	728568	741707	rs200582253	NC_000019.10:17837162:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 19, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1746G>A (p.Arg582=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002822892	19	17947978	19	17837169	2822892	2988680		NC_000019.10:17837168:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 21, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1745G>A (p.Arg582Gln)	JAK3	R582Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002144634	19	17947979	19	17837170	2144634	1873036		NC_000019.10:17837169:C:T	single nucleotide variant	missense variant	Uncertain significance	May 3, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1744C>T (p.Arg582Trp)	JAK3	R582W	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000036415	19	17947980	19	17837171	36415	45078	rs193922361	NC_000019.10:17837170:G:A	single nucleotide variant	missense variant	Likely pathogenic	Nov 14, 2023	reviewed by expert panel							
NM_000215.4(JAK3):c.1740G>T (p.Ser580=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003023135	19	17947984	19	17837175	3023135	3173038		NC_000019.10:17837174:C:A	single nucleotide variant	synonymous variant	Likely benign	May 2, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1740G>A (p.Ser580=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001156010	19	17947984	19	17837175	1156010	1148619	rs143605793	NC_000019.10:17837174:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 12, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1739C>G (p.Ser580Trp)	JAK3	S580W	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001362550	19	17947985	19	17837176	1362550	1373298	rs587778414	NC_000019.10:17837175:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1739C>T (p.Ser580Leu)	JAK3	S580L	not specified	VCV000134568	19	17947985	19	17837176	134568	138307	rs587778414	NC_000019.10:17837175:G:A	single nucleotide variant	missense variant	not provided	Sep 19, 2013	no classification provided							
NM_000215.4(JAK3):c.1732C>T (p.Gln578Ter)	JAK3	Q578*	Susceptibility to severe COVID-19	VCV003256936	19	17947992	19	17837183	3256936	3415692		NC_000019.10:17837182:G:A	single nucleotide variant	nonsense	Likely pathogenic	Jul 22, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1719G>A (p.Ala573=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002919406	19	17948005	19	17837196	2919406	3072289		NC_000019.10:17837195:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1719G>C (p.Ala573=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002904444	19	17948005	19	17837196	2904444	3058738		NC_000019.10:17837195:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1719G>T (p.Ala573=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001119745	19	17948005	19	17837196	1119745	1106274	rs201371931	NC_000019.10:17837195:C:A	single nucleotide variant	synonymous variant	Likely benign	May 21, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1710G>C (p.Leu570=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002919525	19	17948014	19	17837205	2919525	3072407		NC_000019.10:17837204:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 7, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1710G>A (p.Leu570=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000532750	19	17948014	19	17837205	532750	532780	rs3212755	NC_000019.10:17837204:C:T	single nucleotide variant	synonymous variant	Benign	Jan 22, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.1704A>G (p.Ser568=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002870880	19	17948020	19	17837211	2870880	3028059		NC_000019.10:17837210:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1702-3del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002731732	19	17948025	19	17837216	2731732	2890487		NC_000019.10:17837215:GGGG:GGG	Deletion	intron variant	Benign	Jun 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1702-4C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002992417	19	17948026	19	17837217	2992417	3155306		NC_000019.10:17837216:G:T	single nucleotide variant	intron variant	Likely benign	Aug 10, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1702-6C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002805115	19	17948028	19	17837219	2805115	2967499		NC_000019.10:17837218:G:A	single nucleotide variant	intron variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1702-9C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002714350	19	17948031	19	17837222	2714350	2868887		NC_000019.10:17837221:G:A	single nucleotide variant	intron variant	Likely benign	Jan 31, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1702-12C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003701594	19	17948034	19	17837225	3701594	3834197		NC_000019.10:17837224:G:A	single nucleotide variant	intron variant	Likely benign	Feb 10, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1702-15T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002723897	19	17948037	19	17837228	2723897	2881809		NC_000019.10:17837227:A:G	single nucleotide variant	intron variant	Likely benign	Dec 21, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1702-16T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002875360	19	17948038	19	17837229	2875360	3032769		NC_000019.10:17837228:A:G	single nucleotide variant	intron variant	Likely benign	Jan 30, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1701+83A>G	JAK3		not provided	VCV001266323	19	17948658	19	17837849	1266323	1256654	rs3212753	NC_000019.10:17837848:T:C	single nucleotide variant	intron variant	Benign	Aug 19, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1701+19A>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002773278	19	17948722	19	17837913	2773278	2934011		NC_000019.10:17837912:T:C	single nucleotide variant	intron variant	Likely benign	Nov 1, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1701+17C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002997565	19	17948724	19	17837915	2997565	3166910		NC_000019.10:17837914:G:A	single nucleotide variant	intron variant	Likely benign	Jun 25, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1701+11T>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002972779	19	17948730	19	17837921	2972779	3132726		NC_000019.10:17837920:A:C	single nucleotide variant	intron variant	Likely benign	Apr 15, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1701+9A>G	JAK3		not provided|not specified|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000137597	19	17948732	19	17837923	137597	141300	rs3212752	NC_000019.10:17837922:T:C	single nucleotide variant	intron variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1701+7G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002894448	19	17948734	19	17837925	2894448	3056089		NC_000019.10:17837924:C:T	single nucleotide variant	intron variant	Likely benign	Oct 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1701+6A>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002416641	19	17948735	19	17837926	2416641	1943864		NC_000019.10:17837925:T:C	single nucleotide variant	intron variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1701+5G>A	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002902514	19	17948736	19	17837927	2902514	3058110		NC_000019.10:17837926:C:T	single nucleotide variant	intron variant	Uncertain significance	Aug 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1701+2T>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001508758	19	17948739	19	17837930	1508758	1439969	rs2147687373	NC_000019.10:17837929:A:T	single nucleotide variant	splice donor variant	Pathogenic	Nov 15, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1701+1G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002131140	19	17948740	19	17837931	2131140	2191275		NC_000019.10:17837930:C:T	single nucleotide variant	splice donor variant	Pathogenic	Dec 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1688_1696del (p.Lys563_Cys565del)	JAK3		NK-cell enteropathy	VCV000638620	19	17948746 - 17948754	19	17837937 - 17837945	638620	626403	rs1599873586	NC_000019.10:17837936:TGCAGTTCTTG:TG	Deletion	inframe_deletion	Pathogenic	Jul 31, 2019	no assertion criteria provided							
NM_000215.4(JAK3):c.1695C>A (p.Cys565Ter)	JAK3	C565*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000009363	19	17948747	19	17837938	9363	24402	rs137852625	NC_000019.10:17837937:G:T	single nucleotide variant	nonsense	Pathogenic	Jun 13, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.1688_1693delinsTGGAGGTGAGA (p.Lys563fs)	JAK3	K563fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000643419	19	17948749 - 17948754	19	17837940 - 17837945	643419	647808	rs1599873591	NC_000019.10:17837939:AGTTCT:TCTCACCTCCA	Indel	frameshift variant	Pathogenic	Aug 6, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1686C>T (p.His562=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002711025	19	17948756	19	17837947	2711025	2878477		NC_000019.10:17837946:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1684C>T (p.His562Tyr)	JAK3	H562Y	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002163940	19	17948758	19	17837949	2163940	1905652		NC_000019.10:17837948:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1683G>A (p.Lys561=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001551459	19	17948759	19	17837950	1551459	1551238	rs2094228255	NC_000019.10:17837949:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 11, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1679C>G (p.Ala560Gly)	JAK3	A560G	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328511	19	17948763	19	17837954	328511	332828	rs886054279	NC_000019.10:17837953:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1678G>A (p.Ala560Thr)	JAK3	A560T	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000582570	19	17948764	19	17837955	582570	574909	rs771634723	NC_000019.10:17837954:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1678G>T (p.Ala560Ser)	JAK3	A560S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328512	19	17948764	19	17837955	328512	348338	rs771634723	NC_000019.10:17837954:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1677T>C (p.Asp559=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002704231	19	17948765	19	17837956	2704231	2866501		NC_000019.10:17837955:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 19, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1673T>C (p.Met558Thr)	JAK3	M558T	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001369531	19	17948769	19	17837960	1369531	1414543	rs777252992	NC_000019.10:17837959:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1672A>G (p.Met558Val)	JAK3	M558V	T-B+ severe combined immunodeficiency due to JAK3 deficiency|Inborn genetic diseases	VCV001003603	19	17948770	19	17837961	1003603	998451	rs200993230	NC_000019.10:17837960:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1662G>A (p.Leu554=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002826654	19	17948780	19	17837971	2826654	2986456		NC_000019.10:17837970:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 15, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1659G>A (p.Val553=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002899412	19	17948783	19	17837974	2899412	3057593		NC_000019.10:17837973:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1659G>C (p.Val553=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002838114	19	17948783	19	17837974	2838114	2992832		NC_000019.10:17837973:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1657dup (p.Val553fs)	JAK3	V553fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003583524	19	17948784 - 17948785	19	17837975 - 17837976	3583524	3709369		NC_000019.10:17837975:CC:CCC	Duplication	frameshift variant	Likely pathogenic	Apr 28, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1653A>G (p.Thr551=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328513	19	17948789	19	17837980	328513	348339	rs201698409	NC_000019.10:17837979:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Sep 19, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.1646G>A (p.Arg549Gln)	JAK3	R549Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000889060	19	17948796	19	17837987	889060	880118	rs201972084	NC_000019.10:17837986:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1645C>T (p.Arg549Ter)	JAK3	R549*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000803542	19	17948797	19	17837988	803542	791913	rs1011307501	NC_000019.10:17837987:G:A	single nucleotide variant	nonsense	Pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1644C>T (p.Ala548=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000532749	19	17948798	19	17837989	532749	533182	rs764363104	NC_000019.10:17837988:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 12, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1641G>A (p.Glu547=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002735798	19	17948801	19	17837992	2735798	2898808		NC_000019.10:17837991:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 13, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1639G>A (p.Glu547Lys)	JAK3	E547K	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002718497	19	17948803	19	17837994	2718497	2876893		NC_000019.10:17837993:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1635T>C (p.Asp545=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002874318	19	17948807	19	17837998	2874318	3038097		NC_000019.10:17837997:A:G	single nucleotide variant	synonymous variant	Likely benign	Jun 3, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1633G>C (p.Asp545His)	JAK3	D545H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001497773	19	17948809	19	17838000	1497773	1376293	rs2147687557	NC_000019.10:17837999:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2020	criteria provided, single submitter							
NM_000215.4(JAK3):c.1632G>T (p.Val544=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000751175	19	17948810	19	17838001	751175	772518	rs779887883	NC_000019.10:17838000:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 15, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.1631T>C (p.Val544Ala)	JAK3	V544A	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000648146	19	17948811	19	17838002	648146	647809	rs1367182709	NC_000019.10:17838001:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1622A>T (p.His541Leu)	JAK3	H541L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000661007	19	17948820	19	17838011	661007	647810	rs148777897	NC_000019.10:17838010:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1618C>T (p.Arg540Cys)	JAK3	R540C	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000941606	19	17948824	19	17838015	941606	938615	rs747854515	NC_000019.10:17838014:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1611G>A (p.Arg537=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002817860	19	17948831	19	17838022	2817860	2987501		NC_000019.10:17838021:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1610G>A (p.Arg537Gln)	JAK3	R537Q	not specified	VCV000134567	19	17948832	19	17838023	134567	138306	rs587778413	NC_000019.10:17838022:C:T	single nucleotide variant	missense variant	not provided	Sep 19, 2013	no classification provided							
NM_000215.4(JAK3):c.1609C>T (p.Arg537Trp)	JAK3	R537W	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000889750	19	17948833	19	17838024	889750	880119	rs746305522	NC_000019.10:17838023:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1593C>T (p.Ser531=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002697372	19	17948849	19	17838040	2697372	2864769		NC_000019.10:17838039:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 7, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1590G>T (p.Gly530=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003705976	19	17948852	19	17838043	3705976	3839429		NC_000019.10:17838042:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 3, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1587T>C (p.His529=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003616383	19	17948855	19	17838046	3616383	3742608		NC_000019.10:17838045:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1586A>G (p.His529Arg)	JAK3	H529R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000848740	19	17948856	19	17838047	848740	847426	rs142805245	NC_000019.10:17838046:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1583G>A (p.Gly528Asp)	JAK3	G528D	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002506461	19	17948859	19	17838050	2506461	2671419		NC_000019.10:17838049:C:T	single nucleotide variant	missense variant	Likely pathogenic	Sep 23, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1581G>A (p.Leu527=)	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000464097	19	17948861	19	17838052	464097	469484	rs3213408	NC_000019.10:17838051:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.1572T>C (p.His524=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002976376	19	17948870	19	17838061	2976376	3133732		NC_000019.10:17838060:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1570-5T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003021492	19	17948877	19	17838068	3021492	3172697		NC_000019.10:17838067:A:G	single nucleotide variant	intron variant	Likely benign	Nov 15, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1570-10C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002798509	19	17948882	19	17838073	2798509	2951864		NC_000019.10:17838072:G:C	single nucleotide variant	intron variant	Likely benign	Nov 10, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1570-13C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002872686	19	17948885	19	17838076	2872686	3037765		NC_000019.10:17838075:G:C	single nucleotide variant	intron variant	Likely benign	Dec 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1570-14C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003662402	19	17948886	19	17838077	3662402	3794836		NC_000019.10:17838076:G:C	single nucleotide variant	intron variant	Likely benign	Oct 28, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1570-15C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002979548	19	17948887	19	17838078	2979548	3138140		NC_000019.10:17838077:G:A	single nucleotide variant	intron variant	Likely benign	Sep 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1570-17del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002909767	19	17948889	19	17838080	2909767	3078434		NC_000019.10:17838079:C:	Deletion	intron variant	Likely benign	Dec 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1570-20G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002796826	19	17948892	19	17838083	2796826	2951480		NC_000019.10:17838082:C:T	single nucleotide variant	intron variant	Likely benign	Dec 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1569+19T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002880378	19	17949053	19	17838244	2880378	3033871		NC_000019.10:17838243:A:G	single nucleotide variant	intron variant	Likely benign	Dec 31, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1569+15G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002101241	19	17949057	19	17838248	2101241	2151261		NC_000019.10:17838247:C:A	single nucleotide variant	intron variant	Likely benign	Feb 21, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1569+14G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001535082	19	17949058	19	17838249	1535082	1531794	rs200624424	NC_000019.10:17838248:C:T	single nucleotide variant	intron variant	Likely benign	Sep 23, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1569+11C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003630727	19	17949061	19	17838252	3630727	3766193		NC_000019.10:17838251:G:A	single nucleotide variant	intron variant	Likely benign	Mar 6, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1569+8G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002985649	19	17949064	19	17838255	2985649	3153711		NC_000019.10:17838254:C:T	single nucleotide variant	intron variant	Likely benign	Apr 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1569G>A (p.Trp523Ter)	JAK3	W523*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002780389	19	17949072	19	17838263	2780389	2944129		NC_000019.10:17838262:C:T	single nucleotide variant	nonsense	Pathogenic	Jul 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1567T>G (p.Trp523Gly)	JAK3	W523G	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001435504	19	17949074	19	17838265	1435504	1432789	rs199635089	NC_000019.10:17838264:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2021	criteria provided, single submitter							
NC_000019.10:g.17838268_17838271delinsGTCA	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000567299	19	17949077 - 17949080	19	17838268 - 17838271	567299	574910	rs1568404443	NC_000019.10:17838267:CCAG:GTCA	Indel		Pathogenic	Aug 1, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1561C>G (p.Leu521Val)	JAK3	L521V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000134566	19	17949080	19	17838271	134566	138305	rs55666418	NC_000019.10:17838270:G:C	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1551T>A (p.Pro517=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided	VCV000328514	19	17949090	19	17838281	328514	343018	rs143936463	NC_000019.10:17838280:A:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.1550C>T (p.Pro517Leu)	JAK3	P517L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328515	19	17949091	19	17838282	328515	348343	rs759375144	NC_000019.10:17838281:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1548C>T (p.Ile516=)	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328516	19	17949093	19	17838284	328516	349531	rs144203232	NC_000019.10:17838283:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1547T>A (p.Ile516Asn)	JAK3	I516N	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000976341	19	17949094	19	17838285	976341	964517	rs2094229284	NC_000019.10:17838284:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1546A>T (p.Ile516Phe)	JAK3	I516F	Inborn genetic diseases	VCV002314670	19	17949095	19	17838286	2314670	2303148		NC_000019.10:17838285:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1545G>A (p.Lys515=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002871751	19	17949096	19	17838287	2871751	3031769		NC_000019.10:17838286:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1533G>A (p.Met511Ile)	JAK3	M511I	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002851082	19	17949108	19	17838299	2851082	3009584		NC_000019.10:17838298:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1529A>G (p.Gln510Arg)	JAK3	Q510R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001382356	19	17949112	19	17838303	1382356	1434785	rs762398167	NC_000019.10:17838302:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 14, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.1528C>A (p.Gln510Lys)	JAK3	Q510K	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001977756	19	17949113	19	17838304	1977756	2034429		NC_000019.10:17838303:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1518C>T (p.Tyr506=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002864503	19	17949123	19	17838314	2864503	3023267		NC_000019.10:17838313:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 8, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1514A>G (p.Gln505Arg)	JAK3	Q505R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000950110	19	17949127	19	17838318	950110	928893	rs2094229344	NC_000019.10:17838317:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1509A>G (p.Gln503=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002733737	19	17949132	19	17838323	2733737	2898072		NC_000019.10:17838322:T:C	single nucleotide variant	synonymous variant	Likely benign	Jan 8, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1507C>T (p.Gln503Ter)	JAK3	Q503*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003583525	19	17949134	19	17838325	3583525	3709370		NC_000019.10:17838324:G:A	single nucleotide variant	nonsense	Likely pathogenic	Mar 28, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1503G>T (p.Gln501His)	JAK3	Q501H	not specified|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000376114	19	17949138	19	17838329	376114	362993	rs201283129	NC_000019.10:17838328:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1498G>A (p.Val500Ile)	JAK3	V500I	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001045217	19	17949143	19	17838334	1045217	1034154	rs2094229434	NC_000019.10:17838333:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1495T>C (p.Leu499=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002728279	19	17949146	19	17838337	2728279	2889617		NC_000019.10:17838336:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1485C>T (p.Pro495=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002202602	19	17949156	19	17838347	2202602	1928252		NC_000019.10:17838346:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1483C>T (p.Pro495Ser)	JAK3	P495S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001026456	19	17949158	19	17838349	1026456	1013595	rs2094229513	NC_000019.10:17838348:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.1476del (p.His492fs)	JAK3	H492fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002832336	19	17949165	19	17838356	2832336	2994720		NC_000019.10:17838355:G:	Deletion	frameshift variant	Pathogenic/Likely pathogenic	Mar 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1473T>C (p.Gly491=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002777075	19	17949168	19	17838359	2777075	2943411		NC_000019.10:17838358:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 22, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1471G>C (p.Gly491Arg)	JAK3	G491R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000532745	19	17949170	19	17838361	532745	533187	rs200112185	NC_000019.10:17838360:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1463T>G (p.Val488Gly)	JAK3	V488G	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000840427	19	17949178	19	17838369	840427	847427	rs2094229597	NC_000019.10:17838368:A:C	single nucleotide variant	missense variant	Uncertain significance	May 15, 2020	criteria provided, single submitter							
NM_000215.4(JAK3):c.1459G>A (p.Val487Met)	JAK3	V487M	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001515861	19	17949182	19	17838373	1515861	1407139	rs2147689016	NC_000019.10:17838372:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.1458C>T (p.Ile486=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001119704	19	17949183	19	17838374	1119704	1106275	rs1297346398	NC_000019.10:17838373:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 22, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1453C>T (p.Leu485=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328517	19	17949188	19	17838379	328517	349532	rs55883965	NC_000019.10:17838378:G:A	single nucleotide variant	synonymous variant	Benign	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1452C>T (p.Asn484=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003641785	19	17949189	19	17838380	3641785	3772507		NC_000019.10:17838379:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1442-2A>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|Severe combined immunodeficiency disease	VCV003233962	19	17949201	19	17838392	3233962	3393085		NC_000019.10:17838391:T:C	single nucleotide variant	splice acceptor variant	Likely pathogenic	Mar 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1442-5C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not specified	VCV000137596	19	17949204	19	17838395	137596	141299	rs3212750	NC_000019.10:17838394:G:A	single nucleotide variant	intron variant	Benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1442-6C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002974277	19	17949205	19	17838396	2974277	3136761		NC_000019.10:17838395:G:A	single nucleotide variant	intron variant	Likely benign	Sep 8, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1442-6C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002781589	19	17949205	19	17838396	2781589	2947486		NC_000019.10:17838395:G:C	single nucleotide variant	intron variant	Likely benign	Nov 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1442-7C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002767302	19	17949206	19	17838397	2767302	2922876		NC_000019.10:17838396:G:C	single nucleotide variant	intron variant	Likely benign	Oct 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1442-9T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002957965	19	17949208	19	17838399	2957965	3119177		NC_000019.10:17838398:A:G	single nucleotide variant	intron variant	Likely benign	Mar 13, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1442-10C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002760644	19	17949209	19	17838400	2760644	2921823		NC_000019.10:17838399:G:C	single nucleotide variant	intron variant	Likely benign	Sep 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1442-14T>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002984393	19	17949213	19	17838404	2984393	3146005		NC_000019.10:17838403:A:T	single nucleotide variant	intron variant	Likely benign	Jan 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1442-16C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002727343	19	17949215	19	17838406	2727343	2882661		NC_000019.10:17838405:G:C	single nucleotide variant	intron variant	Likely benign	May 26, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1442-17T>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003614427	19	17949216	19	17838407	3614427	3749122		NC_000019.10:17838406:A:C	single nucleotide variant	intron variant	Likely benign	Feb 19, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1442-18C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002894888	19	17949217	19	17838408	2894888	3052428		NC_000019.10:17838407:G:C	single nucleotide variant	intron variant	Likely benign	Oct 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1442-263A>G	JAK3		not provided	VCV001265839	19	17949462	19	17838653	1265839	1257462	rs3212748	NC_000019.10:17838652:T:C	single nucleotide variant	intron variant	Benign	Aug 19, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1441+262C>A	JAK3		not specified	VCV000135550	19	17950024	19	17839215	135550	139289	rs587777948	NC_000019.10:17839214:G:T	single nucleotide variant	intron variant	not provided	Sep 19, 2013	no classification provided							
NM_000215.4(JAK3):c.1441+131T>C	JAK3		not provided	VCV001217740	19	17950155	19	17839346	1217740	1207723	rs3212746	NC_000019.10:17839345:A:G	single nucleotide variant	intron variant	Likely benign	Aug 19, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1441+19T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001568065	19	17950267	19	17839458	1568065	1657573	rs1204641842	NC_000019.10:17839457:A:G	single nucleotide variant	intron variant	Likely benign	Nov 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1441+17C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003708994	19	17950269	19	17839460	3708994	3843304		NC_000019.10:17839459:G:A	single nucleotide variant	intron variant	Likely benign	Mar 27, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1441+16C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002110389	19	17950270	19	17839461	2110389	2170853		NC_000019.10:17839460:G:A	single nucleotide variant	intron variant	Likely benign	Dec 9, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1441+15C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002026856	19	17950271	19	17839462	2026856	2084776		NC_000019.10:17839461:G:A	single nucleotide variant	intron variant	Likely benign	Oct 5, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1441+9del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002725469	19	17950277	19	17839468	2725469	2882087		NC_000019.10:17839467:GGGG:GGG	Deletion	intron variant	Benign	Dec 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1441+1G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002997577	19	17950285	19	17839476	2997577	3166922		NC_000019.10:17839475:C:A	single nucleotide variant	splice donor variant	Likely pathogenic	Sep 15, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1432dup (p.Arg478fs)	JAK3	R478fs	not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000453184	19	17950294 - 17950295	19	17839485 - 17839486	453184	446071	rs769633203	NC_000019.10:17839485:T:TT	Duplication	frameshift variant	Pathogenic	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1428C>T (p.Ile476=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002813175	19	17950299	19	17839490	2813175	2972977		NC_000019.10:17839489:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1426A>G (p.Ile476Val)	JAK3	I476V	T-B+ severe combined immunodeficiency due to JAK3 deficiency|Inborn genetic diseases	VCV002884254	19	17950301	19	17839492	2884254	3043555		NC_000019.10:17839491:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1425T>C (p.Cys475=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002905493	19	17950302	19	17839493	2905493	3061944		NC_000019.10:17839492:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1414A>G (p.Thr472Ala)	JAK3	T472A	not provided	VCV003390234	19	17950313	19	17839504	3390234	3549357		NC_000019.10:17839503:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1413C>T (p.Leu471=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002797775	19	17950314	19	17839505	2797775	2958895		NC_000019.10:17839504:G:A	single nucleotide variant	synonymous variant	Likely benign	May 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1407G>A (p.Val469=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002736666	19	17950320	19	17839511	2736666	2905241		NC_000019.10:17839510:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 7, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1403C>T (p.Ala468Val)	JAK3	A468V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001364293	19	17950324	19	17839515	1364293	1386232	rs2147691045	NC_000019.10:17839514:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1401G>A (p.Val467=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002867224	19	17950326	19	17839517	2867224	3027012		NC_000019.10:17839516:C:T	single nucleotide variant	synonymous variant	Likely benign	May 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1389C>G (p.His463Gln)	JAK3	H463Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002019970	19	17950338	19	17839529	2019970	2083010		NC_000019.10:17839528:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1389C>T (p.His463=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001155651	19	17950338	19	17839529	1155651	1148620	rs201132330	NC_000019.10:17839528:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 25, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1389C>A (p.His463Gln)	JAK3	H463Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001022314	19	17950338	19	17839529	1022314	1013596	rs201132330	NC_000019.10:17839528:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1388A>T (p.His463Leu)	JAK3	H463L	Inborn genetic diseases	VCV002261826	19	17950339	19	17839530	2261826	2248643		NC_000019.10:17839529:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.1383dup (p.Leu462fs)	JAK3	L462fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001404557	19	17950343 - 17950344	19	17839534 - 17839535	1404557	1405318	rs2147691124	NC_000019.10:17839534:CCCCCC:CCCCCCC	Duplication	frameshift variant	Pathogenic	Mar 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1383G>T (p.Gly461=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002765631	19	17950344	19	17839535	2765631	2922505		NC_000019.10:17839534:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 4, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1379G>A (p.Gly460Glu)	JAK3	G460E	T-B+ severe combined immunodeficiency due to JAK3 deficiency|Inborn genetic diseases	VCV001350977	19	17950348	19	17839539	1350977	1492565	rs199659728	NC_000019.10:17839538:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1371C>T (p.Cys457=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001643110	19	17950356	19	17839547	1643110	1521601	rs200197702	NC_000019.10:17839546:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 29, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1361T>C (p.Leu454Pro)	JAK3	L454P	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002146256	19	17950366	19	17839557	2146256	1876861		NC_000019.10:17839556:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1356G>A (p.Glu452=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002832519	19	17950371	19	17839562	2832519	2994903		NC_000019.10:17839561:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1352G>A (p.Arg451Gln)	JAK3	R451Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000134565	19	17950375	19	17839566	134565	138304	rs145751599	NC_000019.10:17839565:C:T	single nucleotide variant	missense variant	Likely benign	Feb 19, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1351C>T (p.Arg451Ter)	JAK3	R451*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000081020	19	17950376	19	17839567	81020	91911	rs267605358	NC_000019.10:17839566:G:A	single nucleotide variant	nonsense	Pathogenic	Nov 14, 2023	reviewed by expert panel							
NM_000215.4(JAK3):c.1341C>T (p.His447=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001127771	19	17950386	19	17839577	1127771	1127687	rs2147691249	NC_000019.10:17839576:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 25, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1340A>G (p.His447Arg)	JAK3	H447R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001964268	19	17950387	19	17839578	1964268	2020955		NC_000019.10:17839577:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1334G>A (p.Arg445Gln)	JAK3	R445Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002176167	19	17950393	19	17839584	2176167	1904951		NC_000019.10:17839583:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1333C>T (p.Arg445Ter)	JAK3	R445*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000009364	19	17950394	19	17839585	9364	24403	rs137852626	NC_000019.10:17839584:G:A	single nucleotide variant	nonsense	Pathogenic	Jun 13, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.1320G>A (p.Leu440=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003010307	19	17950407	19	17839598	3010307	3173197		NC_000019.10:17839597:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 4, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1315C>T (p.Leu439Phe)	JAK3	L439F	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001919102	19	17950412	19	17839603	1919102	1971542		NC_000019.10:17839602:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1311C>A (p.Thr437=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002752384	19	17950416	19	17839607	2752384	2916150		NC_000019.10:17839606:G:T	single nucleotide variant	synonymous variant	Likely benign	Jun 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1305A>G (p.Thr435=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002067027	19	17950422	19	17839613	2067027	2122289		NC_000019.10:17839612:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 22, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1304C>T (p.Thr435Ile)	JAK3	T435I	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002147001	19	17950423	19	17839614	2147001	1870650		NC_000019.10:17839613:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1300C>G (p.Pro434Ala)	JAK3	P434A	Inborn genetic diseases	VCV002319000	19	17950427	19	17839618	2319000	2307473		NC_000019.10:17839617:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1299C>T (p.Ser433=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002869569	19	17950428	19	17839619	2869569	3024450		NC_000019.10:17839618:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 8, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1295G>A (p.Arg432His)	JAK3	R432H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002157585	19	17950432	19	17839623	2157585	1889891		NC_000019.10:17839622:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1292G>C (p.Arg431Pro)	JAK3	R431P	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002731310	19	17950435	19	17839626	2731310	2893931		NC_000019.10:17839625:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1291C>T (p.Arg431Trp)	JAK3	R431W	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000440938	19	17950436	19	17839627	440938	434671	rs1274345651	NC_000019.10:17839626:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1289T>C (p.Ile430Thr)	JAK3	I430T	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002780436	19	17950438	19	17839629	2780436	2944175		NC_000019.10:17839628:A:G	single nucleotide variant	missense variant	Likely pathogenic	Jun 6, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1287C>T (p.Leu429=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002888072	19	17950440	19	17839631	2888072	3054484		NC_000019.10:17839630:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1284C>A (p.Cys428Ter)	JAK3	C428*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002815803	19	17950443	19	17839634	2815803	2966638		NC_000019.10:17839633:G:T	single nucleotide variant	nonsense	Pathogenic	Dec 2, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1280del (p.Gly427fs)	JAK3	G427fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002768305	19	17950447	19	17839638	2768305	2929473		NC_000019.10:17839637:CCC:CC	Deletion	frameshift variant	Pathogenic	Oct 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1278G>A (p.Lys426=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003638098	19	17950449	19	17839640	3638098	3764727		NC_000019.10:17839639:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 1, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1275T>C (p.Tyr425=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002903510	19	17950452	19	17839643	2903510	3064914		NC_000019.10:17839642:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 8, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1269T>C (p.Pro423=)	JAK3		not provided	VCV000532752	19	17950458	19	17839649	532752	533193	rs1555744931	NC_000019.10:17839648:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 31, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1266T>A (p.Gly422=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000758702	19	17950461	19	17839652	758702	772519	rs754562580	NC_000019.10:17839651:A:T	single nucleotide variant	synonymous variant	Likely benign	Sep 9, 2020	criteria provided, single submitter							
NM_000215.4(JAK3):c.1262T>G (p.Leu421Arg)	JAK3	L421R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001363281	19	17950465	19	17839656	1363281	1489141	rs535740127	NC_000019.10:17839655:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1255-1G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003018489	19	17950473	19	17839664	3018489	3182665		NC_000019.10:17839663:C:T	single nucleotide variant	splice acceptor variant	Pathogenic	May 11, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1255-12T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002977651	19	17950484	19	17839675	2977651	3137540		NC_000019.10:17839674:A:G	single nucleotide variant	intron variant	Likely benign	Oct 6, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1255-15C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003007058	19	17950487	19	17839678	3007058	3162178		NC_000019.10:17839677:G:A	single nucleotide variant	intron variant	Likely benign	Nov 8, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1255-19_1255-17dup	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001561991	19	17950488 - 17950489	19	17839679 - 17839680	1561991	1608530	rs749079957	NC_000019.10:17839679:CCCC:CCCCCCC	Duplication	intron variant	Benign	Nov 23, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1255-17del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002822174	19	17950489	19	17839680	2822174	2981977		NC_000019.10:17839679:CCCC:CCC	Deletion	intron variant	Benign	Jul 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1255-19G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002992602	19	17950491	19	17839682	2992602	3151562		NC_000019.10:17839681:C:G	single nucleotide variant	intron variant	Likely benign	Aug 31, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1255-35G>A	JAK3		not provided	VCV001222486	19	17950507	19	17839698	1222486	1212884	rs3212745	NC_000019.10:17839697:C:T	single nucleotide variant	intron variant	Benign	Aug 10, 2019	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1255-48G>A	JAK3		not provided	VCV001220579	19	17950520	19	17839711	1220579	1212268	rs35060213	NC_000019.10:17839710:C:T	single nucleotide variant	intron variant	Benign	Mar 17, 2019	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1255-94dup	JAK3		not provided	VCV001222406	19	17950547 - 17950548	19	17839738 - 17839739	1222406	1212804	rs71164315	NC_000019.10:17839738:TTTTTTTTTTTTTTTTTTT:TTTTTTTTTTTTTTTTTTTT	Duplication	intron variant	Benign	Aug 10, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.1255-79A>G	JAK3		not provided	VCV001199911	19	17950551	19	17839742	1199911	1192117	rs370696028	NC_000019.10:17839741:T:C	single nucleotide variant	intron variant	Likely benign	Sep 23, 2019	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1255-202G>A	JAK3		not provided	VCV001266269	19	17950674	19	17839865	1266269	1256600	rs3212743	NC_000019.10:17839864:C:T	single nucleotide variant	intron variant	Benign	Aug 26, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1254+20G>A	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001167464	19	17951019	19	17840210	1167464	1158460	rs3212742	NC_000019.10:17840209:C:T	single nucleotide variant	intron variant	Benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1254+18G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003011419	19	17951021	19	17840212	3011419	3180804		NC_000019.10:17840211:C:A	single nucleotide variant	intron variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1254+12G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002802518	19	17951027	19	17840218	2802518	2963203		NC_000019.10:17840217:C:T	single nucleotide variant	intron variant	Likely benign	Jan 9, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1254+9A>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000793332	19	17951030	19	17840221	793332	788263	rs1000957625	NC_000019.10:17840220:T:C	single nucleotide variant	intron variant	Likely benign	Dec 8, 2020	criteria provided, single submitter							
NM_000215.4(JAK3):c.1254+5G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001064270	19	17951034	19	17840225	1064270	1051156	rs2147692649	NC_000019.10:17840224:C:G	single nucleotide variant	intron variant	Uncertain significance	Feb 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1254+4G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001057458	19	17951035	19	17840226	1057458	1051157	rs200084748	NC_000019.10:17840225:C:T	single nucleotide variant	intron variant	Uncertain significance	Dec 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1254+2T>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001323133	19	17951037	19	17840228	1323133	1313419	rs2147692665	NC_000019.10:17840227:A:T	single nucleotide variant	splice donor variant	Pathogenic	Sep 6, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.1252C>G (p.Gln418Glu)	JAK3	Q418E	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001365457	19	17951041	19	17840232	1365457	1402327	rs2147692670	NC_000019.10:17840231:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1239C>T (p.Leu413=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002749921	19	17951054	19	17840245	2749921	2908518		NC_000019.10:17840244:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1236C>T (p.Leu412=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002897750	19	17951057	19	17840248	2897750	3067131		NC_000019.10:17840247:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 19, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1214C>T (p.Pro405Leu)	JAK3	P405L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000956949	19	17951079	19	17840270	956949	950713	rs1267642970	NC_000019.10:17840269:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.1208G>A (p.Arg403His)	JAK3	R403H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000803543	19	17951085	19	17840276	803543	791914	rs1599876167	NC_000019.10:17840275:C:T	single nucleotide variant	missense variant	Likely pathogenic	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1207C>T (p.Arg403Cys)	JAK3	R403C	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002138258	19	17951086	19	17840277	2138258	1868411		NC_000019.10:17840276:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 14, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.1205G>A (p.Arg402His)	JAK3	R402H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002910454	19	17951088	19	17840279	2910454	3072922		NC_000019.10:17840278:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jun 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1197T>G (p.Tyr399Ter)	JAK3	Y399*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003583526	19	17951096	19	17840287	3583526	3709371		NC_000019.10:17840286:A:C	single nucleotide variant	nonsense	Likely pathogenic	Feb 5, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1196A>G (p.Tyr399Cys)	JAK3	Y399C	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001444260	19	17951097	19	17840288	1444260	1388225	rs201199447	NC_000019.10:17840287:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1194C>G (p.Ser398=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003654147	19	17951099	19	17840290	3654147	3782298		NC_000019.10:17840289:G:C	single nucleotide variant	synonymous variant	Likely benign	May 23, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1191C>G (p.Gly397=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002749922	19	17951102	19	17840293	2749922	2908519		NC_000019.10:17840292:G:C	single nucleotide variant	synonymous variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1187C>T (p.Pro396Leu)	JAK3	P396L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000134586	19	17951106	19	17840297	134586	138325	rs149047410	NC_000019.10:17840296:G:A	single nucleotide variant	missense variant	Benign	Jan 23, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.1185T>C (p.Arg395=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002032707	19	17951108	19	17840299	2032707	2082925		NC_000019.10:17840298:A:G	single nucleotide variant	synonymous variant	Likely benign	Sep 26, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1184G>A (p.Arg395His)	JAK3	R395H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000891293	19	17951109	19	17840300	891293	880120	rs143038064	NC_000019.10:17840299:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 28, 2023	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.1182A>G (p.Ser394=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003730359	19	17951111	19	17840302	3730359	3862425		NC_000019.10:17840301:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 1, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1178dup (p.Ser394fs)	JAK3	S394fs	not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001456683	19	17951114 - 17951115	19	17840305 - 17840306	1456683	1454785	rs2094235007	NC_000019.10:17840305:CCCCC:CCCCCC	Duplication	frameshift variant	Pathogenic	May 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1176G>T (p.Gly392=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002694405	19	17951117	19	17840308	2694405	2860544		NC_000019.10:17840307:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 8, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1165del (p.Leu389fs)	JAK3	L389fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002798361	19	17951128	19	17840319	2798361	2951716		NC_000019.10:17840318:G:	Deletion	frameshift variant	Pathogenic	Apr 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1158C>T (p.Ile386=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002880828	19	17951135	19	17840326	2880828	3042426		NC_000019.10:17840325:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 19, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1154C>A (p.Ala385Asp)	JAK3	A385D	Inborn genetic diseases	VCV003531264	19	17951139	19	17840330	3531264	3684180		NC_000019.10:17840329:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1153G>T (p.Ala385Ser)	JAK3	A385S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001372990	19	17951140	19	17840331	1372990	1440368	rs968177323	NC_000019.10:17840330:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1152T>A (p.Phe384Leu)	JAK3	F384L	not provided	VCV000636398	19	17951141	19	17840332	636398	624655	rs1599876253	NC_000019.10:17840331:A:T	single nucleotide variant	missense variant	Uncertain significance	May 8, 2017	criteria provided, single submitter							
NM_000215.4(JAK3):c.1143-1G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003643570	19	17951151	19	17840342	3643570	3783267		NC_000019.10:17840341:C:T	single nucleotide variant	splice acceptor variant	Likely pathogenic	Mar 5, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1143-5C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002728015	19	17951155	19	17840346	2728015	2889353		NC_000019.10:17840345:G:A	single nucleotide variant	intron variant	Likely benign	Dec 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1143-6C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002991987	19	17951156	19	17840347	2991987	3144597		NC_000019.10:17840346:G:A	single nucleotide variant	intron variant	Likely benign	Aug 19, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1143-10T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003023065	19	17951160	19	17840351	3023065	3172969		NC_000019.10:17840350:A:G	single nucleotide variant	intron variant	Likely benign	Jan 14, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1143-13C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002696560	19	17951163	19	17840354	2696560	2857979		NC_000019.10:17840353:G:A	single nucleotide variant	intron variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1143-14A>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002839898	19	17951164	19	17840355	2839898	3003120		NC_000019.10:17840354:T:C	single nucleotide variant	intron variant	Likely benign	Feb 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1143-19C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003009616	19	17951169	19	17840360	3009616	3180307		NC_000019.10:17840359:G:A	single nucleotide variant	intron variant	Likely benign	Jun 3, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1143-28C>T	JAK3		not provided|not specified	VCV001221017	19	17951178	19	17840369	1221017	1211414	rs3212741	NC_000019.10:17840368:G:A	single nucleotide variant	intron variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1143-273dup	JAK3		not provided	VCV001253002	19	17951416 - 17951417	19	17840607 - 17840608	1253002	1242946	rs11447311	NC_000019.10:17840607:AAAAAAA:AAAAAAAA	Duplication	intron variant	Benign	Aug 19, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1143-339C>T	JAK3		not provided	VCV001260441	19	17951489	19	17840680	1260441	1248649	rs3212739	NC_000019.10:17840679:G:A	single nucleotide variant	intron variant	Benign	Aug 19, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1142+207C>A	JAK3		not provided	VCV001269667	19	17951991	19	17841182	1269667	1259525	rs3212735	NC_000019.10:17841181:G:T	single nucleotide variant	intron variant	Benign	Jan 20, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.1142+134G>C	JAK3		not provided	VCV001253638	19	17952064	19	17841255	1253638	1243575	rs3213407	NC_000019.10:17841254:C:G	single nucleotide variant	intron variant	Benign	Oct 10, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.1142+16C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001989256	19	17952182	19	17841373	1989256	2040600		NC_000019.10:17841372:G:A	single nucleotide variant	intron variant	Likely benign	Feb 10, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1142+14C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003022619	19	17952184	19	17841375	3022619	3176373		NC_000019.10:17841374:G:A	single nucleotide variant	intron variant	Likely benign	Jan 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1142+13C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002820876	19	17952185	19	17841376	2820876	2978121		NC_000019.10:17841375:G:A	single nucleotide variant	intron variant	Likely benign	Dec 15, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1142+13C>A	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency|not specified	VCV000137601	19	17952185	19	17841376	137601	141304	rs3212733	NC_000019.10:17841375:G:T	single nucleotide variant	intron variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1142+10T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002853401	19	17952188	19	17841379	2853401	3016871		NC_000019.10:17841378:A:G	single nucleotide variant	intron variant	Likely benign	May 3, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1142+1G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002762790	19	17952197	19	17841388	2762790	2931284		NC_000019.10:17841387:C:A	single nucleotide variant	splice donor variant	Pathogenic	Sep 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1142+1G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001074842	19	17952197	19	17841388	1074842	1064674	rs1232129873	NC_000019.10:17841387:C:G	single nucleotide variant	splice donor variant	Pathogenic	Aug 27, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.1142C>A (p.Thr381Asn)	JAK3	T381N	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000134584	19	17952198	19	17841389	134584	138323	rs373046546	NC_000019.10:17841388:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1140C>T (p.Ile380=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001112861	19	17952200	19	17841391	1112861	1106276	rs910451747	NC_000019.10:17841390:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1134C>T (p.Gly378=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002721075	19	17952206	19	17841397	2721075	2887601		NC_000019.10:17841396:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1131C>T (p.His377=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not specified	VCV000385188	19	17952209	19	17841400	385188	376383	rs55802448	NC_000019.10:17841399:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1120G>A (p.Glu374Lys)	JAK3	E374K	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001966295	19	17952220	19	17841411	1966295	2031461		NC_000019.10:17841410:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1120G>C (p.Glu374Gln)	JAK3	E374Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001347705	19	17952220	19	17841411	1347705	1391622	rs769243134	NC_000019.10:17841410:C:G	single nucleotide variant	missense variant	Uncertain significance	May 7, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.1118C>G (p.Ala373Gly)	JAK3	A373G	Inborn genetic diseases	VCV003531262	19	17952222	19	17841413	3531262	3684178		NC_000019.10:17841412:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1114G>A (p.Val372Met)	JAK3	V372M	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001469659	19	17952226	19	17841417	1469659	1475607	rs1360733708	NC_000019.10:17841416:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.1108G>A (p.Glu370Lys)	JAK3	E370K	T-B+ severe combined immunodeficiency due to JAK3 deficiency|Neoplasm	VCV001028620	19	17952232	19	17841423	1028620	1018527	rs200631515	NC_000019.10:17841422:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, multiple submitters, no conflicts				Uncertain significance	Jul 31, 2024	criteria provided, single submitter	
NM_000215.4(JAK3):c.1106T>C (p.Leu369Pro)	JAK3	L369P	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002506466	19	17952234	19	17841425	2506466	2671424		NC_000019.10:17841424:A:G	single nucleotide variant	missense variant	Likely pathogenic	Sep 23, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1105C>T (p.Leu369=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003645970	19	17952235	19	17841426	3645970	3776490		NC_000019.10:17841425:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 14, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1102C>G (p.Leu368Val)	JAK3	L368V	Inborn genetic diseases	VCV002282268	19	17952238	19	17841429	2282268	2273380		NC_000019.10:17841428:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1098G>T (p.Pro366=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002884975	19	17952242	19	17841433	2884975	3050319		NC_000019.10:17841432:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 31, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1092A>C (p.Ala364=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003723398	19	17952248	19	17841439	3723398	3850609		NC_000019.10:17841438:T:G	single nucleotide variant	synonymous variant	Likely benign	Oct 21, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1086G>A (p.Glu362=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002868602	19	17952254	19	17841445	2868602	3030791		NC_000019.10:17841444:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1083G>C (p.Lys361Asn)	JAK3	K361N	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001045103	19	17952257	19	17841448	1045103	1034155	rs2094238493	NC_000019.10:17841447:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2020	criteria provided, single submitter							
NM_000215.4(JAK3):c.1080C>T (p.Cys360=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000652227	19	17952260	19	17841451	652227	647811	rs564076549	NC_000019.10:17841450:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1079G>T (p.Cys360Phe)	JAK3	C360F	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001361191	19	17952261	19	17841452	1361191	1383563	rs945125325	NC_000019.10:17841451:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1073TCT[1] (p.Phe359del)	JAK3	F359del	not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000495736	19	17952262 - 17952264	19	17841453 - 17841455	495736	487808	rs1555745343	NC_000019.10:17841452:AGAAGAAG:AGAAG	Microsatellite	inframe_deletion	Uncertain significance	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1073T>A (p.Phe358Tyr)	JAK3	F358Y	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002096005	19	17952267	19	17841458	2096005	2149922		NC_000019.10:17841457:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1073T>G (p.Phe358Cys)	JAK3	F358C	T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided	VCV000639318	19	17952267	19	17841458	639318	647812	rs200863318	NC_000019.10:17841457:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1068G>A (p.Gln356=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002989634	19	17952272	19	17841463	2989634	3147363		NC_000019.10:17841462:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1062C>T (p.Asp354=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003674404	19	17952278	19	17841469	3674404	3813315		NC_000019.10:17841468:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 18, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.1059G>T (p.Thr353=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001988925	19	17952281	19	17841472	1988925	2044165		NC_000019.10:17841471:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 26, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1056C>A (p.Thr352=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002956701	19	17952284	19	17841475	2956701	3115755		NC_000019.10:17841474:G:T	single nucleotide variant	synonymous variant	Likely benign	Jun 21, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1053G>A (p.Leu351=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002960712	19	17952287	19	17841478	2960712	3123214		NC_000019.10:17841477:C:T	single nucleotide variant	synonymous variant	Likely benign	May 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1047C>T (p.Phe349=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001140643	19	17952293	19	17841484	1140643	1127688	rs748541941	NC_000019.10:17841483:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 10, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1046T>G (p.Phe349Cys)	JAK3	F349C	Inborn genetic diseases	VCV003112152	19	17952294	19	17841485	3112152	3275306		NC_000019.10:17841484:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1030C>A (p.Leu344Ile)	JAK3	L344I	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000643381	19	17952310	19	17841501	643381	647813	rs1309733826	NC_000019.10:17841500:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.1023C>T (p.Phe341=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001529984	19	17952317	19	17841508	1529984	1665340	rs140073972	NC_000019.10:17841507:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 7, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.1020G>A (p.Ser340=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000760406	19	17952320	19	17841511	760406	772520	rs201997916	NC_000019.10:17841510:C:T	single nucleotide variant	synonymous variant	Benign	Dec 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1019C>A (p.Ser340Ter)	JAK3	S340*	not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000916166	19	17952321	19	17841512	916166	904669	rs2094238720	NC_000019.10:17841511:G:T	single nucleotide variant	nonsense	Pathogenic	Nov 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.1017G>A (p.Leu339=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003685408	19	17952323	19	17841514	3685408	3819581		NC_000019.10:17841513:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 27, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.1014T>G (p.Ala338=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002822010	19	17952326	19	17841517	2822010	2981813		NC_000019.10:17841516:A:C	single nucleotide variant	synonymous variant	Likely benign	Mar 7, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1011G>A (p.Glu337=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002747202	19	17952329	19	17841520	2747202	2907962		NC_000019.10:17841519:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 26, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1008C>T (p.Pro336=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002987065	19	17952332	19	17841523	2987065	3153837		NC_000019.10:17841522:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 5, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1005G>T (p.Leu335=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002914924	19	17952335	19	17841526	2914924	3079662		NC_000019.10:17841525:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.1005G>A (p.Leu335=)	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000778827	19	17952335	19	17841526	778827	704851	rs202231447	NC_000019.10:17841525:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.993G>A (p.Glu331=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001967912	19	17952347	19	17841538	1967912	2022011		NC_000019.10:17841537:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 11, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.991G>A (p.Glu331Lys)	JAK3	E331K	not specified	VCV000134585	19	17952349	19	17841540	134585	138324	rs201387977	NC_000019.10:17841539:C:T	single nucleotide variant	missense variant	not provided	Sep 19, 2013	no classification provided							
NM_000215.4(JAK3):c.990C>T (p.Ala330=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002824420	19	17952350	19	17841541	2824420	2979094		NC_000019.10:17841540:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 26, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.987G>A (p.Glu329=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002823449	19	17952353	19	17841544	2823449	2985814		NC_000019.10:17841543:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.985-4G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002871990	19	17952359	19	17841550	2871990	3032008		NC_000019.10:17841549:C:A	single nucleotide variant	intron variant	Likely benign	Oct 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.985-6T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002764456	19	17952361	19	17841552	2764456	2931659		NC_000019.10:17841551:A:G	single nucleotide variant	intron variant	Likely benign	Oct 13, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.985-7C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003020020	19	17952362	19	17841553	3020020	3182887		NC_000019.10:17841552:G:A	single nucleotide variant	intron variant	Likely benign	May 1, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.985-9C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002726631	19	17952364	19	17841555	2726631	2885822		NC_000019.10:17841554:G:A	single nucleotide variant	intron variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.985-11G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002182876	19	17952366	19	17841557	2182876	1920681		NC_000019.10:17841556:C:A	single nucleotide variant	intron variant	Likely benign	Aug 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.985-14C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002735633	19	17952369	19	17841560	2735633	2901654		NC_000019.10:17841559:G:C	single nucleotide variant	intron variant	Likely benign	Jun 6, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.985-15G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002849216	19	17952370	19	17841561	2849216	3012860		NC_000019.10:17841560:C:A	single nucleotide variant	intron variant	Likely benign	Jan 28, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.985-15G>A	JAK3		not specified|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000513582	19	17952370	19	17841561	513582	506824	rs200067874	NC_000019.10:17841560:C:T	single nucleotide variant	intron variant	Likely benign	Jan 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.985-16C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002858972	19	17952371	19	17841562	2858972	3025187		NC_000019.10:17841561:G:C	single nucleotide variant	intron variant	Likely benign	Apr 24, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.985-17A>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002196366	19	17952372	19	17841563	2196366	1923839		NC_000019.10:17841562:T:C	single nucleotide variant	intron variant	Likely benign	May 9, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.985-18G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002826397	19	17952373	19	17841564	2826397	2989618		NC_000019.10:17841563:C:T	single nucleotide variant	intron variant	Likely benign	Jan 5, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.984+44G>A	JAK3		not provided	VCV001231968	19	17952405	19	17841596	1231968	1219385	rs3212732	NC_000019.10:17841595:C:T	single nucleotide variant	intron variant	Benign	Mar 17, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.984+17C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002895693	19	17952432	19	17841623	2895693	3056469		NC_000019.10:17841622:G:A	single nucleotide variant	intron variant	Likely benign	Jun 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.984+15C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002856075	19	17952434	19	17841625	2856075	3011156		NC_000019.10:17841624:G:C	single nucleotide variant	intron variant	Likely benign	Apr 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.984+11G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002792000	19	17952438	19	17841629	2792000	2960466		NC_000019.10:17841628:C:T	single nucleotide variant	intron variant	Likely benign	Jul 21, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.984+11G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001528915	19	17952438	19	17841629	1528915	1634684	rs756102540	NC_000019.10:17841628:C:A	single nucleotide variant	intron variant	Likely benign	Sep 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.982T>A (p.Leu328Ile)	JAK3	L328I	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000835172	19	17952451	19	17841642	835172	847428	rs1418117194	NC_000019.10:17841641:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.976C>A (p.Gln326Lys)	JAK3	Q326K	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001948655	19	17952457	19	17841648	1948655	1996331		NC_000019.10:17841647:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.975C>T (p.Asn325=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002738284	19	17952458	19	17841649	2738284	2895633		NC_000019.10:17841648:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 5, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.970_973del (p.Asp324fs)	JAK3	D324fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002871548	19	17952460 - 17952463	19	17841651 - 17841654	2871548	3034726		NC_000019.10:17841650:TGTCTGTC:TGTC	Microsatellite	frameshift variant	Pathogenic	Mar 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.971A>G (p.Asp324Gly)	JAK3	D324G	Inborn genetic diseases	VCV003112157	19	17952462	19	17841653	3112157	3275311		NC_000019.10:17841652:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.971A>T (p.Asp324Val)	JAK3	D324V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001029718	19	17952462	19	17841653	1029718	1018528	rs1291046706	NC_000019.10:17841652:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2020	criteria provided, single submitter							
NM_000215.4(JAK3):c.970G>A (p.Asp324Asn)	JAK3	D324N	Hereditary spastic paraplegia	VCV001065841	19	17952463	19	17841654	1065841	1054180	rs1446786243	NC_000019.10:17841653:C:T	single nucleotide variant	missense variant	Affects		no assertion criteria provided							
NM_000215.4(JAK3):c.969A>G (p.Thr323=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003695375	19	17952464	19	17841655	3695375	3821783		NC_000019.10:17841654:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.963C>A (p.Thr321=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002874175	19	17952470	19	17841661	2874175	3037954		NC_000019.10:17841660:G:T	single nucleotide variant	synonymous variant	Likely benign	Dec 11, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.960T>C (p.Val320=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002884361	19	17952473	19	17841664	2884361	3053372		NC_000019.10:17841663:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.958_959del (p.Val320fs)	JAK3	V320fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002759186	19	17952474 - 17952475	19	17841665 - 17841666	2759186	2917768		NC_000019.10:17841664:ACA:A	Deletion	frameshift variant	Pathogenic	Jun 2, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.955A>G (p.Thr319Ala)	JAK3	T319A	Inborn genetic diseases	VCV002528390	19	17952478	19	17841669	2528390	2688084		NC_000019.10:17841668:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.952G>T (p.Val318Phe)	JAK3	V318F	Inborn genetic diseases	VCV003112156	19	17952481	19	17841672	3112156	3275310		NC_000019.10:17841671:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.949C>T (p.Leu317=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002786020	19	17952484	19	17841675	2786020	2941982		NC_000019.10:17841674:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.947G>A (p.Arg316His)	JAK3	R316H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000857073	19	17952486	19	17841677	857073	847429	rs778229078	NC_000019.10:17841676:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.944A>G (p.His315Arg)	JAK3	H315R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001013811	19	17952489	19	17841680	1013811	1013597	rs2094239321	NC_000019.10:17841679:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.941A>G (p.Glu314Gly)	JAK3	E314G	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002134588	19	17952492	19	17841683	2134588	2192146		NC_000019.10:17841682:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.939A>G (p.Gly313=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002914034	19	17952494	19	17841685	2914034	3073888		NC_000019.10:17841684:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.938G>A (p.Gly313Glu)	JAK3	G313E	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000733403	19	17952495	19	17841686	733403	741708	rs200319694	NC_000019.10:17841685:C:T	single nucleotide variant	missense variant	Likely benign	Jan 23, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.936dup (p.Gly313fs)	JAK3	G313fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002844878	19	17952496 - 17952497	19	17841687 - 17841688	2844878	3004679		NC_000019.10:17841687:GG:GGG	Duplication	frameshift variant	Pathogenic	Mar 10, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.936C>T (p.Ala312=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003718917	19	17952497	19	17841688	3718917	3856030		NC_000019.10:17841687:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 17, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.933G>C (p.Pro311=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002764140	19	17952500	19	17841691	2764140	2922309		NC_000019.10:17841690:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.932C>T (p.Pro311Leu)	JAK3	P311L	T-B+ severe combined immunodeficiency due to JAK3 deficiency|Inborn genetic diseases	VCV001032930	19	17952501	19	17841692	1032930	1021838	rs781705937	NC_000019.10:17841691:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.926T>C (p.Val309Ala)	JAK3	V309A	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001477239	19	17952507	19	17841698	1477239	1413424	rs2094239394	NC_000019.10:17841697:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.924C>G (p.Arg308=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002797374	19	17952509	19	17841700	2797374	2961950		NC_000019.10:17841699:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 14, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.918C>T (p.Ala306=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002867589	19	17952515	19	17841706	2867589	3027376		NC_000019.10:17841705:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 3, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.918C>G (p.Ala306=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001539009	19	17952515	19	17841706	1539009	1597890	rs775577056	NC_000019.10:17841705:G:C	single nucleotide variant	synonymous variant	Likely benign	Mar 8, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.916G>A (p.Ala306Thr)	JAK3	A306T	Inborn genetic diseases	VCV003112155	19	17952517	19	17841708	3112155	3275309		NC_000019.10:17841707:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.915G>C (p.Gln305His)	JAK3	Q305H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001489949	19	17952518	19	17841709	1489949	1514942	rs200731212	NC_000019.10:17841708:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.913C>T (p.Gln305Ter)	JAK3	Q305*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000191101	19	17952520	19	17841711	191101	188905	rs786205517	NC_000019.10:17841710:G:A	single nucleotide variant	nonsense	Pathogenic	Mar 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.904_908dup (p.Lys304fs)	JAK3	K304fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002707279	19	17952524 - 17952525	19	17841715 - 17841716	2707279	2866970		NC_000019.10:17841715:ATGCTA:ATGCTATGCTA	Duplication	frameshift variant	Pathogenic	Jan 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.909C>T (p.Ile303=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000702802	19	17952524	19	17841715	702802	694360	rs768850889	NC_000019.10:17841714:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.906C>T (p.Ser302=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002816707	19	17952527	19	17841718	2816707	2984209		NC_000019.10:17841717:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.905G>A (p.Ser302Asn)	JAK3	S302N	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001448722	19	17952528	19	17841719	1448722	1423421	rs751055857	NC_000019.10:17841718:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.903T>A (p.Ile301=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003621476	19	17952530	19	17841721	3621476	3754026		NC_000019.10:17841720:A:T	single nucleotide variant	synonymous variant	Likely benign	Jun 25, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.900C>T (p.Asp300=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002999659	19	17952533	19	17841724	2999659	3163782		NC_000019.10:17841723:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 19, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.898G>A (p.Asp300Asn)	JAK3	D300N	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001353217	19	17952535	19	17841726	1353217	1499216	rs1216814401	NC_000019.10:17841725:C:T	single nucleotide variant	missense variant	Uncertain significance	May 12, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.896T>C (p.Val299Ala)	JAK3	V299A	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000891294	19	17952537	19	17841728	891294	880121	rs571404212	NC_000019.10:17841727:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2023	reviewed by expert panel							
NM_000215.4(JAK3):c.879C>T (p.Cys293=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002860014	19	17952554	19	17841745	2860014	3028651		NC_000019.10:17841744:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.874T>G (p.Phe292Val)	JAK3	F292V	not specified	VCV002506155	19	17952559	19	17841750	2506155	2671114		NC_000019.10:17841749:A:C	single nucleotide variant	missense variant	Uncertain significance	May 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.873C>T (p.Pro291=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002828549	19	17952560	19	17841751	2828549	2987068		NC_000019.10:17841750:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.873C>A (p.Pro291=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002812033	19	17952560	19	17841751	2812033	2969271		NC_000019.10:17841750:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 1, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.871C>T (p.Pro291Ser)	JAK3	P291S	Inborn genetic diseases	VCV003531261	19	17952562	19	17841753	3531261	3684177		NC_000019.10:17841752:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.870G>T (p.Gln290His)	JAK3	Q290H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001434985	19	17952563	19	17841754	1434985	1507189	rs2147695669	NC_000019.10:17841753:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.862-2A>G	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000390413	19	17952573	19	17841764	390413	377346	rs1057523762	NC_000019.10:17841763:T:C	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	Apr 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.862-5C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001147777	19	17952576	19	17841767	1147777	1148621	rs2147695701	NC_000019.10:17841766:G:T	single nucleotide variant	intron variant	Likely benign	Jan 15, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.862-8C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002757533	19	17952579	19	17841770	2757533	2917405		NC_000019.10:17841769:G:A	single nucleotide variant	intron variant	Likely benign	Nov 6, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.862-11dup	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001930079	19	17952581 - 17952582	19	17841772 - 17841773	1930079	1991551		NC_000019.10:17841772:GGGGG:GGGGGG	Duplication	intron variant	Benign	Jun 20, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.862-11C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001645075	19	17952582	19	17841773	1645075	1598973	rs752415312	NC_000019.10:17841772:G:T	single nucleotide variant	intron variant	Likely benign	Jun 15, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.862-12C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002912672	19	17952583	19	17841774	2912672	3070784		NC_000019.10:17841773:G:C	single nucleotide variant	intron variant	Likely benign	Dec 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.862-13C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002733906	19	17952584	19	17841775	2733906	2898240		NC_000019.10:17841774:G:C	single nucleotide variant	intron variant	Likely benign	Nov 3, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.862-13C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002707559	19	17952584	19	17841775	2707559	2867248		NC_000019.10:17841774:G:T	single nucleotide variant	intron variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.862-15C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001556789	19	17952586	19	17841777	1556789	1592933	rs1335495836	NC_000019.10:17841776:G:C	single nucleotide variant	intron variant	Likely benign	Nov 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.862-16T>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002716435	19	17952587	19	17841778	2716435	2879981		NC_000019.10:17841777:A:T	single nucleotide variant	intron variant	Likely benign	Jan 22, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.862-17C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001674437	19	17952588	19	17841779	1674437	1618250	rs966548994	NC_000019.10:17841778:G:A	single nucleotide variant	intron variant	Likely benign	Feb 3, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.862-18A>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002866474	19	17952589	19	17841780	2866474	3020082		NC_000019.10:17841779:T:G	single nucleotide variant	intron variant	Likely benign	Jun 1, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.862-21G>A	JAK3		not provided	VCV001294182	19	17952592	19	17841783	1294182	1283981	rs3212731	NC_000019.10:17841782:C:T	single nucleotide variant	intron variant	Benign	Aug 19, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.862-38A>C	JAK3		not specified|not provided	VCV001264995	19	17952609	19	17841800	1264995	1255321	rs3212730	NC_000019.10:17841799:T:G	single nucleotide variant	intron variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.862-107A>G	JAK3		not provided	VCV001289121	19	17952678	19	17841869	1289121	1278952	rs3212729	NC_000019.10:17841868:T:C	single nucleotide variant	intron variant	Benign	Aug 19, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.862-252G>C	JAK3		not provided	VCV001254076	19	17952823	19	17842014	1254076	1244013	rs7247752	NC_000019.10:17842013:C:G	single nucleotide variant	intron variant	Benign	Mar 17, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.862-274G>T	JAK3		not provided	VCV001288704	19	17952845	19	17842036	1288704	1278536	rs7247763	NC_000019.10:17842035:C:A	single nucleotide variant	intron variant	Benign	Aug 19, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.861+195T>C	JAK3		not provided	VCV001232380	19	17952930	19	17842121	1232380	1224088	rs867174	NC_000019.10:17842120:A:G	single nucleotide variant	intron variant	Benign	Jul 9, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.861+19G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002880917	19	17953106	19	17842297	2880917	3042515		NC_000019.10:17842296:C:G	single nucleotide variant	intron variant	Likely benign	Jan 25, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.861+18C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002818942	19	17953107	19	17842298	2818942	2981314		NC_000019.10:17842297:G:A	single nucleotide variant	intron variant	Likely benign	Nov 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.861+10G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003681267	19	17953115	19	17842306	3681267	3815008		NC_000019.10:17842305:C:A	single nucleotide variant	intron variant	Likely benign	Mar 6, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.861+9G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001592890	19	17953116	19	17842307	1592890	1620445	rs779139433	NC_000019.10:17842306:C:A	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.861+6G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001493821	19	17953119	19	17842310	1493821	1449323	rs748305273	NC_000019.10:17842309:C:T	single nucleotide variant	intron variant	Uncertain significance	Oct 21, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.859G>A (p.Glu287Lys)	JAK3	E287K	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001020697	19	17953127	19	17842318	1020697	1013598	rs776551276	NC_000019.10:17842317:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2020	criteria provided, single submitter							
NM_000215.4(JAK3):c.858G>A (p.Gln286=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003009373	19	17953128	19	17842319	3009373	3169711		NC_000019.10:17842318:C:T	single nucleotide variant	synonymous variant	Likely benign	May 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.852A>G (p.Gly284=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002908489	19	17953134	19	17842325	2908489	3070087		NC_000019.10:17842324:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.851G>A (p.Gly284Glu)	JAK3	G284E	not specified	VCV000134583	19	17953135	19	17842326	134583	138322	rs587778420	NC_000019.10:17842325:C:T	single nucleotide variant	missense variant	not provided	Sep 19, 2013	no classification provided							
NM_000215.4(JAK3):c.850G>C (p.Gly284Arg)	JAK3	G284R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001980303	19	17953136	19	17842327	1980303	2042075		NC_000019.10:17842326:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.846C>A (p.Thr282=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002866504	19	17953140	19	17842331	2866504	3020112		NC_000019.10:17842330:G:T	single nucleotide variant	synonymous variant	Likely benign	May 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.843G>C (p.Trp281Cys)	JAK3	W281C	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000134582	19	17953143	19	17842334	134582	138321	rs587778419	NC_000019.10:17842333:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.838G>T (p.Ala280Ser)	JAK3	A280S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001949727	19	17953148	19	17842339	1949727	2003428		NC_000019.10:17842338:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.835A>T (p.Ile279Phe)	JAK3	I279F	not provided	VCV003389945	19	17953151	19	17842342	3389945	3549068		NC_000019.10:17842341:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.831C>T (p.Gly277=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002825515	19	17953155	19	17842346	2825515	2982748		NC_000019.10:17842345:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 11, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.829G>A (p.Gly277Ser)	JAK3	G277S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001979153	19	17953157	19	17842348	1979153	2038330		NC_000019.10:17842347:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.828C>T (p.Asp276=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002882386	19	17953158	19	17842349	2882386	3042988		NC_000019.10:17842348:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 13, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.828C>A (p.Asp276Glu)	JAK3	D276E	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000660263	19	17953158	19	17842349	660263	647814	rs569160156	NC_000019.10:17842348:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.822T>C (p.Ala274=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002809151	19	17953164	19	17842355	2809151	2974947		NC_000019.10:17842354:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 2, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.822T>G (p.Ala274=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002746802	19	17953164	19	17842355	2746802	2897677		NC_000019.10:17842354:A:C	single nucleotide variant	synonymous variant	Likely benign	Jul 31, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.820G>A (p.Ala274Thr)	JAK3	A274T	Inborn genetic diseases	VCV002528262	19	17953166	19	17842357	2528262	2687957		NC_000019.10:17842356:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.813C>T (p.Leu271=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002759132	19	17953173	19	17842364	2759132	2917714		NC_000019.10:17842363:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 8, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.806G>A (p.Gly269Glu)	JAK3	G269E	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002095582	19	17953180	19	17842371	2095582	2153488		NC_000019.10:17842370:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.805G>A (p.Gly269Arg)	JAK3	G269R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001362499	19	17953181	19	17842372	1362499	1373247	rs766895335	NC_000019.10:17842371:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.792C>T (p.Gly264=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002844004	19	17953194	19	17842385	2844004	3011477		NC_000019.10:17842384:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.786T>C (p.Leu262=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002786298	19	17953200	19	17842391	2786298	2938804		NC_000019.10:17842390:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.784C>T (p.Leu262Phe)	JAK3	L262F	T-B+ severe combined immunodeficiency due to JAK3 deficiency|Inborn genetic diseases	VCV002735500	19	17953202	19	17842393	2735500	2901523		NC_000019.10:17842392:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.783C>T (p.Ala261=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003020983	19	17953203	19	17842394	3020983	3176042		NC_000019.10:17842393:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.782C>T (p.Ala261Val)	JAK3	A261V	Inborn genetic diseases	VCV002408807	19	17953204	19	17842395	2408807	2389406		NC_000019.10:17842394:G:A	single nucleotide variant	missense variant	Likely benign	Apr 13, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.777T>C (p.Pro259=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003709891	19	17953209	19	17842400	3709891	3836869		NC_000019.10:17842399:A:G	single nucleotide variant	synonymous variant	Likely benign	Jun 28, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.773_775del (p.Leu258del)	JAK3	L258del	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001952464	19	17953211 - 17953213	19	17842402 - 17842404	1952464	2017774		NC_000019.10:17842401:GGAGG:GG	Deletion	inframe_deletion	Uncertain significance	May 20, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.774C>T (p.Leu258=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002731266	19	17953212	19	17842403	2731266	2893887		NC_000019.10:17842402:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.757A>G (p.Thr253Ala)	JAK3	T253A	Inborn genetic diseases|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002150743	19	17953229	19	17842420	2150743	1888238		NC_000019.10:17842419:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.756G>A (p.Glu252=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002695942	19	17953230	19	17842421	2695942	2864629		NC_000019.10:17842420:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.753C>G (p.Ala251=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002989996	19	17953233	19	17842424	2989996	3143901		NC_000019.10:17842423:G:C	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.750C>T (p.Ala250=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002733021	19	17953236	19	17842427	2733021	2894349		NC_000019.10:17842426:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 7, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.749C>T (p.Ala250Val)	JAK3	A250V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001353952	19	17953237	19	17842428	1353952	1496071	rs1286914027	NC_000019.10:17842427:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.744C>A (p.Ala248=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002903088	19	17953242	19	17842433	2903088	3068582		NC_000019.10:17842432:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 31, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.744C>G (p.Ala248=)	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002171181	19	17953242	19	17842433	2171181	1903832		NC_000019.10:17842432:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.744C>T (p.Ala248=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001991896	19	17953242	19	17842433	1991896	2048645		NC_000019.10:17842432:G:A	single nucleotide variant	synonymous variant	Likely benign	May 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.742G>C (p.Ala248Pro)	JAK3	A248P	Inborn genetic diseases	VCV002525281	19	17953244	19	17842435	2525281	2697784		NC_000019.10:17842434:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.741A>C (p.Pro247=)	JAK3		not provided	VCV002649557	19	17953245	19	17842436	2649557	2811824		NC_000019.10:17842435:T:G	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.740C>T (p.Pro247Leu)	JAK3	P247L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001353056	19	17953246	19	17842437	1353056	1421038	rs761196525	NC_000019.10:17842436:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.722_723insAGGA (p.Asp241fs)	JAK3	D241fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002880889	19	17953263 - 17953264	19	17842454 - 17842455	2880889	3042487		NC_000019.10:17842454:TCC:TCCTTCC	Insertion	frameshift variant	Pathogenic	Apr 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.718A>G (p.Met240Val)	JAK3	M240V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001957584	19	17953268	19	17842459	1957584	2009112		NC_000019.10:17842458:T:C	single nucleotide variant	missense variant	Uncertain significance	May 16, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.717C>A (p.Ile239=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002863112	19	17953269	19	17842460	2863112	3019300		NC_000019.10:17842459:G:T	single nucleotide variant	synonymous variant	Likely benign	May 11, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.708C>T (p.Ala236=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002704582	19	17953278	19	17842469	2704582	2862994		NC_000019.10:17842468:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 21, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.698C>G (p.Ser233Trp)	JAK3	S233W	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001492840	19	17953288	19	17842479	1492840	1515676	rs941028266	NC_000019.10:17842478:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.696C>T (p.His232=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000464100	19	17953290	19	17842481	464100	469485	rs199902822	NC_000019.10:17842480:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.693G>A (p.Arg231=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003726632	19	17953293	19	17842484	3726632	3855122		NC_000019.10:17842483:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.678_679del (p.Cys227fs)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000036423	19	17953307 - 17953308	19	17842498 - 17842499	36423	45086	rs193922364	NC_000019.10:17842497:AG:	Deletion	frameshift variant	Pathogenic	Nov 14, 2023	reviewed by expert panel							
NM_000215.4(JAK3):c.678C>G (p.Ala226=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001647090	19	17953308	19	17842499	1647090	1653514	rs2147697716	NC_000019.10:17842498:G:C	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.664_670del (p.Arg222fs)	JAK3	R222fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002767886	19	17953316 - 17953322	19	17842507 - 17842513	2767886	2932498		NC_000019.10:17842506:CGCGGCGC:C	Deletion	frameshift variant	Pathogenic	Oct 13, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.669C>T (p.Arg223=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002715816	19	17953317	19	17842508	2715816	2869054		NC_000019.10:17842507:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 15, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.668G>A (p.Arg223His)	JAK3	R223H	not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001971336	19	17953318	19	17842509	1971336	2022850		NC_000019.10:17842508:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.666C>T (p.Arg222=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002771051	19	17953320	19	17842511	2771051	2924025		NC_000019.10:17842510:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 5, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.665G>A (p.Arg222His)	JAK3	R222H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001107911	19	17953321	19	17842512	1107911	1106277	rs199868795	NC_000019.10:17842511:C:T	single nucleotide variant	missense variant	Likely benign	Aug 28, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.660C>T (p.Ala220=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002851315	19	17953326	19	17842517	2851315	3009817		NC_000019.10:17842516:G:A	single nucleotide variant	synonymous variant	Likely benign	May 30, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.658G>C (p.Ala220Pro)	JAK3	A220P	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003068049	19	17953328	19	17842519	3068049	3227385		NC_000019.10:17842518:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.657A>G (p.Arg219=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001661160	19	17953329	19	17842520	1661160	1554412	rs1236808333	NC_000019.10:17842519:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 30, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.653G>T (p.Arg218Leu)	JAK3	R218L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000649654	19	17953333	19	17842524	649654	647815	rs201460834	NC_000019.10:17842523:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.649G>A (p.Val217Met)	JAK3	V217M	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328518	19	17953337	19	17842528	328518	348352	rs202167678	NC_000019.10:17842527:C:T	single nucleotide variant	missense variant	Likely benign	Jan 23, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.648G>C (p.Thr216=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001150380	19	17953338	19	17842529	1150380	1148622	rs200376035	NC_000019.10:17842528:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 13, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.648G>T (p.Thr216=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328519	19	17953338	19	17842529	328519	332830	rs200376035	NC_000019.10:17842528:C:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 18, 2023	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.643A>C (p.Arg215=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002818573	19	17953343	19	17842534	2818573	2980945		NC_000019.10:17842533:T:G	single nucleotide variant	synonymous variant	Likely benign	May 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.639T>C (p.Ile213=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002747717	19	17953347	19	17842538	2747717	2904610		NC_000019.10:17842537:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.637A>C (p.Ile213Leu)	JAK3	I213L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001003727	19	17953349	19	17842540	1003727	998452	rs1007002260	NC_000019.10:17842539:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.633G>T (p.Arg211Ser)	JAK3	R211S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002126968	19	17953353	19	17842544	2126968	2178281		NC_000019.10:17842543:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.631A>G (p.Arg211Gly)	JAK3	R211G	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001979556	19	17953355	19	17842546	1979556	2034935		NC_000019.10:17842545:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.631A>C (p.Arg211=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided	VCV000380482	19	17953355	19	17842546	380482	377347	rs56269787	NC_000019.10:17842545:T:G	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.630G>A (p.Arg210=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000532753	19	17953356	19	17842547	532753	533204	rs201101011	NC_000019.10:17842546:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 11, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.628C>T (p.Arg210Trp)	JAK3	R210W	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002731312	19	17953358	19	17842549	2731312	2893933		NC_000019.10:17842548:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.624G>T (p.Val208=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001540580	19	17953362	19	17842553	1540580	1598596	rs868243883	NC_000019.10:17842552:C:A	single nucleotide variant	synonymous variant	Likely benign	Feb 13, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.621C>T (p.Phe207=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002888684	19	17953365	19	17842556	2888684	3047542		NC_000019.10:17842555:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 11, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.619T>G (p.Phe207Val)	JAK3	F207V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001967515	19	17953367	19	17842558	1967515	2024943		NC_000019.10:17842557:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.610_611delinsAA (p.Gly204Asn)	JAK3	G204N	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000848295	19	17953375 - 17953376	19	17842566 - 17842567	848295	847430	rs2094242511	NC_000019.10:17842565:CC:TT	Indel	missense variant	Uncertain significance	Jan 28, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.607C>T (p.Gln203Ter)	JAK3	Q203*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002791246	19	17953379	19	17842570	2791246	2953677		NC_000019.10:17842569:G:A	single nucleotide variant	nonsense	Pathogenic	Jul 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.606C>A (p.Ile202=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002883368	19	17953380	19	17842571	2883368	3050008		NC_000019.10:17842570:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.598G>A (p.Asp200Asn)	JAK3	D200N	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002107284	19	17953388	19	17842579	2107284	2170338		NC_000019.10:17842578:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 5, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.594G>T (p.Leu198=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002961629	19	17953392	19	17842583	2961629	3116791		NC_000019.10:17842582:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.590G>C (p.Ser197Thr)	JAK3	S197T	Inborn genetic diseases	VCV003287142	19	17953396	19	17842587	3287142	3448066		NC_000019.10:17842586:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.586C>T (p.Pro196Ser)	JAK3	P196S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003629185	19	17953400	19	17842591	3629185	3753059		NC_000019.10:17842590:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.578G>A (p.Cys193Tyr)	JAK3	C193Y	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001070168	19	17953408	19	17842599	1070168	1064675	rs1467075214	NC_000019.10:17842598:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.570C>T (p.Tyr190=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001111591	19	17953416	19	17842607	1111591	1106278	rs759887019	NC_000019.10:17842606:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.567-6C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002743958	19	17953425	19	17842616	2743958	2903435		NC_000019.10:17842615:G:A	single nucleotide variant	intron variant	Likely benign	Jul 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.567-7C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003680107	19	17953426	19	17842617	3680107	3811411		NC_000019.10:17842616:G:C	single nucleotide variant	intron variant	Likely benign	Jul 6, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.567-8C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000755587	19	17953427	19	17842618	755587	776569	rs753082440	NC_000019.10:17842617:G:T	single nucleotide variant	intron variant	Likely benign	Jan 20, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.567-9C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002123514	19	17953428	19	17842619	2123514	2177413		NC_000019.10:17842618:G:A	single nucleotide variant	intron variant	Likely benign	Jul 2, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.567-15del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002912941	19	17953434	19	17842625	2912941	3078982		NC_000019.10:17842624:GGGG:GGG	Deletion	intron variant	Benign	Apr 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.567-15C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002786998	19	17953434	19	17842625	2786998	2949002		NC_000019.10:17842624:G:A	single nucleotide variant	intron variant	Likely benign	Dec 18, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.567-16C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002875188	19	17953435	19	17842626	2875188	3032597		NC_000019.10:17842625:G:A	single nucleotide variant	intron variant	Likely benign	Nov 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.567-17C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002875768	19	17953436	19	17842627	2875768	3041283		NC_000019.10:17842626:G:A	single nucleotide variant	intron variant	Likely benign	Nov 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.567-17C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002825675	19	17953436	19	17842627	2825675	2982908		NC_000019.10:17842626:G:C	single nucleotide variant	intron variant	Likely benign	May 31, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.567-18C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002808801	19	17953437	19	17842628	2808801	2964752		NC_000019.10:17842627:G:A	single nucleotide variant	intron variant	Likely benign	Mar 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.567-18C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002721302	19	17953437	19	17842628	2721302	2887827		NC_000019.10:17842627:G:T	single nucleotide variant	intron variant	Likely benign	Jul 15, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.566+73G>A	JAK3		not provided	VCV001208869	19	17953763	19	17842954	1208869	1199092	rs3212727	NC_000019.10:17842953:C:T	single nucleotide variant	intron variant	Likely benign	Mar 17, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.566+6_566+41del	JAK3		not specified|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000420884	19	17953795 - 17953830	19	17842986 - 17843021	420884	410549	rs754402855	NC_000019.10:17842985:CTCCCAAGCAGAGGCCGTCCCCACAGCCTGGTGGCTCTC:CTC	Deletion	intron variant	Conflicting classifications of pathogenicity	Jul 11, 2022	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.566+20G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002983334	19	17953816	19	17843007	2983334	3142410		NC_000019.10:17843006:C:T	single nucleotide variant	intron variant	Likely benign	Jan 14, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.566+19T>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002759452	19	17953817	19	17843008	2759452	2918034		NC_000019.10:17843007:A:C	single nucleotide variant	intron variant	Likely benign	Sep 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.566+15G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002750978	19	17953821	19	17843012	2750978	2913016		NC_000019.10:17843011:C:G	single nucleotide variant	intron variant	Likely benign	Jan 20, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.566+13A>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002971774	19	17953823	19	17843014	2971774	3129567		NC_000019.10:17843013:T:G	single nucleotide variant	intron variant	Likely benign	Apr 3, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.566+11C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003008277	19	17953825	19	17843016	3008277	3165928		NC_000019.10:17843015:G:A	single nucleotide variant	intron variant	Likely benign	Jul 12, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.564C>T (p.Val188=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002021185	19	17953838	19	17843029	2021185	2086788		NC_000019.10:17843028:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 21, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.564C>G (p.Val188=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001619583	19	17953838	19	17843029	1619583	1615129	rs199853515	NC_000019.10:17843028:G:C	single nucleotide variant	synonymous variant	Likely benign	Jul 1, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.548del (p.Glu183fs)	JAK3	E183fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002701655	19	17953854	19	17843045	2701655	2859238		NC_000019.10:17843044:T:	Deletion	frameshift variant	Pathogenic	Jan 11, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.544G>A (p.Gly182Arg)	JAK3	G182R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003680445	19	17953858	19	17843049	3680445	3807885		NC_000019.10:17843048:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 31, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.543G>C (p.Pro181=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003679330	19	17953859	19	17843050	3679330	3814354		NC_000019.10:17843049:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.538_543del (p.Arg180_Pro181del)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002018163	19	17953859 - 17953864	19	17843050 - 17843055	2018163	2076080		NC_000019.10:17843049:CGGCCGC:C	Deletion	inframe_deletion	Uncertain significance	Dec 8, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.540G>T (p.Arg180=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002737778	19	17953862	19	17843053	2737778	2899425		NC_000019.10:17843052:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 5, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.538C>A (p.Arg180=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002806756	19	17953864	19	17843055	2806756	2967845		NC_000019.10:17843054:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.537G>A (p.Gln179=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002707092	19	17953865	19	17843056	2707092	2870665		NC_000019.10:17843055:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 12, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.534C>T (p.Ala178=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003021396	19	17953868	19	17843059	3021396	3172601		NC_000019.10:17843058:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 19, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.532G>A (p.Ala178Thr)	JAK3	A178T	not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001040598	19	17953870	19	17843061	1040598	1034156	rs759903379	NC_000019.10:17843060:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.528G>C (p.Glu176Asp)	JAK3	E176D	T-B+ severe combined immunodeficiency due to JAK3 deficiency|Inborn genetic diseases	VCV002781744	19	17953874	19	17843065	2781744	2947641		NC_000019.10:17843064:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.528G>A (p.Glu176=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002723210	19	17953874	19	17843065	2723210	2885000		NC_000019.10:17843064:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.527_528del (p.Glu176fs)	JAK3	E176fs	not provided	VCV000422247	19	17953874 - 17953875	19	17843065 - 17843066	422247	410550	rs1064795657	NC_000019.10:17843064:CTCTC:CTC	Microsatellite	frameshift variant	Likely pathogenic	Sep 15, 2016	criteria provided, single submitter							
NM_000215.4(JAK3):c.524G>A (p.Arg175Gln)	JAK3	R175Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001473539	19	17953878	19	17843069	1473539	1391418	rs776089693	NC_000019.10:17843068:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.523C>T (p.Arg175Ter)	JAK3	R175*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002910455	19	17953879	19	17843070	2910455	3072923		NC_000019.10:17843069:G:A	single nucleotide variant	nonsense	Pathogenic	Dec 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.522G>C (p.Ala174=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002920240	19	17953880	19	17843071	2920240	3081044		NC_000019.10:17843070:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.521C>T (p.Ala174Val)	JAK3	A174V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000892489	19	17953881	19	17843072	892489	880122	rs767865565	NC_000019.10:17843071:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.516G>A (p.Arg172=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000796542	19	17953886	19	17843077	796542	786110	rs1599880017	NC_000019.10:17843076:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 4, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.512C>T (p.Ala171Val)	JAK3	A171V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000662597	19	17953890	19	17843081	662597	647816	rs764890523	NC_000019.10:17843080:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.507C>A (p.Asp169Glu)	JAK3	D169E	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000009365	19	17953895	19	17843086	9365	24404	rs147181709	NC_000019.10:17843085:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.502T>C (p.Leu168=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000758841	19	17953900	19	17843091	758841	772521	rs1599880046	NC_000019.10:17843090:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.501G>T (p.Val167=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000751938	19	17953901	19	17843092	751938	772522	rs1599880049	NC_000019.10:17843091:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 19, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.499G>A (p.Val167Met)	JAK3	V167M	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000835177	19	17953903	19	17843094	835177	847431	rs973863737	NC_000019.10:17843093:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.498C>A (p.Ala166=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000964763	19	17953904	19	17843095	964763	958570	rs201527800	NC_000019.10:17843094:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 20, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.495G>A (p.Leu165=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002018246	19	17953907	19	17843098	2018246	2072330		NC_000019.10:17843097:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 19, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.492C>T (p.Ser164=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002067345	19	17953910	19	17843101	2067345	2118738		NC_000019.10:17843100:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 5, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.489C>T (p.Leu163=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001631466	19	17953913	19	17843104	1631466	1597270	rs138218812	NC_000019.10:17843103:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 19, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.482A>C (p.Glu161Ala)	JAK3	E161A	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001395751	19	17953920	19	17843111	1395751	1425150	rs756695301	NC_000019.10:17843110:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.478G>T (p.Gly160Cys)	JAK3	G160C	Inborn genetic diseases|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000663479	19	17953924	19	17843115	663479	647817	rs149579831	NC_000019.10:17843114:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.471G>A (p.Lys157=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002877154	19	17953931	19	17843122	2877154	3033259		NC_000019.10:17843121:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 16, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.462_463del (p.Leu156fs)	JAK3	L156fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003583527	19	17953939 - 17953940	19	17843130 - 17843131	3583527	3709372		NC_000019.10:17843129:TG:	Deletion	frameshift variant	Likely pathogenic	May 23, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.453C>G (p.Pro151=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003622441	19	17953949	19	17843140	3622441	3760339		NC_000019.10:17843139:G:C	single nucleotide variant	synonymous variant	Likely benign	May 17, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.453C>T (p.Pro151=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003010512	19	17953949	19	17843140	3010512	3173402		NC_000019.10:17843139:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 7, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.452C>G (p.Pro151Arg)	JAK3	P151R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000036422	19	17953950	19	17843141	36422	45085	rs55778349	NC_000019.10:17843140:G:C	single nucleotide variant	missense variant	Benign	Jan 23, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.450C>T (p.Leu150=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002907678	19	17953952	19	17843143	2907678	3059377		NC_000019.10:17843142:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.450C>A (p.Leu150=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002719810	19	17953952	19	17843143	2719810	2884195		NC_000019.10:17843142:G:T	single nucleotide variant	synonymous variant	Likely benign	Jun 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.446G>C (p.Arg149Pro)	JAK3	R149P	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000574258	19	17953956	19	17843147	574258	570592	rs774941503	NC_000019.10:17843146:C:G	single nucleotide variant	missense variant	Uncertain significance	May 22, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.445C>A (p.Arg149Ser)	JAK3	R149S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001519189	19	17953957	19	17843148	1519189	1433686	rs1342240526	NC_000019.10:17843147:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.437T>G (p.Val146Gly)	JAK3	V146G	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002007667	19	17953965	19	17843156	2007667	2073328		NC_000019.10:17843155:A:C	single nucleotide variant	missense variant	Likely pathogenic	Dec 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.436G>A (p.Val146Met)	JAK3	V146M	Inborn genetic diseases	VCV002235310	19	17953966	19	17843157	2235310	2224751		NC_000019.10:17843156:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.432C>T (p.Asp144=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002999950	19	17953970	19	17843161	2999950	3160246		NC_000019.10:17843160:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 3, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.431A>T (p.Asp144Val)	JAK3	D144V	T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided|JAK3-related disorder	VCV000432225	19	17953971	19	17843162	432225	426294	rs1486760100	NC_000019.10:17843161:T:A	single nucleotide variant	missense variant	Likely pathogenic	Mar 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.425G>T (p.Arg142Leu)	JAK3	R142L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002073654	19	17953977	19	17843168	2073654	2123742		NC_000019.10:17843167:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.424C>T (p.Arg142Cys)	JAK3	R142C	not provided	VCV000418266	19	17953978	19	17843169	418266	410551	rs773590163	NC_000019.10:17843168:G:A	single nucleotide variant	missense variant	Likely pathogenic	Feb 11, 2015	criteria provided, single submitter							
NM_000215.4(JAK3):c.423C>T (p.His141=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003018454	19	17953979	19	17843170	3018454	3182630		NC_000019.10:17843169:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 2, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.421-3del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003724082	19	17953984	19	17843175	3724082	3857299		NC_000019.10:17843174:GGGGGG:GGGGG	Deletion	intron variant	Benign	Feb 2, 2025	criteria provided, single submitter							
NM_000215.4(JAK3):c.421-4_421-3del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002968429	19	17953984 - 17953985	19	17843175 - 17843176	2968429	3138739		NC_000019.10:17843174:GGGGGG:GGGG	Deletion	intron variant	Likely benign	Oct 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.421-6C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002968430	19	17953987	19	17843178	2968430	3138740		NC_000019.10:17843177:G:A	single nucleotide variant	intron variant	Likely benign	Oct 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.421-7C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002701209	19	17953988	19	17843179	2701209	2862203		NC_000019.10:17843178:G:C	single nucleotide variant	intron variant	Likely benign	Jan 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.421-7C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001154491	19	17953988	19	17843179	1154491	1148623	rs200101939	NC_000019.10:17843178:G:A	single nucleotide variant	intron variant	Likely benign	Jan 11, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.421-8C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003723632	19	17953989	19	17843180	3723632	3850843		NC_000019.10:17843179:G:A	single nucleotide variant	intron variant	Likely benign	Oct 28, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.421-9del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002724905	19	17953990	19	17843181	2724905	2885397		NC_000019.10:17843180:CC:C	Deletion	intron variant	Likely benign	Jun 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.421-9G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002721272	19	17953990	19	17843181	2721272	2887798		NC_000019.10:17843180:C:A	single nucleotide variant	intron variant	Likely benign	Nov 5, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.421-10G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001021755	19	17953991	19	17843182	1021755	1013599	rs976205515	NC_000019.10:17843181:C:T	single nucleotide variant	intron variant	Uncertain significance	Sep 16, 2020	criteria provided, single submitter							
NM_000215.4(JAK3):c.421-11C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002714970	19	17953992	19	17843183	2714970	2875970		NC_000019.10:17843182:G:A	single nucleotide variant	intron variant	Likely benign	Aug 2, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.421-16del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002764034	19	17953997	19	17843188	2764034	2922203		NC_000019.10:17843187:A:	Deletion	intron variant	Likely benign	Sep 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.421-19C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002849552	19	17954000	19	17843191	2849552	3009341		NC_000019.10:17843190:G:C	single nucleotide variant	intron variant	Likely benign	Aug 30, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.420+59A>G	JAK3		not provided	VCV001226775	19	17954130	19	17843321	1226775	1216747	rs3212726	NC_000019.10:17843320:T:C	single nucleotide variant	intron variant	Benign	Mar 17, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.420+40T>C	JAK3		not provided	VCV001234683	19	17954149	19	17843340	1234683	1223798	rs3212725	NC_000019.10:17843339:A:G	single nucleotide variant	intron variant	Benign	Mar 17, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.420+31G>T	JAK3		not provided	VCV001269378	19	17954158	19	17843349	1269378	1260519	rs3212724	NC_000019.10:17843348:C:A	single nucleotide variant	intron variant	Benign	Jul 7, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.420+3G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001387556	19	17954186	19	17843377	1387556	1474281	rs748616863	NC_000019.10:17843376:C:T	single nucleotide variant	intron variant	Uncertain significance	Jun 27, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.420+2T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002719869	19	17954187	19	17843378	2719869	2884254		NC_000019.10:17843377:A:G	single nucleotide variant	splice donor variant	Likely pathogenic	Jun 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.405G>A (p.Glu135=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000751934	19	17954204	19	17843395	751934	772523	rs867072615	NC_000019.10:17843394:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 12, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.394C>A (p.Pro132Thr)	JAK3	P132T	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000134580	19	17954215	19	17843406	134580	138319	rs3212723	NC_000019.10:17843405:G:T	single nucleotide variant	missense variant	Benign	Jan 23, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.393G>T (p.Leu131=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002817723	19	17954216	19	17843407	2817723	2987364		NC_000019.10:17843406:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 2, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.387T>A (p.Leu129=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002853788	19	17954222	19	17843413	2853788	3013587		NC_000019.10:17843412:A:T	single nucleotide variant	synonymous variant	Likely benign	Apr 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.381T>C (p.Ala127=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000134581	19	17954228	19	17843419	134581	138320	rs587778418	NC_000019.10:17843418:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.367G>A (p.Asp123Asn)	JAK3	D123N	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001039179	19	17954242	19	17843433	1039179	1034157	rs201419310	NC_000019.10:17843432:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2020	criteria provided, single submitter							
NM_000215.4(JAK3):c.363C>T (p.Arg121=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002994358	19	17954246	19	17843437	2994358	3152026		NC_000019.10:17843436:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.362G>A (p.Arg121His)	JAK3	R121H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000532747	19	17954247	19	17843438	532747	532753	rs143586866	NC_000019.10:17843437:C:T	single nucleotide variant	missense variant	Likely benign	Jan 23, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.361C>G (p.Arg121Gly)	JAK3	R121G	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001419469	19	17954248	19	17843439	1419469	1387148	rs776850935	NC_000019.10:17843438:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.361C>T (p.Arg121Cys)	JAK3	R121C	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000849417	19	17954248	19	17843439	849417	847432	rs776850935	NC_000019.10:17843438:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2021	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.358C>T (p.Leu120=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001561397	19	17954251	19	17843442	1561397	1554822	rs762655525	NC_000019.10:17843441:G:A	single nucleotide variant	synonymous variant	Likely benign	May 2, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.357G>T (p.Gly119=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002999324	19	17954252	19	17843443	2999324	3167374		NC_000019.10:17843442:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.355G>C (p.Gly119Arg)	JAK3	G119R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001062719	19	17954254	19	17843445	1062719	1051158	rs763832096	NC_000019.10:17843444:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 9, 2020	criteria provided, single submitter							
NM_000215.4(JAK3):c.354C>T (p.Phe118=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000532755	19	17954255	19	17843446	532755	532759	rs751336782	NC_000019.10:17843445:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 18, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.350G>A (p.Arg117His)	JAK3	R117H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000964788	19	17954259	19	17843450	964788	958571	rs2094244927	NC_000019.10:17843449:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.349C>T (p.Arg117Cys)	JAK3	R117C	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000381576	19	17954260	19	17843451	381576	379507	rs201233697	NC_000019.10:17843450:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.342G>A (p.Lys114=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003008796	19	17954267	19	17843458	3008796	3162624		NC_000019.10:17843457:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.324T>C (p.Asn108=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002840407	19	17954285	19	17843476	2840407	3000231		NC_000019.10:17843475:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 1, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.323A>G (p.Asn108Ser)	JAK3	N108S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000944953	19	17954286	19	17843477	944953	928894	rs199790370	NC_000019.10:17843476:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.309-7dup	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001529039	19	17954306 - 17954307	19	17843497 - 17843498	1529039	1634808	rs2147699635	NC_000019.10:17843497:GG:GGG	Duplication	intron variant	Likely benign	Jun 3, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.309-7C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002777509	19	17954307	19	17843498	2777509	2939959		NC_000019.10:17843497:G:A	single nucleotide variant	intron variant	Likely benign	Jan 14, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.309-8C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002084919	19	17954308	19	17843499	2084919	2140262		NC_000019.10:17843498:G:A	single nucleotide variant	intron variant	Likely benign	Jan 16, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.309-11T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002745258	19	17954311	19	17843502	2745258	2907318		NC_000019.10:17843501:A:G	single nucleotide variant	intron variant	Likely benign	Jan 30, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.309-15C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001633358	19	17954315	19	17843506	1633358	1598283	rs755593886	NC_000019.10:17843505:G:A	single nucleotide variant	intron variant	Likely benign	Aug 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.309-17C>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002855857	19	17954317	19	17843508	2855857	3010938		NC_000019.10:17843507:G:C	single nucleotide variant	intron variant	Likely benign	Apr 13, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.309-19T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002872531	19	17954319	19	17843510	2872531	3037611		NC_000019.10:17843509:A:G	single nucleotide variant	intron variant	Likely benign	Aug 1, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.309-20G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001547824	19	17954320	19	17843511	1547824	1624898	rs753489606	NC_000019.10:17843510:C:T	single nucleotide variant	intron variant	Likely benign	Jul 21, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.309-89G>A	JAK3		not provided	VCV001179396	19	17954389	19	17843580	1179396	1169808	rs3212722	NC_000019.10:17843579:C:T	single nucleotide variant	intron variant	Benign	Mar 17, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.309-113C>A	JAK3		not provided	VCV001267664	19	17954413	19	17843604	1267664	1258000	rs3212721	NC_000019.10:17843603:G:T	single nucleotide variant	intron variant	Benign	Mar 17, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.309-114A>C	JAK3		not provided	VCV001266087	19	17954414	19	17843605	1266087	1256418	rs3212720	NC_000019.10:17843604:T:G	single nucleotide variant	intron variant	Benign	Mar 17, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.308+92G>A	JAK3		not provided	VCV001229486	19	17954494	19	17843685	1229486	1220741	rs3212719	NC_000019.10:17843684:C:T	single nucleotide variant	intron variant	Benign	Mar 17, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.308+62G>A	JAK3		not provided	VCV001294296	19	17954524	19	17843715	1294296	1284086	rs3212718	NC_000019.10:17843714:C:T	single nucleotide variant	intron variant	Benign	Mar 17, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.308+19C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002703944	19	17954567	19	17843758	2703944	2856370		NC_000019.10:17843757:G:A	single nucleotide variant	intron variant	Likely benign	Dec 18, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.308+18G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002963182	19	17954568	19	17843759	2963182	3120502		NC_000019.10:17843758:C:T	single nucleotide variant	intron variant	Likely benign	Dec 14, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.308+16dup	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001661254	19	17954569 - 17954570	19	17843760 - 17843761	1661254	1554506	rs3212717	NC_000019.10:17843760:GGGGGG:GGGGGGG	Duplication	intron variant	Benign	Nov 2, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.308+16del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not specified|Severe combined immunodeficiency disease	VCV000036420	19	17954570	19	17843761	36420	45083	rs3212717	NC_000019.10:17843760:GGGGGG:GGGGG	Deletion	intron variant	Benign	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.308+11C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002993627	19	17954575	19	17843766	2993627	3144945		NC_000019.10:17843765:G:A	single nucleotide variant	intron variant	Likely benign	Sep 30, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.308+8G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001994184	19	17954578	19	17843769	1994184	2055984		NC_000019.10:17843768:C:G	single nucleotide variant	intron variant	Likely benign	Sep 13, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.308+5del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003016197	19	17954581	19	17843772	3016197	3171321		NC_000019.10:17843771:CC:C	Deletion	intron variant	Uncertain significance	Jun 9, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.308+2T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002768381	19	17954584	19	17843775	2768381	2929549		NC_000019.10:17843774:A:G	single nucleotide variant	splice donor variant	Likely pathogenic	Feb 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.308G>A (p.Arg103His)	JAK3	R103H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000191102	19	17954586	19	17843777	191102	188906	rs774202259	NC_000019.10:17843776:C:T	single nucleotide variant	missense variant	Pathogenic	Mar 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.307C>T (p.Arg103Cys)	JAK3	R103C	not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000384359	19	17954587	19	17843778	384359	379510	rs761583890	NC_000019.10:17843777:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.299A>G (p.Tyr100Cys)	JAK3	Y100C	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000009360	19	17954595	19	17843786	9360	24399	rs137852624	NC_000019.10:17843785:T:C	single nucleotide variant	missense variant	Pathogenic	Nov 1, 2001	no assertion criteria provided							
NM_000215.4(JAK3):c.297G>A (p.Leu99=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000892490	19	17954597	19	17843788	892490	880123	rs3212716	NC_000019.10:17843787:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Oct 28, 2023	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.297G>C (p.Leu99=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not specified|not provided	VCV000137600	19	17954597	19	17843788	137600	141303	rs3212716	NC_000019.10:17843787:C:G	single nucleotide variant	synonymous variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.291C>T (p.Val97=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided	VCV002649558	19	17954603	19	17843794	2649558	2811825		NC_000019.10:17843793:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.281G>A (p.Ser94Asn)	JAK3	S94N	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002126666	19	17954613	19	17843804	2126666	2181966		NC_000019.10:17843803:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.268G>A (p.Val90Met)	JAK3	V90M	Inborn genetic diseases|T-B+ severe combined immunodeficiency due to JAK3 deficiency|not specified	VCV001696103	19	17954626	19	17843817	1696103	1688512	rs1016346013	NC_000019.10:17843816:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.267C>T (p.Ser89=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002058342	19	17954627	19	17843818	2058342	2109749		NC_000019.10:17843817:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 27, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.267C>A (p.Ser89=)	JAK3		not provided|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000681594	19	17954627	19	17843818	681594	656520	rs754716735	NC_000019.10:17843817:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.260TCT[1] (p.Phe88del)	JAK3	F88del	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000572359	19	17954629 - 17954631	19	17843820 - 17843822	572359	570597	rs1568408091	NC_000019.10:17843819:AGAAGA:AGA	Microsatellite	inframe_deletion	Uncertain significance	Aug 31, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.252G>A (p.Pro84=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328520	19	17954642	19	17843833	328520	349533	rs139738701	NC_000019.10:17843832:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.251C>T (p.Pro84Leu)	JAK3	P84L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002172905	19	17954643	19	17843834	2172905	1904267		NC_000019.10:17843833:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.246C>T (p.Phe82=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002902659	19	17954648	19	17843839	2902659	3058255		NC_000019.10:17843838:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.235_242dup (p.Trp81fs)	JAK3	W81fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002762708	19	17954651 - 17954652	19	17843842 - 17843843	2762708	2931202		NC_000019.10:17843842:CAGCAGGACAG:CAGCAGGACAGCAGGACAG	Duplication	frameshift variant	Pathogenic	Sep 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.237C>A (p.Ser79=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002818376	19	17954657	19	17843848	2818376	2984591		NC_000019.10:17843847:G:T	single nucleotide variant	synonymous variant	Likely benign	Dec 3, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.230dup (p.Asp77fs)	JAK3	D77fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003583528	19	17954663 - 17954664	19	17843854 - 17843855	3583528	3709373		NC_000019.10:17843854:T:TT	Duplication	frameshift variant	Likely pathogenic	Mar 5, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.231C>T (p.Asp77=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001105454	19	17954663	19	17843854	1105454	1106279	rs771323120	NC_000019.10:17843853:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 16, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.225G>T (p.Thr75=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002815327	19	17954669	19	17843860	2815327	2969998		NC_000019.10:17843859:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.218T>G (p.Leu73Arg)	JAK3	L73R	not provided	VCV000418264	19	17954676	19	17843867	418264	410552	rs1064793156	NC_000019.10:17843866:A:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 14, 2013	criteria provided, single submitter							
NM_000215.4(JAK3):c.217C>G (p.Leu73Val)	JAK3	L73V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001475880	19	17954677	19	17843868	1475880	1423600	rs2094245829	NC_000019.10:17843867:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.213T>C (p.Phe71=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002830087	19	17954681	19	17843872	2830087	2997567		NC_000019.10:17843871:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 19, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.192G>A (p.Leu64=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001604549	19	17954702	19	17843893	1604549	1623704	rs771814824	NC_000019.10:17843892:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 8, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.190C>T (p.Leu64=)	JAK3		Severe combined immunodeficiency disease	VCV000328521	19	17954704	19	17843895	328521	348355	rs886054280	NC_000019.10:17843894:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_000215.4(JAK3):c.187A>G (p.Ile63Val)	JAK3	I63V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000252471	19	17954707	19	17843898	252471	247160	rs144405201	NC_000019.10:17843897:T:C	single nucleotide variant	missense variant	Likely benign	Jan 23, 2024	reviewed by expert panel							
NM_000215.4(JAK3):c.185-15G>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002868356	19	17954724	19	17843915	2868356	3020669		NC_000019.10:17843914:C:A	single nucleotide variant	intron variant	Likely benign	Jul 17, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.185-15G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001927312	19	17954724	19	17843915	1927312	1987493		NC_000019.10:17843914:C:T	single nucleotide variant	intron variant	Likely benign	Jul 27, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.184+97G>A	JAK3		not provided	VCV001272732	19	17954946	19	17844137	1272732	1262197	rs3212715	NC_000019.10:17844136:C:T	single nucleotide variant	intron variant	Benign	Aug 19, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.184+96C>T	JAK3		not specified|not provided	VCV001272699	19	17954947	19	17844138	1272699	1262164	rs3212714	NC_000019.10:17844137:G:A	single nucleotide variant	intron variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.184+42G>A	JAK3		not provided|not specified	VCV001291547	19	17955001	19	17844192	1291547	1281361	rs3212713	NC_000019.10:17844191:C:T	single nucleotide variant	intron variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.184+40G>A	JAK3		not provided|not specified	VCV001291546	19	17955003	19	17844194	1291546	1281360	rs3212712	NC_000019.10:17844193:C:T	single nucleotide variant	intron variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.184+22C>T	JAK3		not provided|not specified	VCV001183811	19	17955021	19	17844212	1183811	1173205	rs3212711	NC_000019.10:17844211:G:A	single nucleotide variant	intron variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.184+19G>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003001714	19	17955024	19	17844215	3001714	3160715		NC_000019.10:17844214:C:G	single nucleotide variant	intron variant	Likely benign	May 22, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.184+18G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003696305	19	17955025	19	17844216	3696305	3829206		NC_000019.10:17844215:C:T	single nucleotide variant	intron variant	Likely benign	Jan 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.184+17T>C	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001543038	19	17955026	19	17844217	1543038	1523313	rs200903837	NC_000019.10:17844216:A:G	single nucleotide variant	intron variant	Likely benign	Feb 19, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.184+11C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002708520	19	17955032	19	17844223	2708520	2870811		NC_000019.10:17844222:G:A	single nucleotide variant	intron variant	Likely benign	Jan 9, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.184+11C>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001652572	19	17955032	19	17844223	1652572	1664485	rs1331165925	NC_000019.10:17844222:G:T	single nucleotide variant	intron variant	Likely benign	Dec 27, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.184+9A>G	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002977329	19	17955034	19	17844225	2977329	3141154		NC_000019.10:17844224:T:C	single nucleotide variant	intron variant	Likely benign	Sep 8, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.184+5G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002432945	19	17955038	19	17844229	2432945	2405574		NC_000019.10:17844228:C:T	single nucleotide variant	intron variant	Uncertain significance	Jan 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.184G>A (p.Gly62Ser)	JAK3	G62S	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000952603	19	17955043	19	17844234	952603	928895	rs199602590	NC_000019.10:17844233:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.183C>T (p.Ser61=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000889117	19	17955044	19	17844235	889117	880124	rs200269517	NC_000019.10:17844234:G:A	single nucleotide variant	synonymous variant	Uncertain significance	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.175A>T (p.Lys59Ter)	JAK3	K59*	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001999662	19	17955052	19	17844243	1999662	2057596		NC_000019.10:17844242:T:A	single nucleotide variant	nonsense	Likely pathogenic	Nov 14, 2023	reviewed by expert panel							
NM_000215.4(JAK3):c.172_174del (p.Ala58del)	JAK3	A58del	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000009366	19	17955053 - 17955055	19	17844244 - 17844246	9366	24405	rs137852627	NC_000019.10:17844243:GGC:	Deletion	inframe_deletion	Pathogenic	Nov 1, 2001	no assertion criteria provided							
NM_000215.4(JAK3):c.172G>A (p.Ala58Thr)	JAK3	A58T	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001479492	19	17955055	19	17844246	1479492	1439215	rs2046340891	NC_000019.10:17844245:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.165G>C (p.Val55=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002993118	19	17955062	19	17844253	2993118	3148257		NC_000019.10:17844252:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 5, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.165G>A (p.Val55=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001897817	19	17955062	19	17844253	1897817	1959791		NC_000019.10:17844252:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 21, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.163G>A (p.Val55Met)	JAK3	V55M	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001940722	19	17955064	19	17844255	1940722	2004756		NC_000019.10:17844254:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.162C>T (p.Cys54=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002893740	19	17955065	19	17844256	2893740	3049125		NC_000019.10:17844255:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 25, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.156C>T (p.Asp52=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002699861	19	17955071	19	17844262	2699861	2862133		NC_000019.10:17844261:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 30, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.154G>A (p.Asp52Asn)	JAK3	D52N	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001060010	19	17955073	19	17844264	1060010	1051159	rs2147700846	NC_000019.10:17844263:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 7, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.150T>C (p.Ala50=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001079400	19	17955077	19	17844268	1079400	1084519	rs2094246845	NC_000019.10:17844267:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 6, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.141C>G (p.Asp47Glu)	JAK3	D47E	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000657107	19	17955086	19	17844277	657107	647818	rs1599881400	NC_000019.10:17844276:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.136G>A (p.Gly46Arg)	JAK3	G46R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000836993	19	17955091	19	17844282	836993	847433	rs778988303	NC_000019.10:17844281:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.131C>T (p.Ser44Phe)	JAK3	S44F	Inborn genetic diseases	VCV003112153	19	17955096	19	17844287	3112153	3275307		NC_000019.10:17844286:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.129C>T (p.Phe43=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002764375	19	17955098	19	17844289	2764375	2931578		NC_000019.10:17844288:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.123_126del (p.Phe43fs)	JAK3	F43fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002816110	19	17955101 - 17955104	19	17844292 - 17844295	2816110	2976780		NC_000019.10:17844291:AGATAG:AG	Deletion	frameshift variant	Pathogenic	Nov 23, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.125C>A (p.Ser42Tyr)	JAK3	S42Y	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000839962	19	17955102	19	17844293	839962	847434	rs2094246939	NC_000019.10:17844292:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2019	criteria provided, single submitter							
NM_000215.4(JAK3):c.123A>G (p.Leu41=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001982439	19	17955104	19	17844295	1982439	2038999		NC_000019.10:17844294:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 16, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.119G>A (p.Arg40His)	JAK3	R40H	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328522	19	17955108	19	17844299	328522	332832	rs56384680	NC_000019.10:17844298:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.115dup (p.Gln39fs)	JAK3	Q39fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency|Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency	VCV002501779	19	17955111 - 17955112	19	17844302 - 17844303	2501779	2524718		NC_000019.10:17844302:GGGGGGG:GGGGGGGG	Duplication	frameshift variant	Pathogenic/Likely pathogenic	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.115C>G (p.Gln39Glu)	JAK3	Q39E	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001998303	19	17955112	19	17844303	1998303	2054084		NC_000019.10:17844302:G:C	single nucleotide variant	missense variant	Uncertain significance	May 24, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.115del (p.Gln39fs)	JAK3	Q39fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided	VCV000649414	19	17955112	19	17844303	649414	647819	rs755706305	NC_000019.10:17844302:GGGGGGG:GGGGGG	Deletion	frameshift variant	Pathogenic	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.114C>A (p.Pro38=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000626122	19	17955113	19	17844304	626122	614457	rs1448668382	NC_000019.10:17844303:G:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 22, 2024	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.110C>G (p.Pro37Arg)	JAK3	P37R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001006935	19	17955117	19	17844308	1006935	998453	rs200960683	NC_000019.10:17844307:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.109C>A (p.Pro37Thr)	JAK3	P37T	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002794529	19	17955118	19	17844309	2794529	2954364		NC_000019.10:17844308:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.108G>C (p.Gly36=)	JAK3		not provided|not specified|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000137599	19	17955119	19	17844310	137599	141302	rs149701114	NC_000019.10:17844309:C:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_000215.4(JAK3):c.106G>A (p.Gly36Arg)	JAK3	G36R	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001981508	19	17955121	19	17844312	1981508	2045874		NC_000019.10:17844311:C:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.105C>A (p.Pro35=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002058193	19	17955122	19	17844313	2058193	2109601		NC_000019.10:17844312:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 19, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.105C>T (p.Pro35=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000532756	19	17955122	19	17844313	532756	533209	rs199988158	NC_000019.10:17844312:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.101del (p.Gly34fs)	JAK3	G34fs	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002796382	19	17955126	19	17844317	2796382	2954920		NC_000019.10:17844316:CCCC:CCC	Deletion	frameshift variant	Pathogenic	Aug 29, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.97C>A (p.Arg33=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002957736	19	17955130	19	17844321	2957736	3118948		NC_000019.10:17844320:G:T	single nucleotide variant	synonymous variant	Likely benign	Dec 19, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.94G>A (p.Ala32Thr)	JAK3	A32T	not specified	VCV000134576	19	17955133	19	17844324	134576	138315	rs587778416	NC_000019.10:17844323:C:T	single nucleotide variant	missense variant	not provided	Sep 19, 2013	no classification provided							
NM_000215.4(JAK3):c.93C>T (p.Pro31=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001100434	19	17955134	19	17844325	1100434	1106280	rs201917022	NC_000019.10:17844324:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.84G>A (p.Val28=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003706184	19	17955143	19	17844334	3706184	3839637		NC_000019.10:17844333:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 17, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.81T>C (p.His27=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003675921	19	17955146	19	17844337	3675921	3813537		NC_000019.10:17844336:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 14, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.81T>G (p.His27Gln)	JAK3	H27Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001502150	19	17955146	19	17844337	1502150	1411366	rs1039181282	NC_000019.10:17844336:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.81T>A (p.His27Gln)	JAK3	H27Q	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000464101	19	17955146	19	17844337	464101	470527	rs1039181282	NC_000019.10:17844336:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.78G>A (p.Leu26=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002793462	19	17955149	19	17844340	2793462	2950709		NC_000019.10:17844339:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 1, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.76C>T (p.Leu26=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002964304	19	17955151	19	17844342	2964304	3124207		NC_000019.10:17844341:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 7, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.63G>C (p.Thr21=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001933398	19	17955164	19	17844355	1933398	1982368		NC_000019.10:17844354:C:G	single nucleotide variant	synonymous variant	Likely benign	Oct 23, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.63G>A (p.Thr21=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001434594	19	17955164	19	17844355	1434594	1494410	rs754954318	NC_000019.10:17844354:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Oct 1, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.62C>T (p.Thr21Met)	JAK3	T21M	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001004560	19	17955165	19	17844356	1004560	998454	rs752820429	NC_000019.10:17844355:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2020	criteria provided, single submitter							
NM_000215.4(JAK3):c.60C>T (p.Ser20=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002721514	19	17955167	19	17844358	2721514	2884603		NC_000019.10:17844357:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 30, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.58T>A (p.Ser20Thr)	JAK3	S20T	Inborn genetic diseases	VCV000134577	19	17955169	19	17844360	134577	138316	rs199773433	NC_000019.10:17844359:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.48C>T (p.Cys16=)	JAK3		not specified	VCV000381092	19	17955179	19	17844370	381092	377359	rs1057520953	NC_000019.10:17844369:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 20, 2015	criteria provided, single submitter							
NM_000215.4(JAK3):c.42T>A (p.Arg14=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001086663	19	17955185	19	17844376	1086663	1084520	rs769914477	NC_000019.10:17844375:A:T	single nucleotide variant	synonymous variant	Likely benign	Apr 12, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.35C>T (p.Pro12Leu)	JAK3	P12L	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328523	19	17955192	19	17844383	328523	348358	rs56061056	NC_000019.10:17844382:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.30G>A (p.Leu10=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002707409	19	17955197	19	17844388	2707409	2867099		NC_000019.10:17844387:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_000215.4(JAK3):c.28C>G (p.Leu10Val)	JAK3	L10V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000532748	19	17955199	19	17844390	532748	532782	rs1052019264	NC_000019.10:17844389:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.24G>A (p.Thr8=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002897864	19	17955203	19	17844394	2897864	3067245		NC_000019.10:17844393:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.23C>T (p.Thr8Met)	JAK3	T8M	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000134575	19	17955204	19	17844395	134575	138314	rs145500023	NC_000019.10:17844394:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.18A>G (p.Glu6=)	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002761928	19	17955209	19	17844400	2761928	2911457		NC_000019.10:17844399:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 19, 2023	criteria provided, single submitter							
NM_000215.4(JAK3):c.14G>A (p.Ser5Asn)	JAK3	S5N	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000837106	19	17955213	19	17844404	837106	847435	rs566269022	NC_000019.10:17844403:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.5C>T (p.Ala2Val)	JAK3	A2V	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000582051	19	17955222	19	17844413	582051	570599	rs1568408509	NC_000019.10:17844412:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2021	criteria provided, single submitter							
NM_000215.4(JAK3):c.4G>C (p.Ala2Pro)	JAK3	A2P	T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002135073	19	17955223	19	17844414	2135073	2190481		NC_000019.10:17844413:C:G	single nucleotide variant	missense variant	Uncertain significance	May 7, 2022	criteria provided, single submitter							
NM_000215.4(JAK3):c.-3C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328524	19	17955229	19	17844420	328524	343021	rs754275786	NC_000019.10:17844419:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.-19C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000889118	19	17958760	19	17847951	889118	880125	rs181416110	NC_000019.10:17847950:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_000215.4(JAK3):c.-26C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency|not provided	VCV000668930	19	17958767	19	17847958	668930	656521	rs199713123	NC_000019.10:17847957:G:A	single nucleotide variant	5 prime UTR variant	Likely benign	Mar 19, 2018	criteria provided, multiple submitters, no conflicts							
NM_000215.4(JAK3):c.-36A>G	JAK3		not provided|not specified|T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328525	19	17958777	19	17847968	328525	349534	rs7254346	NC_000019.10:17847967:T:C	single nucleotide variant	5 prime UTR variant	Benign	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000215.3(JAK3):c.-54C>T	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000328526	19	17958795	19	17847986	328526	348359	rs201353678	NC_000019.10:17847985:G:A	single nucleotide variant		Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_000215.3(JAK3):c.-105G>A	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000889806	19	17958846	19	17848037	889806	880713	rs950208815	NC_000019.10:17848036:C:T	single nucleotide variant		Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NC_000019.9:g.(?_17943332)_(17949808_?)del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003248439	19	17943332 - 17949808			3248439	3407247			Deletion		Pathogenic	Mar 22, 2023	criteria provided, single submitter							
NC_000019.9:g.(?_17951019)_(17955226_?)del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003248438	19	17951019 - 17955226			3248438	3407246			Deletion		Pathogenic	Aug 9, 2023	criteria provided, single submitter							
NC_000019.9:g.(?_17952429)_(17955226_?)del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003248437	19	17952429 - 17955226			3248437	3407245			Deletion		Pathogenic	May 3, 2023	criteria provided, single submitter							
NC_000019.9:g.(?_17948721)_(17950492_?)del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV003248436	19	17948721 - 17950492			3248436	3407244			Deletion		Pathogenic	Feb 2, 2023	criteria provided, single submitter							
GRCh37/hg19 19p13.13-13.11(chr19:13970692-18139376)x3	CYP4F8|DCAF15|OR1I1|OR7A10|OR7A17|PGLS|PGLS-DT|PGLYRP2|PKN1|PLVAP|PODNL1|PTGER1|OR7A5|OR7C1|OR7C2|PALM3|PRKACA|DDA1|DDX39A|FAM32A|FCHO1|GIPC1|GTPBP3|HAUS8|HSH2D|EPS15L1|F2RL3|IL27RA|DNAJB1|EPHX3|ABHD8|ADGRE2|ADGRE3|ADGRE5|ADGRL1|AKAP8|AKAP8L|ANKLE1|ANO8|AP1M1|ARRDC2|ASF1B|B3GNT3|BABAM1|BRD4|BRME1|BST2|C19orf44|C19orf67|CALR3|CASP14|CC2D1A|CCDC124|CHERP|CIB3|CLEC17A|COLGALT1|CPAMD8|CYP4F11|CYP4F12|CYP4F2|CYP4F22|CYP4F3|ILVBL|INSL3|JAK3|KCNN1|KLF2|MAP1S|MED26|MIR181C|MRPL34|MVB12A|MYO9B|NANOS3|NDUFB7|NIBAN3|NOTCH3|NR2F6|NWD1|NXNL1|OCEL1|OR10H1|OR10H2|OR10H3|OR10H4|OR10H5|RAB8A|RASAL3|RFX1|RLN3|RPL18A|SAMD1|SIN3B|SLC1A6|SLC27A1|SLC35E1|SLC5A5|SMIM7|SYDE1|TECR|TEKTL1|TMEM221|TMEM38A|TPM4|UCA1|UNC13A|USE1|USHBP1|WIZ|ZNF333		not specified	VCV003062393	19	13970692 - 18139376			3062393	3222618			copy number gain		Uncertain significance		criteria provided, single submitter							
NC_000019.9:g.(?_17927663)_(19312528_?)dup	ISYNA1|JAK3|JUND|KCNN1|KLHL26|SSBP4|SUGP2|TMEM161A|MAST3|PDE4C|SLC5A5|KXD1|LRRC25|LSM4|TMEM59L|MEF2B|MPV17L2|NR2C2AP|PGPEP1|ARMC6|ARRDC2|BORCS8|CCDC124|CERS1|COMP|COPE|CRLF1|CRTC1|DDX49|ELL|FKBP8|GDF1|GDF15|HOMER3|IFI30|IL12RB1|INSL3|IQCN|PIK3R2|RAB3A|REX1BD|RFXANK|RPL18A|SLC25A42|UBA52|UPF1		Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	VCV002425279	19	17927663 - 19312528			2425279	1943007			Duplication		Uncertain significance	Oct 11, 2022	criteria provided, single submitter							
NC_000019.9:g.(?_17952178)_(17955226_?)dup	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV002422589	19	17952178 - 17955226			2422589	1938901			Duplication		Uncertain significance	Mar 27, 2022	criteria provided, single submitter							
NC_000019.9:g.(?_17937552)_(17937739_?)dup	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001440766	19	17937552 - 17937739			1440766	1361913			Duplication		Uncertain significance	Sep 28, 2022	criteria provided, single submitter							
NC_000019.9:g.(?_17927663)_(17983505_?)dup	INSL3|JAK3|RPL18A|SLC5A5		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001409213	19	17927663 - 17983505			1409213	1497002			Duplication		Uncertain significance	Mar 19, 2022	criteria provided, single submitter							
NC_000019.9:g.(?_17940897)_(17943758_?)del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001390045	19	17940897 - 17943758			1390045	1373644			Deletion		Pathogenic	Oct 9, 2021	criteria provided, single submitter							
NC_000019.9:g.(?_17944409)_(17945894_?)del	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV001348959	19	17944409 - 17945894			1348959	1478970			Deletion		Likely pathogenic	Sep 28, 2021	criteria provided, single submitter							
GRCh37/hg19 19p13.12-12(chr19:14286624-20956753)x3	BST2|NWD1|NXNL1|PGLS-DT|PGLYRP2|OR10H4|OR10H5|OR1I1|OR7A10|OR7A17|OCEL1|OR10H1|OR7A5|OR7C1|OR10H2|OR10H3|OR7C2|PBX4|PDE4C|PGLS|COPE|CPAMD8|CASP14|CCDC105|C19orf44|CALR3|CCDC124|CERS1|CHERP|CIB3|CILP2|CLEC17A|COLGALT1|COMP|ABHD8|ADGRE2|ADGRE3|ADGRE5|ADGRL1|AKAP8|AKAP8L|ANKLE1|ANO8|AP1M1|ARMC6|ARRDC2|ATP13A1|B3GNT3|BABAM1|BORCS8|BRD4|CRLF1|CRTC1|CYP4F11|CYP4F12|CYP4F2|CYP4F22|CYP4F3|CYP4F8|DDA1|DDX39A|DDX49|DNAJB1|ELL|EPHX3|EPS15L1|F2RL3|FAM32A|FCHO1|FKBP8|GATAD2A|GDF1|GDF15|GIPC1|GMIP|GTPBP3|HAPLN4|HAUS8|HOMER3|HSH2D|IFI30|IL12RB1|ILVBL|INSL3|IQCN|ISYNA1|JAK3|JUND|KCNN1|KLF2|KLHL26|KXD1|LPAR2|LRRC25|LSM4|MAP1S|MAST3|MAU2|MED26|MEF2B|MPV17L2|MRPL34|MVB12A|MYO9B|NCAN|NDUFA13|NDUFB7|NIBAN3|NOTCH3|NR2C2AP|NR2F6|PGPEP1|PIK3R2|PKN1|PLVAP|PTGER1|RAB3A|RAB8A|RASAL3|REX1BD|RFXANK|RPL18A|SIN3B|SLC1A6|SLC25A42|SLC27A1|SLC35E1|SLC5A5|SMIM7|SSBP4|SUGP1|SUGP2|SYDE1|TECR|TM6SF2|TMEM161A|TMEM221|TMEM38A|TMEM59L|TPM4|TSSK6|UBA52|UCA1|UNC13A|UPF1|USE1|USHBP1|WIZ|YJEFN3|ZNF101|ZNF14|ZNF253|ZNF333|ZNF486|ZNF506|ZNF626|ZNF682|ZNF737|ZNF90|ZNF93		not provided	VCV000980194	19	14286624 - 20956753			980194	968272			copy number gain		Pathogenic	Feb 5, 2020	no assertion criteria provided							
GRCh37/hg19 19p13.11(chr19:17639605-17992841)x3	RPL18A|NIBAN3|UNC13A|INSL3|JAK3|FCHO1|SLC5A5|B3GNT3|COLGALT1|MAP1S		not provided	VCV000980193	19	17639605 - 17992841			980193	968271			copy number gain		Uncertain significance	Jun 17, 2019	no assertion criteria provided							
GRCh37/hg19 19p13.11(chr19:17921282-18025754)x3	B3GNT3|INSL3|JAK3|RPL18A|SLC5A5		not provided	VCV000687270	19	17921282 - 18025754			687270	674862			copy number gain		Uncertain significance	Aug 31, 2017	no assertion criteria provided							
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888)	PGLYRP1|PGLYRP2|PGPEP1|PHLDB3|PIAS4|PIH1D1|PIK3R2|PIN1|PINLYP|PIP5K1C|PKN1|PLA2G4C|PLAUR|PLD3|PLEKHA4|PLEKHF1|PLEKHG2|PLEKHJ1|PLIN3|PLIN4|PLIN5|PLK5|PLPP2|PLPPR3|PLVAP|PNKP|PNMA8A|PNMA8B|PNPLA6|PODNL1|POLD1|POLR1G|POLR2E|POLR2I|POLRMT|POP4|POU2F2|PPAN|PPAN-P2RY11|PPFIA3|PPM1N|PPP1R12C|PPP1R13L|PPP1R14A|PPP1R15A|PPP1R37|PPP2R1A|PPP5C|PPP5D1|PPP6R1|PRAM1|PRDX2|PRG1|PRKACA|PRKCG|PRKCSH|PRKD2|PRMT1|PRODH2|PROSER3|PRPF31|PRR12|PRR19|PRR22|PRRG2|PRSS57|PRTN3|PRX|PSENEN|PSG1|PSG11|PSG2|PSG3|PSG4|PSG5|PSG6|PSG7|PSG8|PSG9|PSMC4|PSMD8|PSPN|PTBP1|PTGER1|PTGIR|PTH2|PTOV1|PTOV1-AS2|PTPRH|PTPRS|PVR|PWWP3A|QPCTL|QTRT1|R3HDM4|RAB11B|RAB3A|RAB3D|RAB4B|RAB8A|RABAC1|RAD23A|RANBP3|RASAL3|RASGRP4|RASIP1|RAVER1|RAX2|RBM42|RCN3|REX1BD|RDH13|RDH8|REEP6|RELB|RETN|REXO1|RFPL4A|RFPL4AL1|RFX1|RFX2|RFXANK|RGL3|RGS9BP|RHPN2|RINL|RLN3|RNASEH2A|RNF126|RPL13A|RPL18|RPL18A|RPL28|RPL36|RPS11|RPS15|RPS16|RPS19|RPS28|RPS5|RPS9|RRAS|RSPH6A|RTBDN|RTN2|RUVBL2|RYR1|S1PR2|S1PR4|S1PR5|SAE1|SAFB|SAFB2|SAMD1|SAMD4B|SARS2|SAXO5|SBK2|SBNO2|SBSN|SCAF1|SCAMP4|SCGB2B2|SCN1B|SDHAF1|SELENOV|SELENOW|SEMA6B|SERTAD1|SERTAD3|SF3A2|SGTA|SH2D3A|SH3GL1|SHANK1|SHC2|SHD|SHFL|SHISA7|SHKBP1|SIGLEC10|SIGLEC11|SIGLEC12|SIGLEC14|SIGLEC5|SIGLEC6|SIGLEC7|SIGLEC8|SIGLEC9|SIGLECL1|SIN3B|SIPA1L3|SIRT2|SIRT6|SIX5|SLC17A7|SLC1A5|SLC1A6|SLC25A23|SLC25A41|SLC25A42|SLC27A1|SLC35E1|SLC39A3|SLC44A2|SLC5A5|SLC6A16|SLC7A10|SLC7A9|SLC8A2|SMARCA4|SMG9|SMIM17|SMIM24|SMIM7|SNAPC2|SNRNP70|SNRPA|SNRPD2|SPACA4|SPC24|SPHK2|SPIB|SPINT2|SPMAP2|SPPL2B|SPRED3|SPTBN4|SRRM5|SSBP4|SSC5D|STAP2|STK11|STRN4|STX10|STXBP2|SUGP1|SUGP2|SULT2A1|SULT2B1|SUPT5H|SWSAP1|SYCE2|SYCN|SYDE1|SYMPK|SYNE4|SYNGR4|SYT3|SYT5|TARM1|TBC1D17|TBCB|TBXA2R|TCF3|TDRD12|TEAD2|TECR|TEKTIP1|TEKTL1|TEX101|TFPT|TGFB1|TGFBR3L|THAP8|THOP1|TICAM1|TIMM13|TIMM29|TIMM44|TIMM50|TINCR|TJP3|TLE2|TLE5|TLE6|TM6SF2|TMC4|TMED1|TMEM143|TMEM145|TMEM147|TMEM150B|TMEM160|TMEM161A|TMEM190|TMEM205|TMEM221|TMEM238|TMEM259|TMEM38A|TMEM59L|TMEM86B|TMEM91|TMIGD2|TMPRSS9|TNFAIP8L1|TNFSF14|TNFSF9|TNNI3|TNNT1|TNPO2|TOMM40|TPGS1|TPM4|TPRX1|TRAPPC5|TRAPPC6A|TRIP10|TRIR|TRMT1|TRPM4|TRU-TCA1-1|TSEN34|TSHZ3|TSKS|TSPAN16|TSSK6|TTC9B|TTYH1|UBA2|TUBB4A|TULP2|TYK2|TYROBP|U2AF1L4|U2AF2|UBA52|UBE2S|UBL5|UBXN6|UCA1|UHRF1|UNC13A|UPF1|UPK1A|UQCR11|UQCRFS1|URI1|USE1|USF2|USHBP1|USP29|VASP|VAV1|VMAC|VN1R1|VN1R2|VN1R4|VRK3|VSIG10L|VSTM1|VSTM2B|WDR18|WDR62|WDR83|WDR83OS|WDR87|WDR88|WIZ|WTIP|XAB2|XRCC1|YIF1B|YIPF2|YJEFN3|YJU2|YJU2B|ZBTB32|ZBTB7A|ZC3H4|ZFP14|ZFP28|ZFP30|ZFP36|ZFP82|ZFR2|ZGLP1|ZIK1|ZIM2|ZIM2-AS1|ZIM3|ZNF100|ZNF101|ZNF112|ZNF114|ZNF121|ZNF132|ZNF134|ZNF135|ZNF136|ZNF14|ZNF146|ZNF154|ZNF155|ZNF160|ZNF17|ZNF175|ZNF177|ZNF180|ZNF181|ZNF20|ZNF208|ZNF211|ZNF221|ZNF222|ZNF223|ZNF224|ZNF225|ZNF226|ZNF227|ZNF229|ZNF230|ZNF233|ZNF234|ZNF235|ZNF253|ZNF254|ZNF256|ZNF257|ZNF260|ZNF264|ZNF266|ZNF274|ZNF28|ZNF283|ZNF284|ZNF285|ZNF296|ZNF30|ZNF302|ZNF304|ZNF317|ZNF320|ZNF329|ZNF331|ZNF333|ZNF345|ZNF347|ZNF350|ZNF358|ZNF382|ZNF383|ZNF404|ZNF414|ZNF415|ZNF416|ZNF417|ZNF418|ZNF419|ZNF420|ZNF426|ZNF428|ZNF429|ZNF43|ZNF430|ZNF431|ZNF432|ZNF433|ZNF439|ZNF44|ZNF440|ZNF441|ZNF442|ZNF443|ZNF444|ZNF45|ZNF460|ZNF461|ZNF468|ZNF470|ZNF471|ZNF473|ZNF480|ZNF486|ZNF490|ZNF491|ZNF492|ZNF493|ZNF497|ZNF506|ZNF507|ZNF524|ZNF526|ZNF527|ZNF528|ZNF529|ZNF530|ZNF534|ZNF536|ZNF540|ZNF541|ZNF543|ZNF544|ZNF546|ZNF547|ZNF548|ZNF549|ZNF550|ZNF551|ZNF552|ZNF554|ZNF555|ZNF556|ZNF557|ZNF558|ZNF559|ZNF559-ZNF177|ZNF560|ZNF561|ZNF562|ZNF563|ZNF564|ZNF565|ZNF566|ZNF567|ZNF568|ZNF569|ZNF570|ZNF571|ZNF573|ZNF574|ZNF575|ZNF576|ZNF577|ZNF578|ZNF579|ZNF580|ZNF581|ZNF582|ZNF583|ZNF584|ZNF585A|ZNF585B|ZNF586|ZNF587|ZNF587B|ZNF599|ZNF600|ZNF606|COX6B1|COX6B2|COX7A1|CPAMD8|CPT1C|CRB3|CREB3L3|CRLF1|CRTC1|CRX|CSNK1G2|CTU1|CTXN1|CXCL17|CYP2A13|CYP2A6|CYP2A7|CYP2B6|CYP2F1|CYP2S1|CYP4F11|CYP4F12|CYP4F2|CYP4F22|CYP4F3|CYP4F8|CYTH2|DACT3|DAND5|DAPK3|DAZAP1|DBP|DCAF15|DDA1|DDX39A|DDX49|DEDD2|DENND1C|DHDH|DHPS|DHX34|DIRAS1|DKKL1|DLL3|DMAC2|DMKN|DMPK|DMRTC2|DMWD|DNAAF3|DNAJB1|DNASE2|DNM2|DNMT1|DOCK6|DOHH|DOT1L|DPF1|DPP9|DPRX|DPY19L3|DUS3L|DUXA|DYRK1B|EBI3|ECH1|ECSIT|EEF2|EFNA2|EGLN2|EHD2|EID2|EID2B|EIF3G|EIF3K|EMC10|ELANE|ELAVL1|ELAVL3|ELL|ELOF1|ELSPBP1|EML2|EMP3|EPHX3|EPN1|EPOR|EPS15L1|EPS8L1|ERCC1|ERCC2|ERF|ERICH4|ERVV-1|ERVV-2|ETFB|ETHE1|ETV2|EVI5L|EXOC3L2|EXOSC5|F2RL3|FAAP24|FAM174C|FAM187B|FAM32A|FAM83E|FAM98C|FARSA|FBL|FBN3|FBXL12|FBXO17|FBXO27|FBXO46|FBXW9|FCAR|FCER2|FCGBP|FCGRT|FCHO1|FDX2|FEM1A|FFAR1|FFAR2|FFAR3|FGF21|FGF22|FIZ1|FKBP8|FKRP|FLT3LG|FOSB|FOXA3|FPR1|FPR2|FPR3|FSD1|FSTL3|FTL|FUT1|FUT2|FUT3|FUT5|FUT6|FUZ|FXYD1|FXYD3|FXYD5|FXYD7|FZR1|GADD45B|GADD45GIP1|GALP|GAMT|GAPDHS|GARIN5A|GARIN5B|GARRE1|GATAD2A|GCDH|GDF1|GDF15|GEMIN7|GET3|GGN|GIPC1|GIPC3|GIPR|GMFG|GMIP|GNA11|GNA15|GNG7|GNG8|GP6|GPATCH1|GPI|GPR108|GPR32|GPR4|GPR42|GPX4|GRAMD1A|GRIK5|GRIN2D|GRIN3B|GRWD1|GSK3A|GTF2F1|GTPBP3|GYS1|GZMM|HAMP|HAPLN4|HAS1|HAUS5|HAUS8|HCN2|HCST|HIF3A|HIPK4|HMG20B|HNRNPL|HNRNPM|HNRNPUL1|HOMER3|HOOK2|HPN|HRC|HSD11B1L|HSD17B14|HSH2D|HSPB6|HSPBP1|ICAM1|ICAM3|ICAM4|ICAM5|IER2|IFI30|IFNL1|IFNL2|IFNL3|IGFL1|IGFL2|IGFL3|IGFL4|IGFLR1|IGLON5|IGSF23|IL11|IL12RB1|IL27RA|IL4I1|ILF3|ILVBL|INAFM1|INSL3|INSR|IQCN|IRF2BP1|IRF3|IRGC|IRGQ|ISOC2|ISYNA1|ITPKC|IZUMO1|IZUMO2|IZUMO4|JAK3|JOSD2|JSRP1|JUNB|JUND|KANK2|KANK3|KASH5|KCNA7|KCNC3|KCNJ14|KCNK6|KCNN1|KCNN4|KCTD15|KDELR1|KDM4B|KEAP1|KHSRP|KIRREL2|KISS1R|KLC3|KLF1|KLF16|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|KIR3DL3|KLF2|KLHL26|KLK1|KLK10|KLK11|KLK12|KLK13|KLK14|KLK15|KLK2|KLK3|KLK4|KLK5|KLK6|KLK7|KLK8|KLK9|KMT2B|KMT5C|KPTN|KRI1|KRTDAP|KXD1|LAIR1|LAIR2|LDLR|LENG1|LENG8|LENG9|LEUTX|LGALS13|LGALS14|LGALS16|LGALS4|LGALS7|LGALS7B|LGI4|LHB|LIG1|LILRA1|LILRA2|LILRA3|LIM2|LILRA4|LILRA5|LILRA6|LILRB1|LILRB2|LILRB3|LILRB4|LILRB5|LIN37|LIN7B|LINGO3|LIPE|LMNB2|LMTK3|LONP1|LPAR2|LRFN1|LRFN3|LRG1|LRP3|LRRC25|LRRC4B|LRRC8E|LSM14A|LSM4|LSM7|LSR|LTBP4|LYL1|LYPD3|LYPD4|LYPD5|MADCAM1|MAG|MAMSTR|MAN2B1|MAP1S|MAP2K2|MAP2K7|MAP3K10|MAP4K1|MARCHF2|MARK4|MAST1|MAST3|MATK|MAU2|MBD3|MBD3L1|MBD3L2|MBD3L3|MBD3L4|MBD3L5|MBOAT7|MCEMP1|MCOLN1|MED16|MED25|MED26|MED29|MEF2B|MEGF8|MEIS3|MEX3D|MFSD12|MIA|MICOS13|MIDN|MIER2|MIR125A|MIR150|MIR181C|MIR1909|MIR199A1|MIR23A|MIR24-2|MIR27A|MIR371A|MIR372|MIR373|MIR519D|MIR520H|MIR99B|MIRLET7E|MISP|MKNK2|MLLT1|MOB3A|MPND|MPV17L2|MRI1|MRPL34|MRPL4|MRPL54|MRPS12|MUC16|MVB12A|MYADM|MYBPC2|MYDGF|MYH14|MYO1F|MYO9B|MYPOP|NACC1|NANOS2|NANOS3|NAPA|NAPSA|NAT14|NCAN|NCCRP1|NCLN|NFIC|NFIX|NCR1|NDUFA11|NDUFA13|NDUFA3|NDUFA7|NDUFB7|NDUFS7|NECTIN2|NFKBIB|NFKBID|NIBAN3|NKG7|NKPD1|NLRP11|NLRP12|NLRP13|NLRP2|NLRP4|NLRP5|NLRP7|NLRP8|NLRP9|NMRK2|NOP53|NOSIP|NOTCH3|NOVA2|NPAS1|NPHS1|NR1H2|NR2C2AP|NR2F6|NRTN|NTF4|NTN5|NUCB1|NUDT19|NUMBL|NUP62|NWD1|NXNL1|OAZ1|OCEL1|ODAD1|ODAD3|OLFM2|ONECUT3|OPA3|OR10H1|OR10H2|OR10H3|OR10H4|OR10H5|OR1I1|OR1M1|OR2Z1|OR7A10|OR7A17|OR7A5|OR7C1|OR7C2|OR7D2|OR7D4|OR7E24|OR7G1|OR7G2|OR7G3|OSCAR|OVOL3|P2RY11|PAF1|PAFAH1B3|PAK4|PALM|PALM3|PBX4|PCP2|PCSK4|PDCD2L|PDCD5|PDE4A|PDE4C|PEAK3|PEG3|PEPD|PET100|PEX11G|PGLS|PGLS-DT|A1BG|ABCA7|ABHD17A|ABHD8|ACER1|ACP4|ACP5|ACP7|ACSBG2|ACTL9|ACTMAP|ACTN4|ADAMTS10|ADAMTSL5|ADAT3|ADGRE1|ADGRE2|ADGRE3|ADGRE5|ADGRL1|ADM5|AKAP8|AKAP8L|AKT1S1|AKT2|ALDH16A1|ALKBH6|ALKBH7|AMH|ANGPTL4|ANGPTL6|ANGPTL8|ANKLE1|ANKRD24|ANKRD27|ANO8|AP1M1|AP1M2|AP2A1|AP2S1|AP3D1|APBA3|APC2|APLP1|APOC1|APOC2|APOC4|APOE|ARHGAP33|ARHGAP35|ARHGAP45|ARHGEF1|ARHGEF18|ARID3A|ARMC6|ARRDC2|ARRDC5|ASF1B|ASPDH|ATCAY|ATF5|ATG4D|ATP13A1|ATP1A3|ATP4A|ATP5F1D|ATP8B3|AURKC|AXL|AZU1|B3GNT3|B3GNT8|B9D2|BABAM1|BAX|BBC3|BCAM|BCAT2|BCKDHA|BCL2L12|BCL3|BEST2|BICRA|BLOC1S3|BLVRB|BORCS8|BRD4|BRME1|BRSK1|BSG|BSPH1|BST2|BTBD2|C19orf12|C19orf18|C19orf25|C19orf33|C19orf38|C19orf44|C19orf47|C19orf53|C19orf67|C19orf73|C19orf81|C2CD4C|C3|C5AR1|C5AR2|CA11|CABP5|CACNA1A|CACNG6|CACNG7|CACNG8|CACTIN|CADM4|CALM3|CALR|CALR3|CAMSAP3|CAPN12|CAPNS1|CAPS|CARD8|CARM1|CASP14|CATSPERD|CATSPERG|CBARP|CBLC|CC2D1A|CCDC106|CCDC124|CCDC159|CCDC61|CCDC8|CCDC9|CCDC97|CCL25|CCNE1|CCNP|CD177|CD209|CD22|CD320|CD33|CD37|CD70|CD79A|CDC34|CDC37|CDC42EP5|CDKN2D|CEACAM1|CEACAM16|CEACAM18|CEACAM19|CEACAM20|CEACAM21|CEACAM3|CEACAM4|CEACAM5|CEACAM6|CEACAM7|CEACAM8|CEBPA|CEBPG|CELF5|CEP89|CERS1|CERS4|CFD|CGB1|CGB2|CGB3|CGB5|CGB7|CGB8|CHAF1A|CHERP|CHST8|CIB3|CIC|CILP2|CIMAP1D|CIRBP|CKM|CLASRP|CLC|CLDND2|CLEC11A|CLEC17A|CLEC4G|CLEC4M|CLIP3|CLPP|CLPTM1|CNFN|CNN1|CNN2|CNOT3|COL5A3|COLGALT1|COMP|COPE|COQ8B|ZNF607|ZNF610|ZNF611|ZNF613|ZNF614|ZNF615|ZNF616|ZNF625|ZNF626|ZNF627|ZNF628|ZNF649|ZNF653|ZNF665|ZNF667|ZNF671|ZNF675|ZNF676|ZNF677|ZNF681|ZNF682|ZNF69|ZNF699|ZNF700|ZNF701|ZNF708|ZNF709|ZNF71|ZNF714|ZNF726|ZNF728|ZNF729|ZNF730|ZNF737|ZNF749|ZNF761|ZNF763|ZNF765|ZNF766|ZNF77|ZNF772|ZNF773|ZNF776|ZNF780A|ZNF780B|ZNF781|ZNF784|ZNF787|ZNF790|ZNF791|ZNF792|ZNF793|ZNF799|ZNF8|ZNF805|ZNF808|ZNF813|ZNF814|ZNF816|ZNF816-ZNF321P|ZNF823|ZNF829|ZNF83|ZNF835|ZNF836|ZNF837|ZNF841|ZNF844|ZNF845|ZNF846|ZNF85|ZNF850|ZNF865|ZNF875|ZNF878|ZNF880|ZNF888|ZNF90|ZNF91|ZNF93|ZNF98|ZNF99|ZNRF4|ZSCAN1|ZSCAN18|ZSCAN22|ZSCAN4|ZSCAN5A|ZSCAN5B|ZSWIM4|ZSWIM9		See cases	VCV000443499	19	260912 - 58956888			443499	437161			copy number gain		Pathogenic	Jul 14, 2015	no assertion criteria provided							
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888)x3	TMC4|TMED1|TMEM143|KLK13|KLK14|KLK15|KLK2|KLK3|KLK4|KLK5|KLK6|KLK7|KLK8|KLK9|KMT2B|KMT5C|KPTN|KRI1|KRTDAP|KXD1|LAIR1|LAIR2|LDLR|LENG1|LENG8|LENG9|LEUTX|LGALS13|LGALS14|LGALS16|LGALS4|LGALS7|LGALS7B|LGI4|LHB|LIG1|LILRA1|LILRA2|LILRA3|LIM2|LILRA4|LILRA5|LILRA6|LILRB1|LILRB2|LILRB3|LILRB4|LILRB5|LIN37|LIN7B|LINGO3|LIPE|LMNB2|LMTK3|LONP1|LPAR2|LRFN1|LRFN3|LRG1|LRP3|LRRC25|LRRC4B|LRRC8E|LSM14A|LSM4|LSM7|LSR|LTBP4|LYL1|LYPD3|LYPD4|LYPD5|MADCAM1|MAG|MAMSTR|MAN2B1|MAP1S|MAP2K2|MAP2K7|MAP3K10|MAP4K1|MARCHF2|MARK4|MAST1|MAST3|MATK|MAU2|MBD3|MBD3L1|MBD3L2|MBD3L3|MBD3L4|MBD3L5|MBOAT7|MCEMP1|MCOLN1|MED16|MED25|MED26|MED29|MEF2B|MEGF8|MEIS3|MEX3D|MFSD12|MIA|MICOS13|MIDN|MIER2|MIR125A|MIR150|MIR181C|MIR1909|MIR199A1|MIR23A|MIR24-2|MIR27A|MIR371A|MIR372|MIR373|MIR519D|MIR520H|MIR99B|MIRLET7E|MISP|MKNK2|MLLT1|MOB3A|MPND|MPV17L2|MRI1|MRPL34|MRPL4|MRPL54|MRPS12|MUC16|MVB12A|MYADM|MYBPC2|MYDGF|MYH14|MYO1F|MYO9B|MYPOP|NACC1|NANOS2|NANOS3|NAPA|NAPSA|NAT14|NCAN|NCCRP1|NCLN|NFIC|NFIX|NCR1|NDUFA11|NDUFA13|NDUFA3|NDUFA7|NDUFB7|NDUFS7|NECTIN2|NFKBIB|NFKBID|NIBAN3|NKG7|NKPD1|NLRP11|NLRP12|NLRP13|NLRP2|NLRP4|NLRP5|NLRP7|NLRP8|NLRP9|NMRK2|NOP53|NOSIP|NOTCH3|NOVA2|NPAS1|NPHS1|NR1H2|NR2C2AP|NR2F6|NRTN|NTF4|NTN5|NUCB1|NUDT19|NUMBL|NUP62|NWD1|NXNL1|OAZ1|OCEL1|ODAD1|ODAD3|OLFM2|ONECUT3|OPA3|OR10H1|OR10H2|OR10H3|OR10H4|OR10H5|OR1I1|OR1M1|OR2Z1|OR7A10|OR7A17|OR7A5|OR7C1|OR7C2|OR7D2|OR7D4|OR7E24|OR7G1|OR7G2|OR7G3|OSCAR|OVOL3|P2RY11|PAF1|PAFAH1B3|PAK4|PALM|PALM3|PBX4|PCP2|PCSK4|PDCD2L|PDCD5|PDE4A|PDE4C|PEAK3|PEG3|PEPD|PET100|PEX11G|PGLS|PGLS-DT|PGLYRP1|PGLYRP2|PGPEP1|PHLDB3|PIAS4|PIH1D1|PIK3R2|PIN1|PINLYP|PIP5K1C|PKN1|PLA2G4C|PLAUR|PLD3|PLEKHA4|PLEKHF1|PLEKHG2|PLEKHJ1|PLIN3|PLIN4|PLIN5|PLK5|PLPP2|PLPPR3|PLVAP|PNKP|PNMA8A|PNMA8B|PNPLA6|PODNL1|POLD1|POLR1G|POLR2E|POLR2I|POLRMT|POP4|POU2F2|PPAN|PPAN-P2RY11|PPFIA3|PPM1N|PPP1R12C|PPP1R13L|PPP1R14A|PPP1R15A|PPP1R37|PPP2R1A|PPP5C|PPP5D1|PPP6R1|PRAM1|PRDX2|PRG1|PRKACA|PRKCG|PRKCSH|PRKD2|PRMT1|PRODH2|PROSER3|PRSS57|PRPF31|PRR12|PRR19|PRR22|PRRG2|PRTN3|PRX|PSENEN|PSG1|PSG11|PSG2|PSG3|PSG4|PSG5|PSG6|PSG7|PSG8|PSG9|PSMC4|PSMD8|PSPN|PTBP1|PTGER1|PTGIR|PTH2|PTOV1|PTOV1-AS2|PTPRH|PTPRS|PVR|PWWP3A|QPCTL|QTRT1|R3HDM4|RAB11B|RAB3A|RAB3D|RAB4B|RAB8A|RABAC1|RAD23A|RANBP3|RASAL3|RASGRP4|RASIP1|RAVER1|RAX2|RBM42|RCN3|RDH13|RDH8|REEP6|RELB|RETN|REX1BD|REXO1|RFPL4A|RFPL4AL1|RFX1|RFX2|RFXANK|RGL3|RGS9BP|RHPN2|RINL|RLN3|RNASEH2A|RNF126|RPL13A|RPL18|RPL18A|RPL28|RPL36|RPS11|RPS15|RPS16|RPS19|RPS28|RPS5|RPS9|RRAS|RSPH6A|RTBDN|RTN2|RUVBL2|RYR1|S1PR2|S1PR4|S1PR5|SAE1|SAFB|SAFB2|SAMD1|SAMD4B|SARS2|SAXO5|SBK2|SBNO2|SBSN|SCAF1|SCAMP4|SCGB2B2|SCN1B|SDHAF1|SELENOV|SELENOW|SEMA6B|SERTAD1|SERTAD3|SF3A2|SGTA|SH2D3A|SH3GL1|SHANK1|SHC2|SHD|SHFL|SHISA7|SHKBP1|SIGLEC10|SIGLEC11|SIGLEC12|SIGLEC14|SIGLEC5|SIGLEC6|SIGLEC7|SIGLEC8|SIGLEC9|SIGLECL1|SIN3B|SIPA1L3|SIRT2|SIRT6|SIX5|SLC17A7|SLC1A5|SLC1A6|SLC25A23|SLC25A41|SLC25A42|SLC27A1|SLC35E1|SLC39A3|SLC44A2|SLC5A5|SLC6A16|SLC7A10|SLC7A9|SLC8A2|SMARCA4|SMG9|SMIM17|SMIM24|SMIM7|SNAPC2|SNRNP70|SNRPA|SNRPD2|SPACA4|SPC24|SPHK2|SPIB|SPINT2|SPMAP2|SPPL2B|SPRED3|SPTBN4|SRRM5|SSBP4|SSC5D|STAP2|STK11|STRN4|STX10|STXBP2|SUGP1|SUGP2|SULT2A1|SULT2B1|SUPT5H|SWSAP1|SYCE2|SYCN|SYDE1|SYMPK|SYNE4|SYNGR4|SYT3|SYT5|TARM1|TBC1D17|TBCB|TBXA2R|TCF3|TDRD12|TEAD2|TECR|TEKTIP1|TEKTL1|TEX101|TFPT|TGFB1|TGFBR3L|THAP8|THOP1|TICAM1|TIMM13|TIMM29|TIMM44|TIMM50|TINCR|TJP3|TLE2|TLE5|TLE6|TM6SF2|TMEM145|TMEM147|TMEM150B|TMEM160|TMEM161A|TMEM190|TMEM205|TMEM221|TMEM238|A1BG|ABCA7|ABHD17A|ABHD8|ACER1|ACP4|ACP5|ACP7|ACSBG2|ACTL9|ACTMAP|ACTN4|ADAMTS10|ADAMTSL5|ADAT3|ADGRE1|ADGRE2|ADGRE3|ADGRE5|ADGRL1|ADM5|AKAP8|AKAP8L|AKT1S1|AKT2|ALDH16A1|ALKBH6|ALKBH7|AMH|ANGPTL4|ANGPTL6|ANGPTL8|ANKLE1|ANKRD24|ANKRD27|ANO8|AP1M1|AP1M2|AP2A1|AP2S1|AP3D1|APBA3|APC2|APLP1|APOC1|APOC2|APOC4|APOE|ARHGAP33|ARHGAP35|ARHGAP45|ARHGEF1|ARHGEF18|ARID3A|ARMC6|ARRDC2|ARRDC5|ASF1B|ASPDH|ATCAY|ATF5|ATG4D|ATP13A1|ATP1A3|ATP4A|ATP5F1D|ATP8B3|AURKC|AXL|AZU1|B3GNT3|B3GNT8|B9D2|BABAM1|BAX|BBC3|BCAM|BCAT2|BCKDHA|BCL2L12|BCL3|BEST2|BICRA|BLOC1S3|BLVRB|BORCS8|BRD4|BRME1|BRSK1|BSG|BSPH1|BST2|BTBD2|C19orf12|C19orf18|C19orf25|C19orf33|C19orf38|C19orf44|C19orf47|C19orf53|C19orf67|C19orf73|C19orf81|C2CD4C|C3|C5AR1|C5AR2|CA11|CABP5|CACNA1A|CACNG6|CACNG7|CACNG8|CACTIN|CADM4|CALM3|CALR|CALR3|CAMSAP3|CAPN12|CAPNS1|CAPS|CARD8|CARM1|CASP14|CATSPERD|CATSPERG|CBARP|CBLC|CC2D1A|CCDC106|CCDC124|CCDC159|CCDC61|CCDC8|CCDC9|CCDC97|CCL25|CCNE1|CCNP|CD177|CD209|CD22|CD320|CD33|CD37|CD70|CD79A|CDC34|CDC37|CDC42EP5|CDKN2D|CEACAM1|CEACAM16|CEACAM18|CEACAM19|CEACAM20|CEACAM21|CEACAM3|CEACAM4|CEACAM5|CEACAM6|CEACAM7|CEACAM8|CEBPA|CEBPG|CELF5|CEP89|CERS1|CERS4|CFD|CGB1|CGB2|CGB3|CGB5|CGB7|CGB8|CHAF1A|CHERP|CHST8|CIB3|CIC|CILP2|CIMAP1D|CIRBP|CKM|CLASRP|CLC|CLDND2|CLEC11A|CLEC17A|CLEC4G|CLEC4M|CLIP3|CLPP|CLPTM1|CNFN|CNN1|CNN2|CNOT3|COL5A3|COLGALT1|COMP|COPE|COQ8B|COX6B1|COX6B2|COX7A1|CPAMD8|CPT1C|CRB3|CREB3L3|CRLF1|CRTC1|CRX|CSNK1G2|CTU1|CTXN1|CXCL17|CYP2A13|CYP2A6|CYP2A7|CYP2B6|CYP2F1|CYP2S1|CYP4F11|CYP4F12|CYP4F2|CYP4F22|CYP4F3|CYP4F8|CYTH2|DACT3|DAND5|DAPK3|DAZAP1|DBP|DCAF15|DDA1|DDX39A|DDX49|DEDD2|DENND1C|DHDH|DHPS|DHX34|DIRAS1|DKKL1|DLL3|DMAC2|DMKN|DMPK|DMRTC2|DMWD|DNAAF3|DNAJB1|DNASE2|DNM2|DNMT1|DOCK6|DOHH|DOT1L|DPF1|DPP9|DPRX|DPY19L3|DUS3L|DUXA|DYRK1B|EBI3|ECH1|ECSIT|EEF2|EFNA2|EGLN2|EHD2|EID2|EID2B|EIF3G|EIF3K|ELANE|ELAVL1|ELAVL3|ELL|ELOF1|ELSPBP1|EMC10|EML2|EMP3|EPHX3|EPN1|EPOR|EPS15L1|EPS8L1|ERCC1|ERCC2|ERF|ERICH4|ERVV-1|ERVV-2|ETFB|ETHE1|ETV2|EVI5L|EXOC3L2|EXOSC5|F2RL3|FAAP24|FAM174C|FAM187B|FAM32A|FAM83E|FAM98C|FARSA|FBL|FBN3|FBXL12|FBXO17|FBXO27|FBXO46|FBXW9|FCAR|FCER2|FCGBP|FCGRT|FCHO1|FDX2|FEM1A|FFAR1|FFAR2|FFAR3|FGF21|FGF22|FIZ1|FKBP8|FKRP|FLT3LG|FOSB|FOXA3|FPR1|FPR2|FPR3|FSD1|FSTL3|FTL|FUT1|FUT2|FUT3|FUT5|FUT6|FUZ|FXYD1|FXYD3|FXYD5|FXYD7|FZR1|GADD45B|GADD45GIP1|GALP|GAMT|GAPDHS|GARIN5A|GARIN5B|GARRE1|GATAD2A|GCDH|GDF1|GDF15|GEMIN7|GET3|GGN|GIPC1|GIPC3|GIPR|GMFG|GMIP|GNA11|GNA15|GNG7|GNG8|GP6|GPATCH1|GPI|GPR108|GPR32|GPR4|GPR42|GPX4|GRAMD1A|GRIK5|GRIN2D|GRIN3B|GRWD1|GSK3A|GTF2F1|GTPBP3|GYS1|GZMM|HAMP|HAPLN4|HAS1|HAUS5|HAUS8|HCN2|HCST|HIF3A|HIPK4|HMG20B|HNRNPL|HNRNPM|HNRNPUL1|HOMER3|HOOK2|HPN|HRC|HSD11B1L|HSD17B14|HSH2D|HSPB6|HSPBP1|ICAM1|ICAM3|ICAM4|ICAM5|IER2|IFI30|IFNL1|IFNL2|IFNL3|IGFL1|IGFL2|IGFL3|IGFL4|IGFLR1|IGLON5|IGSF23|IL11|IL12RB1|IL27RA|IL4I1|ILF3|ILVBL|INAFM1|INSL3|INSR|IQCN|IRF2BP1|IRF3|IRGC|IRGQ|ISOC2|ISYNA1|ITPKC|IZUMO1|IZUMO2|IZUMO4|JAK3|JOSD2|JSRP1|JUNB|JUND|KANK2|KANK3|KASH5|KCNA7|KCNC3|KCNJ14|KCNK6|KCNN1|KCNN4|KCTD15|KDELR1|KDM4B|KEAP1|KHSRP|KIRREL2|KISS1R|KLC3|KLF1|KLF16|KIR2DL1|KIR2DL3|KIR2DL4|KIR2DS4|KIR3DL1|KIR3DL2|KIR3DL3|KLF2|KLHL26|KLK1|KLK10|KLK11|KLK12|TMEM259|TMEM38A|TMEM59L|TMEM86B|TMEM91|TMIGD2|TMPRSS9|TNFAIP8L1|TNFSF14|TNFSF9|TNNI3|TNNT1|TNPO2|TOMM40|TPGS1|TPM4|TPRX1|TRAPPC5|TRAPPC6A|TRIP10|TRIR|TRMT1|TRPM4|TRU-TCA1-1|TSEN34|TSHZ3|TSKS|TSPAN16|TSSK6|TTC9B|TTYH1|TUBB4A|TULP2|TYK2|TYROBP|U2AF1L4|U2AF2|UBA2|UBA52|UBE2S|UBL5|UBXN6|UCA1|UHRF1|UNC13A|UPF1|UPK1A|UQCR11|UQCRFS1|URI1|USE1|USF2|USHBP1|USP29|VASP|VAV1|VMAC|VN1R1|VN1R2|VN1R4|VRK3|VSIG10L|VSTM1|VSTM2B|WDR18|WDR62|WDR83|WDR83OS|WDR87|WDR88|WIZ|WTIP|XAB2|XRCC1|YIF1B|YIPF2|YJEFN3|YJU2|YJU2B|ZBTB32|ZBTB7A|ZC3H4|ZFP14|ZFP28|ZFP30|ZFP36|ZFP82|ZFR2|ZGLP1|ZIK1|ZIM2|ZIM2-AS1|ZIM3|ZNF100|ZNF101|ZNF112|ZNF114|ZNF121|ZNF132|ZNF134|ZNF135|ZNF136|ZNF14|ZNF146|ZNF154|ZNF155|ZNF160|ZNF17|ZNF175|ZNF177|ZNF180|ZNF181|ZNF20|ZNF208|ZNF211|ZNF221|ZNF222|ZNF223|ZNF224|ZNF225|ZNF226|ZNF227|ZNF229|ZNF230|ZNF233|ZNF234|ZNF235|ZNF253|ZNF254|ZNF256|ZNF257|ZNF260|ZNF264|ZNF266|ZNF274|ZNF28|ZNF283|ZNF284|ZNF285|ZNF296|ZNF30|ZNF302|ZNF304|ZNF317|ZNF320|ZNF329|ZNF331|ZNF333|ZNF345|ZNF347|ZNF350|ZNF358|ZNF382|ZNF383|ZNF404|ZNF414|ZNF415|ZNF416|ZNF417|ZNF418|ZNF419|ZNF420|ZNF426|ZNF428|ZNF429|ZNF43|ZNF430|ZNF431|ZNF432|ZNF433|ZNF439|ZNF44|ZNF440|ZNF441|ZNF442|ZNF443|ZNF444|ZNF45|ZNF460|ZNF461|ZNF468|ZNF470|ZNF471|ZNF473|ZNF480|ZNF486|ZNF490|ZNF491|ZNF492|ZNF493|ZNF497|ZNF506|ZNF507|ZNF524|ZNF526|ZNF527|ZNF528|ZNF529|ZNF530|ZNF534|ZNF536|ZNF540|ZNF541|ZNF543|ZNF544|ZNF546|ZNF547|ZNF548|ZNF549|ZNF550|ZNF551|ZNF552|ZNF554|ZNF555|ZNF556|ZNF557|ZNF558|ZNF559|ZNF559-ZNF177|ZNF560|ZNF561|ZNF562|ZNF563|ZNF564|ZNF565|ZNF566|ZNF567|ZNF568|ZNF569|ZNF570|ZNF571|ZNF573|ZNF574|ZNF575|ZNF576|ZNF577|ZNF578|ZNF579|ZNF580|ZNF581|ZNF582|ZNF583|ZNF584|ZNF585A|ZNF585B|ZNF586|ZNF587|ZNF587B|ZNF599|ZNF600|ZNF606|ZNF607|ZNF610|ZNF611|ZNF613|ZNF614|ZNF615|ZNF616|ZNF625|ZNF626|ZNF627|ZNF628|ZNF649|ZNF653|ZNF665|ZNF667|ZNF671|ZNF675|ZNF676|ZNF677|ZNF681|ZNF682|ZNF69|ZNF699|ZNF700|ZNF701|ZNF708|ZNF709|ZNF71|ZNF714|ZNF726|ZNF728|ZNF729|ZNF730|ZNF737|ZNF749|ZNF761|ZNF763|ZNF765|ZNF766|ZNF77|ZNF772|ZNF773|ZNF776|ZNF780A|ZNF780B|ZNF781|ZNF784|ZNF787|ZNF790|ZNF791|ZNF792|ZNF793|ZNF799|ZNF8|ZNF805|ZNF808|ZNF813|ZNF814|ZNF816|ZNF816-ZNF321P|ZNF823|ZNF829|ZNF83|ZNF835|ZNF836|ZNF837|ZNF841|ZNF844|ZNF845|ZNF846|ZNF85|ZNF850|ZNF865|ZNF875|ZNF878|ZNF880|ZNF888|ZNF90|ZNF91|ZNF93|ZNF98|ZNF99|ZNRF4|ZSCAN1|ZSCAN18|ZSCAN22|ZSCAN4|ZSCAN5A|ZSCAN5B|ZSWIM4|ZSWIM9		See cases	VCV000443498	19	260912 - 58956888			443498	437160			copy number gain		Pathogenic	Dec 2, 2014	no assertion criteria provided							
JAK3, 151-BP DEL	JAK3		T-B+ severe combined immunodeficiency due to JAK3 deficiency	VCV000009361					9361	24400			Deletion		Pathogenic	Sep 7, 1995	no assertion criteria provided							
